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ABSTRACT 
 
Regulation of blood pressure is a complex interplay between several haemodynamic 
mechanisms, but only resting blood pressure and heart rate are commonly measured 
in clinical practice to determine a patient’s haemodynamic status. However, the value 
of single blood pressure measurements as diagnostic tests has recently been 
questioned. In addition, changes in for example arterial compliance, endothelial 
function, or the regulation of vascular resistance can already be measured before 
clinical manifestations of cardiovascular disease.  
 
The aim of the present study was to test the repeatability and reproducibility of a 
comprehensive haemodynamic measurement protocol in both supine position and 
during head-up tilt. In addition, the effects on two largely endothelium-dependent 
agents, inhaled salbutamol and intravenous L-arginine, and one endothelium-
independent agent, sublingual nitroglycerin, were investigated, and the 
haemodynamic mechanism of nitrate-induced presyncope were examined. Moreover, 
the age-related haemodynamic changes, supine and upright, in normotensive subjects 
were clarified. Finally, the application was tested in patients with either essential 
hypertension or metabolic syndrome. 
 
Non-invasive haemodynamic measurements were performed by applying whole body 
impedance cardiography, continuous pulse wave analysis and plethysmographic 
finger blood pressure measurements in supine position and during head-up tilt. Thus, 
peripheral and central blood pressure, indices of pulse wave reflection, pulse wave 
velocity, vascular resistance, and cardiac function could be simultaneously assessed. 
Repeated measurements were performed to test the repeatability and reproducibility 
of the method, and to study the drug effects in a placebo-controlled manner. All study 
subjects, except for the subjects included in the testing of the method’s clinical 
application, were normotensive and had no medication affecting cardiovascular status. 
 
The measurement protocol was repeatable and reproducible in both supine position 
and during head-up tilt. Inhaled salbutamol decreased blood pressure, vascular 
resistance and augmentation index, while heart rate and cardiac output were 
increased. Sublingual nitroglycerin clearly decreased blood pressure, vascular 
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resistance, augmentation index and pulse wave velocity, and increased heart rate and 
cardiac output. Importantly, the haemodynamic effects of nitroglycerin were 
enhanced during the head-up tilt, while the salbutamol effects were more evident in 
the supine position. Intravenous L-arginine resulted in decreased blood pressure and 
increased aortic reflection time only during the tilt. During nitrate-induced 
presyncope, reduced vascular resistance was observed. Increasing age from 20 to 60 
years was associated with increased arterial stiffness and wave reflection, while no 
changes were observed in cardiac function or vascular resistance. A more pronounced 
decrease in central systolic blood pressure in response to tilt was associated with 
increased age and arterial stiffness. Subjects with metabolic syndrome had higher 
heart rate and arterial stiffness than hypertensive subjects, despite similar elevation of 
blood pressure and vascular resistance. These results suggest more widespread 
changes in cardiovascular status than just elevated blood pressure in metabolic 
syndrome. 
 
In conclusion, the present measurement protocol enables a detailed characterization of 
patients’ haemodynamic profile, including the assessment of the role of the 
endothelium in vascular responsiveness. The divergent effects of research drugs in 
different postures, and the age-related changes in haemodynamic responsiveness to 
head-up tilt underlie the importance to study upright haemodynamics.
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TIIVISTELMÄ 
 
Hyvin moni rakenteellinen ja toiminnallinen tekijä osallistuu ihmisen verenpainetason 
säätelyyn. Kliinisessä työssä tyydytään kuitenkin usein verenpaineen ja syketason 
määrittämiseen levossa, vaikka kertamittausten arvo kohonneen verenpaineen 
diagnostiikassa onkin viime aikoina kyseenalaistettu. Myös muutoksia mm. 
endoteelin toiminnassa, valtimokomplianssissa ja ääreisverenkierron vastuksen 
säätelyssä on mahdollista todeta jo ennen tautitapahtumien ilmaantumista. 
Tutkimuksen tarkoituksena oli kehittää toistettava ja monipuolinen sydän- ja 
verenkiertoelimistön mittausmenetelmä, jossa hemodynaamisia muuttujia mitataan 
sekä makuulla että kallistuskokeen aikana. Lisäksi tutkittiin kahden pääasiassa 
endoteelivälitteisen lääkeaineen, inhaloidun salbutamolin ja suonensisäisen L-
arginiinin, ja yhden endoteelista riippumattoman, sublinguaalisen nitroglyseriinin, 
hemodynaamisia vaikutuksia, sekä nitroglyseriinin aiheuttaman presynkopeen 
hemodynaamisia mekanismeja. Tutkimuksessa selvitettiin myös ikääntymiseen 
liittyviä sydän- ja verenkiertoelimistön muutoksia. Menetelmää testattiin metabolista 
oireyhtymää ja essentielliä verenpainetautia saitastavilla potilailla. 
 
Kajoamattomat hemodynamiikan mittaukset suoritettiin sekä levossa että passiivisen 
kallistuskokeen aikana koko kehon impedanssikardiografiaa, jatkuvaa 
pulssiaaltoanalyysiä ja pletysmografista sormiverenpaineen mittausta käyttäen. 
Samanaikaisesti mitattavia muuttujia olivat perifeerinen ja aorttatason verenpaine, 
pulssiaallon heijastumisesta kertovat suureet, pulssiaallon etenemisnopeus, 
ääreisverenkierron vastus sekä sydämen isku- ja minuuttitilavuus. Toistettuja 
mittauksia suoritettiin menetelmän toistettavuuden ja lumelääkekontrolloitujen 
lääkevasteiden määrittämiseksi. Kaikilla tutkimushenkilöillä, lukuunottomatta 
metabolista oireyhtymää tai verenpainetautia sairastavia, oli normaali verenpaine, eikä 
heillä ollut käytössä hemodynamiikkaan vaikuttavia lääkeaineita. 
 
Mittaukset olivat toistettavia sekä makuulla että kallistuskokeen aikana. Salbutamoli-
inhalaatio laski verenpainetta, ääreisvastusta ja augmentaatioindeksiä, sekä nosti 
sykettä ja sydämen minuuttitilavuutta. Sublinguaalinen nitroglyseriini laski 
huomattavasti verenpainetta, ääreisvastusta, augmentaatioindeksiä ja pulssiaallon 
etenemisnopeutta, ja syke sekä sydämen minuuttitilavuus kasvoivat. Salbutamolin 
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aiheuttamat muutokset korostuivat makuuasennossa, kun taas vaste nitroglyseriinille 
on selvempi kallistuskokeen aikana. Suonensisäinen L-arginiini aiheutti verenpaineen 
laskun ja pulssiaallon takaisinheijastuma-ajan kasvun kallistuskokeen aikana.  
 
Nitroglyseriinin aiheuttaman presynkopeen aikana havaittiin selvästi vähentynyt 
ääreisverenkierron vastus. Valtimojäykkyys ja pulssiaallon takaisinheijastuminen 
lisääntyivät iän myötä, mutta ääreisvastus ja sydämen pumppaustoiminta eivät 
muuttuneet. Suurempi aorttatason systolisen verenpaineen lasku kallistuskokeessa 
liittyi korkeampaan ikään ja suurempaan pulssiaallon etenemisnopeuteen. Metabolista 
oireyhtymää sairastavilla potilailla oli korkeampi syketaso ja pulssiaallon 
etenemisnopeus kuin verenpainetautia sairastavilla, vaikka verenpainetaso ja 
ääreisvastus eivät eronneet merkittäväst. Tulos osoittaa, että tutkituilla potilasryhmillä 
on verenpainetasosta riippumattomia eroja verenkiertoelimistön rakenteessa ja 
toiminnassa. 
 
Mittausmenetelmä on kajoamaton ja toistettava, ja mahdollistaa entistä tarkemman 
sydän- ja verenkiertoelimistön toiminnan määrittämisen. Metelmän avulla voidaan 
arvioida myös endoteelin osuutta hemodynamiikan säätelyssä. Tulokset korostavat 
pystyasennossa suoritettavien mittausten tärkeyttä, koska lääkevasteet ja 
ikääntymiseen liittyvät muutokset olivat erilaisia makuulla ja kallistuskokeessa. 
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INTRODUCTION 
 
Elevated blood pressure (BP) and related cardiovascular complications are the leading 
causes of morbidity and mortality in the modern world (Ezzati et al. 2002). Thus, 
effective antihypertensive medication is widely available, and the target level of BP is 
set lower than ever. However, a significant part of hypertensive patients fail to reach 
the intended BP level despite active treatment. For example, only 50% of the subjects 
with elevated BP in single measurements were aware of the disorder, and only 25-
30% of hypertensive patients receiving antihypertensive medication reached the BP 
goal in a Finnish population study (Antikainen et al. 2006). Besides hypertension, also 
other measurable haemodynamic factors, like increased arterial stiffness or impaired 
endothelial function, have been associated with poor cardiovascular outcome (Laurent 
et al. 2001, Fichtlscherer et al. 2004).  
 
Currently, the diagnosis of hypertension is based on the average values of the repeated  
clinic or home BP measurements, and ambulatory 24-hour BP recording including 
several measurements is applied to selected patients (Mancia et al. 2007). However, 
according to a recent meta-analysis, single BP measurements have insufficient 
sensitivity and specificity as a diagnostic test of hypertension when compared with 
ambulatory recordings (Hodgkinson et al. 2011). Importantly, the knowledge of 
patients’ BP and heart rate (HR) level only, either from single resting measurements 
or from ambulatory recordings, provides limited information about the functional 
haemodynamic status.  
 
The haemodynamic changes resulting in elevated BP may differ substantially between 
patients and disorders. Systemic vascular resistance (SVR) is considered to be 
elevated in essential hypertension (Omvik et al. 2000), while changes in fluid- and 
electrolyte balance are common in chronic kidney disease (Luke 1998). In addition, 
decreased large arterial compliance is associated with various cardiovascular 
disorders, as well as to normal vascular ageing (McEniery et al. 2005, Greenwald 
2007). Antihypertensive medication aims to reduce vascular resistance, left 
ventricular preload, and to improve arterial compliance, but the treatment decisions 
and the assessment of treatment effects are solely based on the BP level. The 
assessment of individual haemodynamic profile beyond elevated BP could aid the 
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physicians to design and follow-up the antihypertensive treatment.  For example, 
measurement of cardiac function and vascular resistance by non-invasive impedance 
cardiography (ICG) before antihypertensive treatment has been shown to improve the 
treatment results when compared with conventionally selected antihypertensive 
medication (Smith et al. 2006). 
 
Traditionally, patients are instructed to rest about 15 minutes before BP measurement 
(Mancia et al. 2007). However, humans spend a great proportion of the waking hours 
in the upright position or in locomotion, which questions the value of measurements 
performed only at rest. Previously, the haemodynamic response to physical challenge 
has been shown to predict cardiovascular outcome. For example, the BP response to 
two-step exercise test strongly predicted the future incidence of hypertension in 
Japanese men (Tsumura et al. 2002). Since the change in body position from supine to 
upright induce significant changes in for example blood volume distribution, 
autonomic nervous tone and cardiac function, it can be considered as a simple 
exercise test (Avolio and Parati 2011).  
 
The aim of the present study was to develop and test a comprehensive haemodynamic 
measurement protocol. The method includes the determination of peripheral and 
central BP, cardiac function, vascular resistance, arterial compliance, indices of pulse 
wave reflection and global endothelial function. Besides the measurements performed 
in the supine position, passive orthostatic challenge is included to the protocol to 
assess functional haemodynamic status.  
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REVIEW OF THE LITERATURE 
 
1. Haemodynamic determinants of blood pressure 
 
1.1. Cardiac function and vascular resistance 
 
As defined in basic physiology, arterial pressure is a balance between blood flow into 
and out of the arteries. Blood flow into the aorta is equal to cardiac output (CO) from 
the left ventricle, while blood flow out of the arteries is mainly influenced by 
resistance to blood flow in arterioles, SVR (Guyton and Hall 2006). CO is defined as 
a product of HR and stroke volume (SV). Stimulation of adrenergic and cholinergic 
receptors of autonomic nervous system influences the HR, while SV is defined by the 
force of ventricular contraction and intravascular fluid volume. Multiple mechanisms 
including structural, neural, humoral and renal factors control the level of SVR 
locally, regionally and systematically (Guyton and Hall 2006). Several 
haemodynamic factors that have an influence on either of the basic determinants of 
BP, CO or SVR, are discussed below.   
 
1.2. Arterial pulse wave form and reflection 
 
1.2.1. Pulse wave form and augmentation 
 
Pulse wave recorded from an artery is a sum of forward pressure wave originating 
from the left ventricle and backward pressure wave reflecting from various reflection 
sites in the circulation. Main sites for wave reflection are branching points in the 
arterial tree, sites where arterial distensibility or lumen cross-sectional area changes, 
and peripheral arterioles with high resistance (Pedley 1980, O'Rourke 1982, Latham 
et al. 1987, Nichols and O'Rourke 1998). Various landmarks are recognizable from 
the pressure waveform, as depicted in Figure 1. Start of the reflected wave can be 
identified in the pressure waveform as an inflection point. In young, compliant 
arteries the velocity of the pulse wave is low and the reflected wave tends to return 
during diastole. In stiffer arteries, the wave reflection occurs already during systole 
while aortic valve is still open. The contribution of the reflected wave to systolic 
pressure is called augmentation pressure (pressure difference of the first and second 
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systolic peaks in the pulse waveform). Augmentation index (AIx) is defined as a ratio 
between augmentation pressure and pulse pressure (PP) (Nichols and O'Rourke 1998).    
 
Figure 1. Pulse wave form  
 
 
 
AP=augmentation pressure, BP= blood pressure, PP=pulse pressure 
 
1.2.2. Amplification 
 
The shape of the pressure pulse originating from the left ventricle is modified as it 
travels through the arterial tree. The pulse waveform features alter, and the amplitude 
increases toward periphery. In young, compliant arteries the systolic peak of the 
peripheral waveform is generally narrower and higher than that of the central arteries, 
while mean BP and diastolic BP remain almost steady (Latham et al. 1985, Pauca et 
al. 1992). This difference in systolic BP and in PP between central and peripheral sites 
is known as amplification (Figure 2). In peripheral arteries, the pulse wave reflection 
sites are closer than in the larger arteries which amplify the pressure wave (Latham et 
al. 1985). Additionally, pulse wave travels faster in stiffer peripheral arteries further 
increasing the amplification.  As the large arteries stiffen, for example with ageing, 
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the amplification phenomenon decreases, thus central and peripheral systolic BPs 
converges.  
 
Figure 2: Variation of pressure wave form along arterial tree; amplification. Modified 
from Protogerou et al. 2007. 
 
 
 
 
1.3. Arterial stiffness 
 
1.3.1. Overview 
 
Arterial distensibility stands for the change in volume or cross-sectional area of a 
vessel for a given change in pressure during cardiac cycle, and arterial stiffness is 
defined by a reduction in arterial distensibility. Young, compliant arteries cushion the 
arterial pulsations so that the flow in the capillary level remains continuous (O'Rourke 
and Hashimoto 2007). Reduced arterial distensibility transfers pulsatile flow further to 
the periphery, which has harmful influences in the microcirculation (O'Rourke and 
Safar 2005). Stiffening of the arteries leads to increased pulse wave velocity (PWV) 
and earlier wave reflection, thus increasing systolic BP and PP and decreasing 
perfusion of the myocardium during the diastole, and increasing the load to left 
ventricle (Nichols and O'Rourke 1998, Mitchell et al. 2004, O'Rourke and Hashimoto 
2007). Additionally, arterial stiffness increases the risk of atherosclerotic plaque 
rupture (Van Bortel 2002). Due to stiffening, arteries undergo a process of 
remodelling to reduce wall stress, leading to intima–media thickening (Dao et al. 
2005). Moreover, endothelial nitric oxide (NO) production is reduced as the shear 
stress rate falls with arterial stiffening, which increases the risk for atheroma 
formation (Soucy et al. 2006). Based on these facts, increased arterial stiffness has 
been recognized as an independent risk factor for cardiovascular mortality and 
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morbidity both in healthy subjects and in subjects with various medical disorders 
(Laurent et al. 2001, Blacher et al. 2002, Safar et al. 2002a, Sutton-Tyrrell et al. 
2005). Harmful effects of arterial stiffening have been presented in Figure 3.  
 
Figure 3.  Typical arterial pulse wave forms in compliant (A) and stiff (B) arteries. 
 
 
Thin black line=forward pressure wave; dashed line=reflecting pressure wave; bold 
line=combined pressure wave  
 
1.3.2. Determinants of arterial stiffness 
 
Structure of the arterial wall 
The molecular, cellular and histological structure of the arterial wall is an important 
determinant of arterial stiffness and it greatly varies along arterial tree. The 
predominant elastic materials of the arterial wall are elastin and collagen, while third 
important component of the arterial wall, smooth muscle, cannot be regarded as true 
elastic material (Nichols and O'Rourke 1998). In the proximal, large arteries elastin is 
the dominant component, while in the distal arteries collagen dominates. The elastic 
modulus of collagen is significantly higher than that of elastin, which results to 
increased arterial stiffness in distal arteries (Armentano et al. 1991). As a result, PWV 
increases from 4-5 m/s in the aorta to 8-9 m/s in the peripheral arteries (Latham et al. 
1985, Nichols and O'Rourke 1998). 
 
Age 
Ageing is associated with progressive structural and functional changes in the 
cardiovascular system. With increasing age large arteries dilate and stiffen as a result 
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of thickening of the intima, reduced elastin content and vascular smooth muscle cell 
number, and increased collagen composition in the vessel wall (Greenwald 2007, 
O'Rourke and Hashimoto 2007). The elastin lamellae undergo structural changes with 
age, showing signs of fragmentation, disorganisation and calcification (O'Rourke 
1976). These changes are apparent especially in large arteries, while aging does not 
seem to affect the mechanical properties of smaller, muscular arteries to the same 
extent probably due to different morphology (Smulyan et al. 1983, Kawasaki et al. 
1987, Bortolotto et al. 1999). The relationship between large arterial stiffening and 
age has documented to be non-linear with an acceleration of age-related aortic 
stiffening after the 5th decade of life (McEniery et al. 2005). 
 
Cardiovascular risk factors and disorders 
Several cardiovascular risk factors and diseases are known to cause similar 
morphological changes in arterial wall as ageing, further accelerating arterial 
stiffening. Hypertension has been shown to be associated with increased large artery 
stiffness when compared with age-matched normotensive subjects (Bouthier et al. 
1985, Liu et al. 1989, Benetos et al. 2002, Greenwald 2007). On the other hand, the 
incidence of hypertension is increased in normotensive subjects with greater large 
arterial stiffness (Liao et al. 1999, Dernellis and Panaretou 2005). Different stages of 
chronic kidney disease has been linked to large and peripheral muscular arterial 
stiffening (Wang et al. 2005, Briet et al. 2006, Lacy et al. 2006), and an inverse 
relationship between aortic and radial arterial stiffness and glomerular filtration rate 
(GFR) has been documented in hypertensive subjects with normal renal function 
(Schillaci et al. 2006). Furthermore, level of fasting plasma glucose has been shown to 
correlate with indices of arterial stiffness in population studies (Salomaa et al. 1995, 
Sipila et al. 2007), and the association between arterial stiffness and Type 1 and 2 
diabetes has been repeatedly demonstrated (Oxlund et al. 1989, McVeigh et al. 1993, 
Taniwaki et al. 1999, Devereux et al. 2000). An association between lipid profile 
abnormalities and arterial stiffening has been demonstrated in some studies (Riggio et 
al. , Juonala et al. 2005), while others have shown no correlation (Saba et al. 1999).  
In addition, other classic risk factors of cardiovascular disease, like increased waist 
circumference, body mass index (BMI) and smoking have been linked to large arterial 
stiffening (Liang et al. 2001, Schillaci et al. 2005).  
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1.4. Autonomic nervous system 
 
It is widely acknowledged that the autonomic nervous system and its sympathetic arm 
have an important role in the short-term regulation of BP via baroreflex mechanisms 
responding to rapid changes in arterial pressure (Cowley et al. 1973). However, the 
role of sympathetic activation in the long-term regulation of BP is a more 
controversial issue. Sympathetic outflow, estimated by the measurement of muscle 
sympathetic nerve activity (MSNA), is not clearly associated with baseline BP levels 
since high MSNA levels have also been demonstrated in normotensive subjects 
(Charkoudian et al. 2005), and the rise in MSNA associated to elevated BP is only 
modest (Floras and Hara 1993). In younger men, an inverse relationship between 
MSNA and both CO and adrenergic sensitivity has been suggested as an explanation 
for the overlap in MSNA distribution between normotensive and hypertensive 
subjects (Charkoudian et al. 2005, Charkoudian et al. 2006). In addition, high MSNA 
is associated with increased endothelial NO release in young (21-33 years) men 
suggesting that endothelium-mediated vasodilatation might compensate for the 
sympathetically driven vasoconstriction (Charkoudian et al. 2006). Moreover, 
sympathetic activity increases with ageing and the relationship between BP and 
MNSA becomes more evident in individuals aged over 40 years (Narkiewicz et al. 
2005). However, the above mentioned mechanisms explaining interindividual 
variability in MNSA could not be demonstrated in older subjects (Hart et al. 2009).   
 
The balance between sympathetic and parasympathetic tone can also be evaluated by 
measuring HR variability (HRV) at rest or in response to physical or pharmacological 
stimuli (Task Force of the European Society of Cardiology and the North American 
Society of Pacing and Electrophysiology 1996). Low HRV representing decreased 
parasympathetic activity is associated with hypertension and with the risk of 
developing elevated BP (Schroeder et al. 2003). In addition, decreased HRV predicts 
mortality in both high risk and low risk populations (Tsuji et al. 1994, Gerritsen et al. 
2001).  
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1.5.  Vascular endothelium 
 
1.5.1. Role of the endothelium in vascular regulation 
 
Endothelium responds to various physical and chemical signals in the circulation by 
releasing factors that regulate vascular permeability, platelet and leucocyte adhesion 
and aggregation, thrombosis, smooth muscle cell proliferation and vascular tone 
(Landmesser et al. 2004, Rumbaut et al. 2005). An important pathway for 
endothelium-mediated vascular smooth muscle cell relaxation is the activation of the 
enzyme endothelial NO synthase (eNOS) and subsequent release of NO, which in turn 
stimulates gyanylate cyclase in vascular smooth muscle inducing vasorelaxation. 
Essential for this reaction is the increase in calcium (Ca2+) concentration within the 
endothelial cells. Moreover, release of prostacyclin from the endothelial cells 
stimulates adenylate cyclase in the vascular smooth muscle leading to vasorelaxation 
via hyperpolarization (Feletou and Vanhoutte 2006).  In addition, several NO and 
prostacyclin-independent pathways of endothelium-derived vascular relaxation via 
hyperpolarization of smooth muscle have been recognized (Feletou and Vanhoutte 
2006, Deanfield et al. 2007). Briefly, these pathways include an increase in 
intracellurar Ca2+ concentration, activation of calcium-activated potassium (K+) 
channels, and subsequent hyperpolarization of endothelial cells. Hyperpolarization is 
spread to the underlying smooth muscle via myo-endothelial gap junctions or via 
increased K+ concentration in the intercellural space (Feletou and Vanhoutte 2006). 
Such mechanisms can compensate for the loss of NO-mediated vasodilatory capacity 
during various pathophysiological conditions (Halcox et al. 2001). Besides 
vasodilatory effects, endothelium produces vasoconstrictors like endothelin, 
prostaglandin F2α and thromboxane, and converts angiotensin I to vasoconstrictive 
angiotensin II (Saye et al. 1984, Kinlay et al. 2001) thus having a diverse role in 
vascular tone regulation. The most important pathways for endothelium-deriver 
relaxation and contraction are presented in Figure 4, and a schematic view of 
endothelium-derived hyperpolarization of smooth muscle is depicted in Figure 5. 
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Figure 4. Most important pathways for endothelium-derived vascular smooth muscle 
cell relaxation and contraction. 
 
 PG F2α=prostaglandin F2α, TXA2=thromboxane, eNOS=endothelial nitric oxide 
synthase, PGI2= prostacyclin, sGC=soluble guanylate cyclase, GTP=guanosine 
triphosphate, cGMP=cyclic guanosine monophosphate, ATP=adenosine triphosphate, 
cAMP=cyclic adenosine monophosphate  
 
Figure 5. Hyperpolarization of endothelial and vascular smooth muscle cells.  
 
 
EET=epoxyeicosatrienoic acid 
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1.5.2. Endothelial dysfunction 
 
The present view is that endothelial dysfunction is characterized by excessive 
production of reactive oxygen species, which reduce the bioavailability of 
endothelium-derived NO and other vasodilatory autacoids (Rhee 2006). As a result, 
expression and synthesis of proinflammatory and prothrombotic factors and adhesion 
molecules are increased, and the healthy regulation of vascular tone is disturbed 
(Drexler 1997). Impaired endothelial function has been repeatedly demonstrated in 
clinically healthy subjects with cardiovascular risk factors, which indicates that the 
changes in endothelial function already appear in the early stages of atherosclerosis 
(Celermajer et al. 1994, Ross 1999, Hashimoto et al. 2000). Furthermore, endothelial 
dysfunction has been linked to various cardiovascular diseases including 
hypertension, dyslipidaemia, coronary artery disease, peripheral arterial disease and 
diabetes (Creager et al. 1990, Neunteufl et al. 1997, Perticone et al. 1998, Yu et al. 
2001), as well as to future cardiovascular  events in subjects with atherosclerotic risk 
factors, stable ischaemic heart disease and acute coronary syndromes (Perticone et al. 
2001, Fichtlscherer et al. 2004). In hypertensive subjects, improved endothelial 
function with antihypertensive medication has been correlated with a more favourable 
prognosis (Modena et al. 2002).  
 
1.6.  Fluid and electrolyte balance – role of the kidneys 
 
Sodium (Na+) and other anions serve as principal effective osmoles holding water in 
the extracellular space, while K+ acts to hold water within the cells. Thus, the control 
of Na+ balance is essential for the maintenance of the extracellular fluid volume and 
BP, and it is known that excessive dietary Na+ intake is associated with increased BP 
(He and MacGregor 2004). The mechanism pressure natriuresis - pressure diuresis 
can explain how the kidney can alter the level of Na+ and water excretion in response 
to changes in renal arterial pressure (Guyton 1989a). Increased free radical generation 
and oxidative stress in the renal medulla may lead to dysfunction in the pressure 
natriuresis system, thus resulting in Na+ and volume retention, which subsequently 
predisposes to the development of hypertension (Cowley 2008).  In addition, a 
decrease in renal BP stimulates the synthesis and release of renin from the 
juxtaglomerular cells thus activating the renin-angiotensin-aldosterone system, which 
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finally leads to increased Na+ reabsorbtion in the renal tubule. Although multiple 
physiological mechanisms act in response to altered body fluid balance, normally only 
a change in Na+ and water excretion by the kidneys can bring fluid balance and 
arterial pressure back to normal levels, thereby emphasizing the role of kidneys in 
long-term control of BP (Guyton 1989b). 
 
2. Measurement of haemodynamics and haemodynamic reactivity in humans 
 
2.1. Overview 
 
Cardiovascular complications related to elevated BP and other disorders are the 
leading causes of mortality and morbidity in the modern world (Ezzati et al. 2002). As 
discussed previously, various changes in the cardiovascular system can result in 
elevated BP. However, in clinical practice only BP and HR are traditionally 
determined when hypertensive subjects are examined. In addition, the traditional 
measurements are only performed in resting conditions with the subject supine or 
seated, even though humans spend a great proportion of the day in the upright 
position or in locomotion. Ideally, the personal characteristics of the cardiovascular 
system should be determined, so that possible treatment decisions of elevated BP 
could be based on physiological facts, not merely on assumptions. Indeed, it has been 
demonstrated in hypertensive subjects that when the cardiovascular status of a patient 
group was examined in more detail by the use of non-invasive CO and SVR 
determinations, target BP levels could be reached more often than in a conventionally 
treated control study group (Smith et al. 2006). Below, the main methods available for 
the measurement of human haemodynamics are discussed. 
 
2.2. Measurement of cardiac output  
 
2.2.1. Fick Principle and indicator dilution techniques 
 
In 1870, Adolph Fick demonstrated the first technique for CO measuring based on the 
assumption that oxygen consumption of the body is equal to the product of blood flow 
(CO) and arterio-venous oxygen content difference (Cournand et al. 1945). However, 
the direct Fick technique is laborious and prone to errors, requiring pulmonary arterial 
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catheterization and determination of several variables under stable conditions. The 
Fick principle can also be applied to other gasses that diffuse through the lungs, 
especially carbon dioxide (Gueret et al. 2006). 
 
Several indicator dilution techniques have been introduced in the measurement of CO 
so that an indicator is injected and detected downstream of the injection site. Dilution 
signal is processed and CO is computed as a ratio of the indicator dose and area under 
dilution curve. Intermittent pulmonary thermodilution is based on the conservation of 
thermal energy with a bolus of cold saline as an indicator, and the technique has been 
accepted as a clinical standard for CO measurement (Jansen et al. 2001). Continuous 
measurement of CO following the principles of thermodilution can be performed 
using a pulmonary arterial cathether with an embedded heating filament (Yelderman 
1990). The filament releases thermal pulses every 30-60 seconds and the change in 
blood temperature is detected downstream. However, these methods are a source of 
potential serious complications due to pulmonary arterial catheterization. In the 
transpulmonary thermodilution method cold saline is injected to central vein and the 
dilution curve is detected from femoral, axillary or brachial artery (Pauli et al. 2002). 
As a less invasive technique, transpulmonary thermodilution is more widely 
applicable. Finally, injection of small dose of lithium chloride into peripheral vein and 
the detection of dilution curve from the peripheral artery relies on the same principles 
mentioned above (Costa et al. 2008). 
 
2.2.2. Invasive and non-invasive pulse contour methods 
 
There are several commercially available invasive techniques that indirectly estimate 
the CO from arterial pressure pulsation (Table 1). In general, arterial pressure 
waveform is obtained using an intra-arterial pressure sensor in a peripheral artery and 
conducted to a CO-device. Using specific algorithms, individual demographic data or 
calibration measurements with indicator dilution technique, SV and subsequently CO 
is calculated from the pressure wave curve. Pulse contour analysis systems have been 
validated against indicator dilution techniques in several patient groups, and naturally 
the methods utilizing calibration with indicator dilution method have documented the 
best agreement with reference techniques. In general, pulse contour derived 
measurements track the changes in CO relatively well despite the potential error in 
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baseline values (de Wilde et al. 2009). In a recent meta-analysis by Peyton and Chong 
(2010) 59 studies with non-calibrated and calibrated pulse contour CO measurements 
in haemodynamically stable patients were evaluated. Altogether 24 studies were 
included in the meta-analysis, and the percentage error for mean bias was 41.3% 
against thermodilution, while the commonly accepted limit for percentage error 
should be less than 30 %.  
  
Arterial pressure wave input for pulse contour analysis of CO can also be captured 
non-invasively for example using plethysmographic finger BP measurements, which 
track the changes in intra-arterial pressure well (Wesseling et al. 1985). However, the 
systematic difference between intra-arterial and finger BP must be taken into 
consideration in CO determination (Guelen et al. 2008).  Recently, two non-invasive 
pulse contour methods with different equations used in the CO determination were 
evaluated against invasive pulse contour methods and thermodilution (Bogert et al. 
2010). One method calculated SV by dividing the area under the systolic portion of 
the arterial pressure curve by the aortic input impedance, while the other generated 
aortic flow curves constructed from pressure waveforms. The results demonstrated 
that the first method but not the second, had a good agreement with thermodilution 
derived CO-values. Thus, comparison of different methods and software version is 
not without concerns. Major limitations of pulse contour CO are listed in Table 1.  
 
2.2.3. Ultrasound methods 
 
CO can be estimated using Doppler ultrasound derived aortic blood flow velocity and 
cross-sectional area of the aorta, obtained either transthoracically or 
transoesophagially. However, ultrasound methods are highly operator-dependent and 
time-consuming, and major potential sources of errors include position and angle of 
the transducer and movements of the subject. Older studies with ultrasound 
techniques have documented poor agreement for baseline values in comparison with 
references methods, but the changes in CO have been tracked well (Lavandier et al. 
1985, Schmid et al. 1993). Studies performed with newer equipment have shown 
better agreement, as stated in a recent meta-analysis (Dark and Singer 2004).
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Table 1. Arterial pulse contour analysis methods for cardiac output (CO) determination  
 
+peripheral arterial catheterization, ++ peripheral and central arterial catheterization. *The limitations column concerns all methods.
Technique Trademark Invasiveness Calibration References Limitations* 
Calibrated continuous  
arterial pulse contour 
PiCCO 
LiDCO 
 ++ (PiCCO)  
 + (LiDCO) 
Transpulmonary thermodilution 
Lithium dilution 
Halvorsen et al. 2007 
Mora et al. 2011  
 Based on  
mathematical models 
 Variation in arterial 
signal quality 
 Rapid changes in  
vascular tone 
 Variety of techniques   
and software versions 
 Peripheral arterial    
pressure instead  
of central pressure 
Pressure recording 
analytical method 
PRAM 
  
 ++ 
  
Independent CO measurement 
eg. by intermittent thermodilution 
Scolletta et al. 2005 
  
Noncalibrated 
continuous arterial pulse 
contour 
Vigileo 
  
 + 
  
No external calibration 
Demographic data used in equation 
Scheeren et al. 2008 
  
Invasive  
modelflow  
Modelflow  + (noncalibrated) 
 ++ (calibrated) 
Demographic data used in equation 
/ independent CO measurement 
Wesseling et al. 1993 
Non-invasive  
modelflow 
Modelflow 
Nexfin CO 
-(finger BP as an 
input signal) 
Demographic data used in equation Bogert et al. 2010 
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2.2.4. Bioimpedance 
 
Impedance cardiography (ICG) technique to determine CO has been available since 
1960's (Kubicek et al. 1966). A constant, high frequency and low alternating electrical 
current is applied to the body through superficial current electrodes and the generated 
voltage is measured with other electrodes (Kööbi et al. 1997b). The impedance is then 
derived according to Ohm’s law where resistance equals voltage over current. 
Changes in bioimpedance signal in response to current are related to cardiac events 
and blood flow, since electrical current passes through the tissues with the lowest 
impedance, i.e. blood and plasma (Baker 1989). Already during its early days, the 
technique has been validated against invasive CO measurements under various 
conditions causing changes in CO (Balasubramanian et al. 1978, Boer et al. 1979). 
The assessment of SV from the changes in impedance requires mathematical 
algorithms and the base equation has been modified for different electrode 
configurations and current magnitudes. In addition, some equations include correction 
factors for example for sex, weight and haematocrit (Lababidi et al. 1971, Kööbi et al. 
1997b, Cotter et al. 2004). ICG is a completely non-invasive and thus widely 
applicable method, which enables the determination of CO also in outpatients, to 
whom potential risks of arterial catheterization are not justified. 
 
In thoracic impedance cardiography (ICGTH) paired electrodes are placed on the neck 
and chest, mainly detecting the change in impedance in the aorta and pulmonary 
artery. In another approach, whole body impedance cardiography (ICGWB), electrodes 
are placed on the extremities proximally to wrists and ankles, and the changes in the 
impedance along the whole arterial tree are detected (Kööbi et al. 1997b, Cotter et al. 
2004). The electrode configuration in both of the ICG techniques is presented in 
Figure 6.  Both techniques have been repeatedly validated against reference methods 
with varying results, newer software versions and developed equations showing better 
agreement when compared with the earlier versions. For example, Van De Water et 
al. (2003) compared three equations for ICGTH derived CO with thermodilution CO 
and documented marked improvement in agreement when using the latest version 
instead of the older ones. In addition, several reports have documented good 
agreement of ICHWB derived CO with thermodilution (Kööbi et al. 1997b, Cotter et 
al. 2004, Paredes et al. 2006).  However, criticism against ICG derived CO 
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determination has also been presented due to over-simplification of human physiology 
by mathematical equations (Geerts et al. 2011).  The major advances and limitations 
of ICG technique are presented in Table 2.  
 
Figure 6. Electrode configuration in whole body impedance cardiography (A) and 
thoracic impedance cardiography (B). 
 
 
 
 
Table 2. Major advantages and limitations of impedance cardiography technique for 
cardiac output monitoring. 
Advances Limitations 
Completely non-invasive Based on a mathematical model 
Safe Heterogeneity of equations 
Inexpensive Ignores individual anatomy 
Easy and fast to perform Variation in validation results 
Repeatable Motion artefacts 
Operator-independent Unreliable during irregular cardiac rhythm 
Widely applicable and in patients with valvular diseases 
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2.3. Non-invasive assessment of central blood pressure 
 
BP and PP in central arteries are better predictors of cardiovascular outcome in 
several populations when compared with peripheral BP, and despite similar effects on 
peripheral BP, different treatments may have divergent influence on central pressure. 
For example, in the CAFE (Conduit Artery Function Evaluation) study 
amlodipine/perindopril based treatment was compared with atenolol/thiazide based 
treatment (Williams et al. 2006). Despite the similar reduction of peripheral BP, 
subjects in the amlodipine/perindopril treatment arm had lower central BP and less 
cardiovascular events during the 4-year follow-up. Higher central BP and PP have 
been shown to be associated with the risk of restenosis after percutaneous 
transluminal coronary angioplasty (Nakayama et al. 2000) and with the severity of 
coronary artery disease (Jankowski et al. 2004). In addition, central BP is better 
associated with the reduction in left ventricular mass after pharmacological treatment 
than peripheral BP (Hashimoto et al. 2007).  
 
Central BP can be estimated non-invasively by arterial applanation tonometry, which 
is performed by placing a tonometric pressure sensor on an artery. Commonly, a pen 
like sensor is used to record 10-20 consecutive cardiac cycles, but also continuous 
recording is possible with a sensor fixed on the artery with e.g. wrist band. Central 
pressure wave can also be obtained directly from the carotid artery, and besides 
applanation tonometry, echotracking device can be used to record arterial distension 
waves produced by variation in BP (Van Bortel et al. 2001).  Applanation tonometry 
can be also performed on a peripheral artery, typically radial or digital, and a 
mathematical transfer function is applied to estimate central pressure wave from the 
peripheral one. A generalized transfer function which is validated against invasive 
central BP measurements is commercially available in the Sphygmocor system 
(Karamanoglu et al. 1993), while other functions have also been developed and 
validated for pulse waves obtained from radial or digital artery (Chen et al. 1997, 
Hope et al. 2003). Sharman et al. (2006) measured central pressure with radial 
applanation tonometry and invasive arterial catheterization and found good agreement 
and high correlation for the measurements both at rest and during supine cycling. The 
recorded arterial pressure wave is usually calibrated by brachial BP measurements 
assuming equal pressure at the two measurement sites, which is the major limitation 
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of the transfer functions. However, the method is widely applicable, easy and fast to 
perform and operator-independent. Figure 7 depicts typical radial and derived aortic 
waveforms from a young study subject obtained with radial applanation tonometry.  
 
Figure 7. A typical measured radial waveform and derived aortic waveform of a 
young, normotensive subject. 
 
 
 
2.4. Non-invasive assessment of arterial stiffness 
 
2.4.1. Pulse pressure 
 
Pulse pressure (PP) is defined as a difference between systolic and diastolic BP and is 
influenced by arterial compliance (Dart and Kingwell 2001). Even though PP is 
considered as a simple measure of arterial stiffness, also many other factors like wave 
reflection, contribute to the level of PP. In addition, the rise in PP can be secondary to 
the rise in SV without a change in arterial distensibility (Alfie et al. 1999). Moreover, 
PP is directly related to mean arterial pressure and thus lowering BP decreases PP 
without a parallel decrease in arterial stiffness. An increase in PP has also been 
documented during -adrenergic stimulation without a change in PWV, a measure of 
arterial stiffness (Lemogoum et al. 2004). Importantly, PP measured at peripheral sites 
is not equal to central PP due to the amplification phenomenon (see above), and 
pathophysiological conditions and drugs may change central PP without changing 
peripheral PP. The discrepancy is emphasized in young subjects with compliant 
arteries and diminished with ageing and arterial stiffening (Nichols and O'Rourke 
1998).  
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Both peripheral and central PP predicts cardiovascular morbidity and mortality in 
various populations. The predictive value of PP has been demonstrated in general 
population (Panagiotakos et al. 2005), healthy individuals (Franklin et al. 1999, Lee et 
al. 1999), treated and untreated hypertensive subjects (Fang et al. 1995, Millar et al. 
1999), patients with left ventricular hypertrophy (Domanski et al. 1999) and subjects 
with type I or II diabetes (Cockcroft et al. 2005). 
 
2.4.2. Pulse wave velocity 
 
Velocity of the pulse wave traveling along the arterial tree has been described as a 
simple, non-invasive and reproducible method, and carotid-femoral PWV is 
considered as the golden standard in the assessment of large arterial stiffness (Laurent 
et al. 2006). Theoretical basis of PWV measurement takes into account the density of 
blood, thickness and diameter of the artery, and Young’s elastic modulus, which is a 
physical parameter representing the stiffness of elastic materials (Franck 1920, 
Bramwell and Hill 1922).  
 
In practice, PWV is calculated as a distance divided by the traveling time of the pulse 
wave between two measurement sites. PWV can be measured from various locations, 
but the measurement of aortic PWV is the most clinically relevant, since the large 
arteries are responsible for most of the pathophysiological events of arterial stiffening 
(Boutouyrie et al. 2002). However, recently it has been demonstrated that also 
brachial-ankle PWV reflects similar characteristics than aortic PWV, and is associated 
with cardiovascular risk (Tsuchikura et al. 2010). 
 
The distance between the two pulse assessment points is usually measured by tape 
over the body surface. To determine the pulse transit time, pulse waveforms are 
obtained from two locations, usually from carotid and femoral arteries to define aortic 
PWV. The foot of the pulse waveform, i.e. end of the diastole, is commonly identified 
when determining the pulse transit time since that part of the waveform is least 
affected by the wave reflection. The waveforms can be obtained using several 
methods. Mechanotransducers placed on the skin simultaneously assess the arterial 
pressure pulse at different sites, and a correlation algorithm is utilized to determine 
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the transit time (Asmar et al. 1995). Pressure waveforms can be determined 
subsequently from different sites using applanation tonometry, and electrocardiogram 
is recorded parallel to define the timing between the waveform foots. The distension 
waveforms can be determined using echotracking devices or continuous Doppler 
probes (Millasseau et al. 2000, Cruickshank et al. 2002). PWV can also be determined 
with an ICGWB device (CircMonR). Briefly, the distal impedance is recorded from a 
popliteal artery at knee joint level, and the active electrode is placed on the lateral side 
of the knee and the reference electrode on the calf below knee. When the PP wave 
enters the aortic arch and the diameter of the aorta changes, the whole-body 
impedance decreases, and this can be measured by the voltage electrodes. To calculate 
the PWV value, the CircMonR software measures the time difference between onset 
of the decrease in impedance in the whole-body impedance signal and the popliteal 
artery signal (Kööbi et al. 1997a, Kööbi et al. 2003). 
  
PWV estimation includes potential errors in both distance and waveform 
determinations. The measurement of the distance over the body surface is 
overestimated in obese subjects, and includes an assumption that the aorta is straight. 
As determining the timing, the identification of pulse waveform foot may fail, and 
several different points can be chosen to indicate the start of the pulse (Chiu et al. 
1991). In addition, the femoral pressure waveform may be difficult to determine in 
subjects with metabolic syndrome, obesity, diabetes or peripheral arterial disease 
(Van Bortel et al. 2002). 
 
Increased PWV has been associated with cardiovascular mortality and morbidity in 
several studies. The prognostic value has been demonstrated both in general 
populations (Mitchell et al. 2010) and in hypertension, diabetes and in end stage renal 
disease (Laurent et al. 2001, Cruickshank et al. 2002, Pannier et al. 2005). However, it 
is not completely clear whether high PWV truly precedes disease or is it solely 
associated with a potentially coexisting cardiovascular disorder.  
 
2.4.3. Augmentation index 
 
As discussed in section 1.3, AIx can be determined from the arterial pressure wave as 
a ratio of augmentation pressure and PP (Figure 1). Central AIx is determined non-
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invasively from the estimated central pressure wave obtained e.g. by radial 
applanation tonometry using pulse wave analysis softwares. The principle of central 
pulse wave estimation using transfer functions is described in section 2.3.  
 
AIx is influenced by the shape and amplitude of volume wave from the left ventricle, 
magnitude and timing of the reflecting wave and arterial stiffness as well as by 
gender, age and height (Kingwell and Gatzka 2002). Thus, AIx cannot be regarded as 
a true indicator of arterial stiffness, but an index of wave reflection including arterial 
compliance. Importantly, a significant linear relationship between AIx and HR has 
been demonstrated so that AIx falls approximately 4 % for every 10 beats/min 
increase in HR (Wilkinson et al. 2000a), since decreased duration of systole shifts the 
reflected wave towards diastole. Therefore, AIx corrected to HR 75 has been recently 
more widely used (Vyssoulis et al. 2010). 
 
As expected, a good correlation between AIx and aortic PWV has been demonstrated 
since the pulse wave travels faster in stiff arteries thus increasing the augmentation 
pressure (Yasmin and Brown 1999, Lemogoum et al. 2004, Filipovsky et al. 2005). 
Increased AIx has been demonstrated in patients with type I diabetes (Wilkinson et al. 
2000b), hypercholesterolemia (Wilkinson et al. 2002b), hypertension (Scuteri et al. 
2001) and end stage renal disease (Safar et al. 2002b). Furthermore, London et al. 
(2001) have shown that increased AIx in patients with end stage renal disease is 
associated with cardiovascular and total mortality, and the same has been observed in 
patients with coronary artery disease (Weber et al. 2005). However, in a cohort of the 
Framingham Heart Study, PWV, but not AIx was associated with cardiovascular 
morbidity (Mitchell et al. 2010) 
 
2.4.4. Ambulatory arterial stiffness index 
 
A novel measure of arterial stiffness, ambulatory arterial stiffness index (AASI), is 
defined as a relationship between diastolic and systolic BP during 24-hour BP 
monitoring, which usually contains approximately 70 brachial cuff BP recordings (Li 
et al. 2006). The technique is based on a hypothesis that increased arterial stiffness 
influences the height of diastolic BP and its relationship to systolic BP, and it is 
thought that AASI mainly reflects the mechanical properties of small arteries 
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(Benetos and Lacolley 2006). In practice, the regression slope of diastolic BP on 
systolic BP is calculated by plotting the individual values of systolic and diastolic BP 
measurements obtained during the 24-hour BP monitoring. The numeric value of 
AASI is then computed using the formula AASI = 1 – gradient of the regression 
slope, and arterial stiffness increases as the gradient approaches 0 and AASI 
approaches 1(Li et al. 2006). This principle is based on an assumption that in a 
compliant artery both systolic and diastolic BP tend to increase in a parallel fashion, 
while in a stiff artery, the increase in systolic BP is accompanied by a lesser increase, 
or even by a decrease, in diastolic BP. 
 
In healthy subjects, a significant correlation between AASI and aortic PWV has been 
demonstrated (Li et al. 2006). Leoncini et al. (2006) demonstrated that AASI is 
associated with target organ damage in patients with primary hypertension.  In 
another study, AASI predicted cardiovascular mortality after adjustment for 
traditional risk factors, but lost its predictive value after adjustment for PP (Dolan et 
al. 2006). This technique is relatively novel and requires further validation. 
 
2.4.5. Diastolic pulse contour method 
 
It is considered that stiffening of the small arteries alters the amplitude and timing of 
reflected waves obtained in the larger vessels, which can be interpreted from 
computer analysis of the diastolic pressure decay of the pressure wave (Cohn et al. 
1995).  Applying a modified Windkessel model, assessment of capacitative 
compliance (C1, large artery compliance) and reflective compliance (C2, small artery 
compliance) is enabled (Cohn et al. 1995). Pressure wave can be measured e.g. by 
applanation tonometry or finger plethysmography. Different algorithms exists, but in 
general C1 is calculated as a ratio between a change in volume and change in pressure 
during diastolic decay, and C2 as a same ratio during oscillations around diastolic 
decay (Cohn et al. 1995, Woodman et al. 2005). Romney and Lewanczuk (2001) have 
documented that both C1 and C2 were reduced in type 1 diabetics before diagnosed 
microvascular complications. In a population sample of 870 subjects, decreased C2 
was an independent predictor of cardiovascular events and death (Grey et al. 2003). 
However, the validity of C1 and C2 as an indexes of systemic arterial stiffness have 
been questioned, since poor correlations between aortic PWV and C1 or C2, and 
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between C1 or C2 measured from radial and tibial arteries, have been documented 
(Manning et al. 2002, Woodman et al. 2005) 
 
2.4.6. Assessment of local arterial stiffness 
 
Local compliance in an artery can be determined by obtaining the changes in vessel 
diameter and BP during cardiac cycle, and all superficial arteries, especially common 
carotid, femoral, brachial and radial arteries are suitable sites for such measurements. 
The measurements are commonly performed using ultrasound systems, and 
simultaneous BP measurement e.g. with tonometry is preferably also performed 
(Perret et al. 1991, Giannattasio et al. 2008). In addition, local stiffness of deeper 
arteries, like aorta, can be determined using magnetic resonance imaging (Mohiaddin 
et al. 1989).  As an advantage, these methods provide a direct measure of local 
stiffness without using any models of circulation. However, no assumptions 
concerning systemic arterial stiffness can be made based on these measurements, 
since arterial compliance may vary even within the same vessel (Reneman et al. 
1992). Furthermore, ultrasound methods demand technical expertise and take time, 
and are highly operator-dependent. 
 
 
2.5.  Assessment of endothelial function 
 
2.5.1. Invasive methods 
 
2.5.1.1. Coronary angiography 
 
Angiographic measurement of coronary vessel diameter after intracoronary infusion 
of endothelium-dependent and -independent agents in increasing concentrations is 
used to assess coronary endothelial function. Acetylcholine (ACh) is most widely 
used as an endothelium-dependent vasodilator substance, while administration of 
nitroglycerin (NTG) is performed to assess endothelium-independent vasorelaxation 
(Table 3). In healthy vessels, both substances induce vasodilatation, while paradoxical 
vasoconstriction in response to ACh has been documented in atherosclerotic coronary 
vessels (Ludmer et al. 1986).  
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Infusion of adenosine or papaverine induces endothelium-independent vasorelaxation 
especially in the coronary microvasculature and increases blood flow (Table 3). 
Adenosine also serves as a partially endothelium-dependent vasodilator via the release 
of NO and endothelium-hyperpolarizing factors (Hein and Kuo 1999). Increased 
blood flow and shear stress result in endothelial release of NO and vasodilatation in 
the proximal coronary tree, which can be measured to assess endothelial function 
(Cox et al. 1989). The measurement of the changes in vessel diameter mainly reflects 
vasomotion in large coronary vessels, while endothelial function of the coronary 
microvasculature can be assessed by measuring changes in coronary blood flow in 
response to stimuli using intracoronary Doppler probe (Treasure et al. 1993).  
As an invasive technique, angiography is only available for selected patient groups 
and is not applicable for repeated measurements. Furthermore, it only reflects the 
possible pathophysiological changes in one vascular bed. 
 
Table 3. Most common pharmacological substances used in studies assessing 
endothelial and vascular smooth muscle function in the control of vascular tone in 
humans. 
Stimuli Administration Action 
Endothelium-dependent   
Acetylcholine Infusion Release of NO, PGI2, EDHF(s) 
Metacholine Infusion Release of NO, PGI2, EDHF(s) 
Bradykinin Infusion Release of NO, PGI2, EDHF(s) 
Substance P Infusion Release of NO, PGI2, EDHF(s) 
Adenosine Infusion Release of NO, PGI2, EDHF(s) 
Salbutamol Inhalation/infusion Release of NO, PGI2, EDHF(s) 
L-arginine Infusion Substrate for endothelial NO synthesis 
L-NMMA Infusion Inhibition of endothelial NO synthesis 
Endothelium-independent   
Nitroglycerin Infusion/sublingual Smooth muscle cell relaxation via cGMP 
Papaverine Infusion Smooth muscle cell relaxation via PDE inhibition 
Sodium nitroprusside Infusion Smooth muscle cell relaxation via cGMP 
Adenosine Infusion Smooth muscle cell relaxation via cAMP 
NO=nitric oxide, PGI2=prostacyclin, EFHF(s)=endothelium derived hyperpolarizing 
factor(s), L-NMMA= LG-monomethyl L-arginine. PDE=phosphodiesterase  
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2.5.1.2. Venous occlusion plethysmography 
 
Venous occlusion plethysmography is based on the measurement of the tissue volume 
change after occlusion of venous return induced by cuff inflation proximal to the site 
of evaluation, usually in the forearm (Hokanson et al. 1975, Fichtlscherer et al. 2004). 
The occlusion pressure only prevents venous outflow without modifying the arterial 
inflow. Measurement of volume change is usually performed with strain gauge placed 
around the examination area (Hokanson et al. 1975). Response in blood flow (volume 
change) to intra-arterial infusion of endothelium-dependent and independent agents is 
used to assess local vasodilatation, and ideally the measurement of blood flow also in 
the contralateral arm should be performed to verify potential systemic effects of drug 
infusion. Impaired increase in ACh-induced forearm blood flow has been 
demonstrated in subjects with cardiovascular risk factors (Panza et al. 1990), and it is 
an independent predictor of cardiovascular events in subjects with hypertension and 
coronary artery disease (Heitzer et al. 2001, Perticone et al. 2001). However, the 
invasive nature of the method limits its use in clinical settings.  
 
2.5.2. Non-invasive methods 
 
2.5.2.1. Flow mediated dilatation 
 
The endothelium responds to increased blood flow and shear stress by releasing NO 
and other vasodilator substances, which leads to flow mediated vasodilatation (FMD).  
FMD is usually measured from brachial, and sometimes from femoral or radial 
arteries, and the increase in blood flow is usually induced by short period (e.g. 2-5 
min) of ischemia with BP cuff inflation above systolic BP. Cuff release leads to 
reactive hyperaemia, and subsequent vasodilatation (change in arterial diameter 
proximally to the ischaemic segment) is documented with ultrasound from straight, 
non-branching segment of the artery (Celermajer et al. 1992). Commonly, also a 
single dose of sublingual NTG or other systemic vasodilator is administrated to assess 
endothelium-independent vasodilation (Celermajer et al. 1994).  
 
The FMD technique is non-invasive and relatively simple. However, obtaining the 
change in arterial diameter with ultrasound requires good technical skills and training, 
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although available computerized edge-detection and wall-tracking software systems 
have improved the reproducibility (Woodman et al. 2001). In addition, variations in 
study protocols (e.g. time of cuff inflation, site for ultrasound measurement, dose of 
NTG) limit the direct comparison of the results of published studies. 
 
A significant association between impaired FMD and cardiovascular risk factors has 
been documented already in the preclinical phase of cardiovascular disease 
(Celermajer et al. 1994). In patients with peripheral arterial disease, impaired FMD 
was an independent predictor of cardiovascular events (Gokce et al. 2003). In 
addition, in a large population of young adults (The Cardiovascular Risk in Young 
Finns Study), a strong inverse relationship has been documented between FMD and 
carotid intima media thickness (Juonala et al. 2004). 
 
2.5.2.2. Peripheral arterial tonometry and pulse contour analysis 
 
AIx, an index of wave reflection, is derived from arterial waveform obtained with 
applanation tonometry, as described previously. Vasodilatation in small arteries 
decreases the proportion of the reflected wave influencing systolic BP and thus leads 
to the reduction of AIx. Accordingly, changes in AIx in response to β2-adrenoceptor 
agonist administration, most commonly inhaled salbutamol, have been used to assess 
the role of endothelium in vascular responsiveness (Hayward et al. 2002).  
Importantly, changes AIx after salbutamol but not after NTG, have been blunted by 
LG-monomethyl L-arginine (eNOS inhibitor) infusion, suggesting that the effect of 
salbutamol is significantly mediated through the endothelial NO release (Hayward et 
al. 2002, Wilkinson et al. 2002a). 
 
Pulse wave form can also be obtained from digital pulse volume using a finger 
photopletysmography (pulse contour analysis, see section 2.2.2.). Changes in 
reflection index, a measure of vascular tone, are automatically calculated as the 
relative amplitude of the forward wave and reflected wave component from the pulse 
contour analysis. Recently, changes in fingertip peripheral arterial tonometry signal 
recorded before and after proximally placed BP cuff inflation (reactive hyperemia) 
have been introduced as a method to evaluate endothelial vasodilator function. This 
method is patented as EndoPAT, and the outcome variable called PAT-ratio is 
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calculated as the ratio of signal amplitude before and after cuff occlusion. Acceptable 
correlation between PAT-ratio and FMD has been documented in some studies 
(Kuvin et al. 2003), while others have reported poor correlation and relation to 
different risk factor profiles between PAT-ratio and FMD (Hamburg et al. 2011, 
Schnabel et al. 2011). Thus, it has been discussed that the methods might reflect 
different cardiovascular pathologies.  
 
Blunted response to endothelial stimuli in above mentioned measures have been 
documented in several clinical conditions, and some studies have shown a relationship 
between decreased vasodilator response and increased mortality or morbidity (Table 
4). However, due to the novelty of these techniques, further data is needed to study 
the association between impaired functional responses and cardiovascular disease and 
effects of various treatments. 
 
The major advantage of tonometry and pulse contour analysis in assessing endothelial 
function is their non-invasive nature. Moreover, when compared with the non-
invasive FMD, these measurements are easier and faster to perform, and do not rely 
on the skills of the examiner as much as FMD. However, it is not completely clear 
whether the changes in the observed responses to various stimuli are uniformly 
endothelium-dependent, since arterial wave reflection is a complex interplay between 
several factors. In addition, mathematical transfer functions and equations are not 
without concerns, as discussed previously. 
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Table 4. Studies of the relationship between endothelial function assessed with pulse wave analysis, pulse contour analysis or fingertip 
peripheral arterial tonometry, and disease or outcome.  
Study Method Stimuli Subjects Finding 
Chowienczyk et al. 1999 PCA Salbutamol Type II diabetes (n=20) Blunted decrease in wave reflection 
Hayward et al. 2002 PWA Salbutamol Coronary artery disease (n=12) Blunted decrease in AIx 
Wilkinson et al. 2002a PWA Salbutamol Hypercholesterolemia (n=27) Blunted decrease in AIx 
Covic et al. 2003 PWA Salbutamol Renal transplant recipient (n=20) Blunted decrease in AIx 
Bonetti et al. 2004 PAT-ratio Reactive hyperemia Abnormal response to intracoronary Ach (n=55) Decreased PAT-ratio 
Lind et al. 2005 PWA Terbutaline Elderly (n=1016) Association between response and risk score* 
Kals et al. 2006 PWA Salbutamol Peripheral arterial disease (n=24) Blunted decrease in AIx and PWV 
Waring et al. 2006 PWA Salbutamol Uncomplicated hypertension (n=20) Preserved decrease in AIx 
Wallberg-Jonsson et al. 2008 PWA Salbutamol Rheumatoid arthritis (n=30) Blunted decrease in AIx and RI 
Kohler et al. 2008 PWA Salbutamol Obstructive sleep apnoea (n=64) Blunted decrease in AIx 
Peled et al. 2009 PAT-ratio Reactive hyperemia Pulmonary arterial hypertension (n=38) Decreased PAT-ratio 
Gordon et al. 2009 PCA Salbutamol Coronary artery disease (n=9) Blunted decrease in wave reflection 
Rubinshtein et al. 2010 PAT-ratio Reactive hyperemia Outpatients with chest pain (n=329) Decreased PAT-ratio as a predictor of CV events 
Duffy et al. 2011 PWA Salbutamol  Critically ill patients (n=94) Blunted decrease in AIx as a predictor of mortality 
 
PCA=pulse contour analysis, PWA= pulse wave analysis, PAT-ratio=ratio of fingertip peripheral arterial tonometry signal before and during 
reactive hyperemia, AIx=augmentation index, RI=reflection index, computed as the relative amplitude of the forward wave and reflected wave 
components. *Framingham risk score. 
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2.5.2.3. Laser Doppler flowmetry 
 
Laser Doppler flowmetry is based on the reflection of a laser beam: light undergoes 
changes in wavelength when it hits moving blood cells. The magnitude and frequency 
distribution of the changes in wavelength are related to the number and velocity of 
blood cells. The technique enables the monitoring of changes in skin microvascular 
blood flow during post-occlusive hyperaemia, local heating of the skin or ACh 
iontophoresis (Gush and King 1991). However, none of these stimuli probably induce 
solely endothelial NO mediated response, but might represent a summation of 
complex responses involving neural, metabolic and NO-independent endothelial 
vasodilators. For example, it has been documented that ACh mediated dilatation of 
human skin vasculature is unchanged or only modestly attenuated following eNOS 
inhibition (Holowatz et al. 2005). Since skin serves as a crucial thermoregulatory 
organ, there is a great interindividual variation in local basal blood. In addition, lack 
in protocol standardization limits the comparison between the published studies.  
 
2.5.2.4. Other methods 
 
Recently, coronary endothelial function (change in arterial diameter or blood flow in 
response to stimuli) has been non-invasively measured applying magnetic resonance 
imaging, computed tomography and positron emission tomography (Prior et al. 2007, 
Terashima et al. 2008). Endothelial function can be assessed also by measuring the 
levels of molecules of endothelial origin in circulating blood. These include direct 
products of endothelial cells that change with endothelial activation, such as measures 
of NO biology, inflammatory cytokines, adhesion molecules, regulators of 
thrombosis, as well as markers of endothelial damage and repair. 
 
2.6. Haemodynamic response to upright posture 
 
2.6.1. Head-up tilt table test 
 
Change in posture from supine to upright leads to significant haemodynamic 
alterations, and can thus be regarded as a challenge to cardiovascular system. Most 
important changes are possibly the effects of gravity on fluid compartments resulting 
42 
 
in increased venous pooling of blood and decreased CO, and the subsequent 
activation of autonomic control mechanisms (baroreflex) to maintain BP. 
Additionally, peripheral vascular resistance increases, and the compliance of large 
conduit arteries changes in a pressure-dependent manner. As a result, arterial wave 
form morphology is different in supine and upright positions. Recently, a decrease in 
AIx from supine to upright posture has been documented with a parallel increase in 
vascular resistance, even though the increase in resistance is generally considered to 
enhance wave reflection (Davis et al. 2011). This possibly implies that the main sites 
for wave reflection are located in larger conduit arteries instead of microvasculature 
with high resistance, but the issue requires further studies. Characteristic changes in 
haemodynamic variables in response to tilting are presented in Table 5. 
 
Table 5. Typical changes in haemodynamic variables in response to head-up tilt 
Variable 
Change in 
response to tilt Explanation 
Systolic BP ↔ / ↓ Maintained by compensatory mechanisms 
Diastolic BP ↔ / ↑ Maintained by compensatory mechanisms 
Stroke volume ↓ Increased venous pooling 
Heart rate ↑ Increased sympathetic activity 
Cardiac output ↓ Increased venous pooling 
Vascular resistance ↑ Increased sympathetic activity 
Augmentation index ↓ Decreased wave reflection 
 
 
In addition to research settings, head-up tilt-table testing is used as a diagnostic tool in 
the examination of syncope and orthostatic hypotension. However, no generally 
accepted standard protocol exits, and for example different tilt-angles from 60 to 90 
degrees have been used, and the duration of the tilt-phase has varied. HR, BP and 
electrocardiogram are generally recorded, preferably continuously, while also 
additional measurements performed for example with ICG, echo-Doppler devices, or 
applanation tonometry have been utilized (Stewart 2000, Cybulski et al. 2004). 
Neurogenic orthostatic hypotension from autonomic failure is generally evident 
within the first 5 to 15 minutes of tilting, while more prolonged protocols are 
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sometimes needed to demonstrate reflex or vasovagal syncope, which are at times 
further delayed or require a pharmacological challenge to appear.  
 
2.6.2. Nitroglycerin-stimulated tilt table test 
 
Tilt-table test without pharmacological stimuli in the diagnostics of vasovagal 
syncope is relatively time-consuming, which has led to the introduction of nitrate-
stimulated tilt table test (Raviele et al. 1994). The precise mechanism of nitrate-
stimulated vasovagal syncope is still under debate. Traditionally, venodilatation and 
venous pooling of blood into the lower extremities and splanchnic vasculature, and 
subsequently reduced left ventricular preload, have been regarded as major 
haemodynamic effects of small-dose NTG in humans, while arterial dilatation is 
thought to occur to a lesser extend (Mason and Braunwald 1965, Raviele et al. 1994). 
However, a reduction in wave reflection and central rather than peripheral BP has 
been documented after sublingual NTG in patients undergoing cardiac catheterization 
(Kelly et al. 1990).This implies that small doses of NTG dilate arteries resulting in 
reduced left ventricular afterload.  
 
Conflicting results concerning nitrate-induced changes in haemodynamics during tilt-
table testing have also been reported. In some studies, nitrate induced presyncope has 
been considered to be CO-mediated without a decrease in SVR (Gisolf et al. 2004). 
However, another report demonstrated a decrease in SVR without a marked change in 
HR or cardiac filling during NTG-induced presyncope (Mitro and Hijova 2006). 
Besides direct haemodynamic alterations, changes in autonomic tone, neurohormonal 
substances and central nervous system function may be involved in nitrate-induced 
syncope (Aerts 2003).  
 
Several protocols for NTG stimulated tilt table test exit. Commonly, a non-stimulated 
phase of head-up tilting for 5-60 minutes precedes the NTG administration and the 
head-up tilt is continued for 10-50 minutes or until presyncopal symptoms appear 
(Aerts 2003). Recently, a protocol without a preceding passive tilt phase was also 
introduced with good sensitivity and specifity (Aerts and Dendale 2005). NTG is 
commonly administrated in the upright posture (Aerts et al. 1999), but some protocols 
have included the lowering of the tilt table before drug administration (Raviele et al. 
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1994). Both intravenous and sublingual NTG and isosorbidedinitrate have been used 
at clinically relevant doses (e.g. sublingual NTG 0.25-0.8 mg) (Aerts et al. 1999, Oraii 
et al. 1999). However, it has not been investigated, how the differences in the 
protocols affect the sensitivity or specificity of the test. 
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AIMS OF THE STUDY 
 
The aim was to establish a comprehensive measurement protocol, during which both 
supine and upright haemodynamics are measured, and which could be utilized in 
future investigations comparing cardiovascular function between healthy subjects and 
patients. 
 
Specific aims of the study were: 
 
1. To test repeatability and reproducibility of the haemodynamic measurement 
protocol utilizing ICG, plethysmographic finger BP measurements, and 
continuous pulse wave analysis in supine position and during passive  
head-up tilt. 
2. To examine the effects of the largely endothelium-dependent vasodilators, 
salbutamol and L-arginine, and the endothelium-independent vasodilator 
NTG, on supine and upright haemodynamics in healthy volunteers. 
3. To compare the underlying haemodynamic mechanisms in subjects without 
and with presyncopal symptoms during NTG-stimulated tilt table test. 
4. To compare haemodynamic responsiveness to upright posture in different age 
groups with normal BP. 
5. To test the application in patients with either essential hypertension or 
metabolic syndrome in comparison with control subjects. 
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SUBJECTS AND METHODS 
 
1. Study subjects 
 
Number of subjects and basic characteristics in all studies are shown in Table 6. The 
population of studies I and II consisted of 35 (19 female and 16 male) healthy 
normotensive volunteers. Two of the study subjects dropped out because of individual 
reasons after 2/4 haemodynamic measurements, and in the Study I the data from 33 
(17 female and 16 male) subjects could be analysed. In the Study I, the repeatability 
and reproducibility of the protocol, and haemodynamic response to tilt table test was 
examined. In the Study II, haemodynamic effects of sublingual NTG and inhaled 
salbutamol were studied in a double-blind, randomized manner in supine position and 
during tilt. 
 
The population of Study III consisted of 9 (4 female and 5 male) healthy, 
normotensive subjects, and the haemodynamic effects of sublingual NTG, inhaled 
salbutamol and intravenous L-arginine was analysed. Six of the study subjects 
underwent alveolar NO concentration measurement to verify salbutamol-induced 
release of NO. 
 
In the Study IV, haemodynamics of 21 (16 female, 5 male) normotensive subjects 
with presyncopal symptoms during nitrate stimulated tilt table test was analysed in 
comparison with 21(16 female, 5 male) age-, gender- and BMI-matched normotensive 
control subjects without presyncopal symptoms. Three subjects experienced a brief 
total loss of consciousness during tilt in the presence of NTG, and their data was 
analysed separately. Additional measurements were performed to 19 (11 female, 8 
male) of the above mentioned subjects using alternative measurement protocol during 
which NTG was administrated in the upright position and the head-up tilt phase was 
longer than in the initial protocol. Of these subjects, ten experienced presyncopal 
symptoms while 9 did not. Two subjects classified to the presyncope group in the 
alternative protocol were originally in the non-syncope group (when NTG was 
administered in supine position), and vice versa. Thus, 79% of the subjects retained 
their classification whether NTG was given supine or during the head-up tilt.  
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In the Study V, 179 (109 female, 70 male) normotensive subjects were examined. 
Subjects were divided to four age groups: 20-29 years (n=34, 21 female, 13 male), 30-
39 years (n=40, 24 female, 16 male), 40-49 years (n=53, 30 female, 23 male) and 50-
59 years (n=52, 34 female, 18 male). Haemodynamics in supine position and during 
head-up tilt was compared between the age groups. 
 
In Studies I-V, only normotensive (BP<140/85 mmHg) subjects over 18 years of age 
were examined. None of the subjects had medication for cardiovascular disorders. 
Exclusion criterion for head-up tilt table test was standing systolic BP ≤ 90 mmHg, 
and for research drug administration allergy to the compounds. 
 
To test the application in patients, 19 subjects with metabolic syndrome (MetS), 19 
age-matched (± 4 years) subjects with essential hypertension, and 19 age-matched 
control subjects were examined (mean ages 48±2, 47±2 and 48±2, respectively). All 
subjects were males, and none had medication for cardiovascular disease. Subjects 
with MetS met the following inclusion criteria: office BP ≥ 135/85mmHg, waist 
circumference ≥ 102 cm, triglycerides ≥ 1.7 mmol/l, fasting plasma glucose ≥ 5.6 
mmol/l or 2 hour value in oral glucose tolerance test ≥ 7.8 mmol/l. Subjects with 
essential hypertension had office BP ≥ 135/85 mmHg and control subjects < 135/85 
mmHg, but other criteria mentioned above were not fulfilled.  
 
2. Medical examination and laboratory analyses 
 
All subjects underwent physical examination, and lifestyle habits, family history for 
cardiovascular disease, and medical history were documented. Present and previous 
smoking history was reported, including the duration of smoking in years and the 
amount of cicarettes in a day. Alcohol consumption was reported as restaurant doses 
per week. Blood and urine samples were obtained after a minimum of 12-h fast, and a 
standard 12-lead electrocardiogram was recorded. The following laboratory tests were 
included: basic blood count, plasma C-reactive protein, K+, Na+, calcium, creatinine, 
uric acid, fasting glucose, alanine aminotransferase, alkaline phosphatase, fasting lipid 
profile and cystatin-C. Urine cell count, over-night urine albumin excretion 
(microalbuminuria) and 24-hour urine K+ and Na+ excretion were also studied. 
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Table 6. Study population in Studies I-V. 
 
Variable Study I Study II Study III Study IV Study V 
    Presyncope Control Additional  
Number of subjects 33 35 9 21 21 19 179 
Age 34.5 ± 1.5 34.0 ± 1.4 32.0 ± 2.5 43.2 ± 2.6 43.3 ± 2.5 41.5 ± 2.6 42.1 ± 0.8 
Female/male 17 / 16 19 / 16 4 / 5 16 / 5 16 / 5 11 / 8 109 / 70 
Body mass index (kg/m2) 23.2 ± 0.5 23.1 ± 0.4 24.5 ± 1.0 24.1 ± 0.7 23.5 ± 0.5  24.8 ± 0.7 25.6 ± 0.3 
Smoking (present/previous/never) 4 / 5 / 24 4 / 5 / 26 0 / 2 / 7 1 / 6 / 14 2 / 6 / 13 0 / 7 / 12 15 / 30 / 134 
Office systolic blood pressure mmHg 125 ± 2 125 ± 2 124 ± 2 126 ± 3 127 ± 3 127 ± 4  132 ± 2 
Office diastolic blood pressure mmHg 82 ± 2 81 ± 2 80 ± 4 79 ± 2  83 ± 3 83 ± 2 85 ± 1 
Office heart rate 66 ± 2 66 ± 2 60 ± 5 62 ± 3 61 ± 3 62 ± 4 66 ± 1 
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3. Haemodynamic measurements 
 
3.1. Measurement protocol 
 
Haemodynamic measurements were performed by trained nurses in a standard 
research laboratory. The subjects were instructed to avoid caffeine containing 
products, smoking and heavy meal for at least 4 h and alcohol for at least 24 h prior to 
the investigation. Subjects were lying on a tilt-table, and the electrodes for ICG were 
placed on the body surface, a tonometric sensor for pulse wave analysis on the radial 
pulsation to the left wrist with a wrist band, a brachial cuff for BP calibration to the 
right upper arm, and a plethysmographic cuff for finger BP measurement to the right 
middle finger. An introductory head-up tilt was performed before actual 
measurements to familiarize the subjects with tilting. Measurement protocols in each 
study are presented in Figures 8, 9 and 10. In general, 5-minute phases in supine or 
upright (60 degrees head-up tilt) positions followed each other and the haemodynamic 
data was captured continuously. Studies I and II consisted of four measurements 
performed on separate days, while in the Study III, five measurements on different 
days were performed.  In the studies IV and V, and when testing the application in 
patients, single measurements were performed to all subjects. In Study IV, 19/42 
subjects underwent an additional measurement with a different protocol (Figure 10). 
The research drugs (studies II, III and IV) were administrated in supine position, 
except for the additional measurements in the Study IV, in which sublingual NTG was 
administrated during tilt. In addition, in this alternative protocol the head-up tilt 
phases lasted longer, for 15-20 minutes. If the subject reported presyncopal symptoms 
during the head-up tilt (dizziness, light-headedness, sweating, nausea), and the 
research nurse observed progressively falling BP, the tilt table was returned to the 
horizontal position before the intended length of head-up tilt was fulfilled.  
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Figure 8. Measurement protocol in Studies I and V and in the clinical application with 
patients. 
 
 
 
Figure 9. Measurement protocol in Studies II, III and IV 
 
 
 
Figure 10. Measurement protocol in Study IV (additional measurements) 
 
 
 
3.2. Research drugs 
 
Research drugs were used in the Studies II, III and IV. In the studies II and III, 
inhaled salbutamol, sublingual NTG and corresponding placebo compounds were 
administrated after a 15-minute measurement in the absence of drugs (Figure 9). 
Placebo inhalation and 400 mg salbutamol inhalation (placebo for Ventolin® and 
Ventolin®, respectively; GlaxoSmithKline, Uxbridge, UK) were given with a spacer 
device (Volumatic; Allen & Hanbury’s, Uxbridge, UK) in a blinded fashion. The 400-
mg salbutamol dose was chosen on the basis of test experiments with the present 
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study protocol and previously published work on the effects of inhaled salbutamol on 
haemodynamics (Hayward et al. 2002, McEniery et al. 2006).  
 
Sublingual placebo resoriblet and 0.25 mg NTG (Nitro resoriblet; Orion Pharma, 
Espoo, Finland) were also administrated in a blinded fashion. The placebo resoriblets 
were professionally manufactured by the University Pharmacy, Helsinki, Finland. The 
NTG dose was chosen on the basis of test experiments with the present study 
protocol, and on previous reports using the same dose (Hayward et al. 2002 ).  
 
During the 5th measurement in the Study III, an intravenous 20-G cannula was placed 
in a brachial vein and a slow saline infusion was started. L-arginine hydrochloride 20 
mg ml-1 (B. Braun Melsungen Ag, Melsungen, Germany) was diluted in 100 ml of 
saline, and infusion at the dose 10 mg kg-1 min-1 was started at 15 min and continued 
for 10 min. Previously, intravenous L-arginine infusion at the rate of 3.33 mg kg-1 
min-1 has induced vasodilation in the renal vasculature in humans (Delles et al. 2003), 
and at rate of 0.3 g min-1 it has enhanced the acute haemodynamic effects of 50 mg of 
losartan (Koifman et al. 2006). Thus, the present dosage is considered sufficient to 
induce cardiovascular changes. In the Study IV, sublingual 0.25 mg NTG was 
administrated in supine and upright positions, as described above. 
 
3.3. Exhaled alveolar nitric oxide measurement (Study III) 
 
To verify the salbutamol-induced release of NO, NO concentration from the alveolar 
air was measured in 6/9 of the subjects in Study III using a Sievers NOA 280 analyser 
(Sievers Instruments, Boulder, CO, USA) at three exhalation flow rates (100, 200 and 
300 ml s-1). The measurements were performed three times before (0, 10 and 20 min) 
and twice after (10 and 20 min) the placebo and salbutamol 400-mg inhalations. 
Exhaled NO output (concentration x flow rate) was plotted against exhalation flow 
rate and a linear regression was set. The slope and intercept of the regression line are 
approximates of alveolar NO concentration and bronchial NO flux, respectively 
(Lehtimaki et al. 2001). The exhalation flow rates were computer-controlled using an 
adjustable flow restrictor, and the subjects maintained the exhalation pressure 
between 5 and 20 cmH2O. 
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3.4. Pulse wave analysis 
 
Radial BP and pulse wave form were continuously determined from the radial 
pulsation by a tonometric sensor (Colin BP-508TR, Colin Medical Instruments Corp., 
USA), which was fixed on the radial pulse with a wrist band. The radial BP signal 
was calibrated approximately every 2.5 minutes by a brachial cuff BP measurement. 
Continuous aortic BP was derived with the SphygmoCor pulse wave monitoring 
system (SpygmoCor PWMx, Atcor medical, Australia) using the previously validated 
generalized transfer function (Chen et al. 1997)(Figure 11A). In addition to aortic and 
radial BP and HR, PP, aortic reflection time, AIx and ejection duration were 
determined. 
 
3.5. Whole-body impedance cardiography 
 
A ICGWB device (CircMonR, JR Medical Ltd., Tallinn, Estonia) and plethysmographic 
BP recordings from fingers (FinapressR, Ohmeda, Englewood, Colorado, USA) were 
used to determine beat-to-beat HR, SV, CO and PWV. CO and SV were related to the 
estimated body surface area to derive cardiac index (CI, l/min/m2) and stroke index 
(SI, ml/m2). A pair of current electrodes was placed on the distal parts of the 
extremities, just proximal of the wrists and ankles. Voltage electrodes were placed 
proximal of the current electrodes so that the distance between the centres of the 
electrodes was 5 cm (see Figure 6). The distal impedance was recorded from a 
popliteal artery at knee joint level, and the active electrode was placed on the lateral 
side of the knee and the reference electrode on the calf 20 cm below knee (Figure 
11C).  
When the pressure wave enters the aortic arch and the diameter of the aorta changes, 
the whole-body impedance decreases, and this can be measured by the voltage 
electrodes on the distal parts of the extremities. To calculate the PWV value, the 
CircMonR software measures the time difference between onset of the decrease in 
impedance in the whole-body impedance signal and the popliteal artery signal. The 
PWV can be determined from the time difference and the distance between the 
electrodes (Kööbi et al. 1997a, Kööbi et al. 2003).  
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Systemic vascular resistance index (SVRI) was calculated using the BP signal from 
the radial tonometric sensor and the CI measured by the CircMonR device. The CO 
values measured with CircMonR ICGWB are in good agreement with the values 
measured by the thermodilution method, in both supine position and during head-up 
tilt (Kööbi et al. 1997a, Kööbi et al. 2003). PWV was not assessed during the head-up 
tilt due to less accurate timing of left ventricular ejection during reduced SV (Kööbi et 
al. 2003). 
 
Figure 11.  An example of the original signals exported from the SphygmocorR and 
CircmonR systems. 10 consecutive tonometric radial and derived aortic pulse waves 
and average BP values from the SphygmocorR system (A);  ECG, impedance 1 and 2 
(ICG1 and 2) and plethysmographig finger blood pressure (BP) signals and the values 
during the first cardiac cycle from the CircmonR system (B). 
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4. Statistical methods 
 
Studies I and III 
Statistical analyses were carried out by SPSS software version 11.5 (SPSS Inc., 
Chicago, Ill., USA) and p-values <0.05 were considered statistically significant. One-
way analysis of variance (ANOVA), ANOVA for repeated measurements and paired 
samples T-test were applied to compare the measurements on different visits and 
different body positions. Values were expressed as mean ± standard error of the mean 
(SEM). In the statistical analysis, two averages of each 5-minute study phase were 
used (averages of the 2nd and 5th minute of the phase). 
 
In the Study I, the associations between AIx and other variables were investigated 
using Pearson’s coefficient of correlation test. The repeatability (two consecutive 
measurements) and reproducibility (four measurements on different days) were 
analysed using two statistical methods: 1) Repeatability and reproducibility indexes 
(R) were calculated from the formula R=1–MSW/MST, in which MSW and MST are 
square sums indicating variation within a subject and in the total study population, 
respectively. R ranges from 0 to 1, with 0 indicating no consistency and 1 complete 
consistency. 2) Repeatability and reproducibility values (limits of agreement) were 
also calculated as recommended by Bland and Altman (1986), showing the range as ± 
2 standard deviations, which covered 95 % of the observed differences between 
repetitive measurements.  
 
Due to the small number of subjects in the Study III, the study power was analysed 
using the PS 3.0.2 power and sample size calculations program (Vanderbilt 
Biostatistics, Nashville, TN, USA). A change in SVRI > 400 dyn*s/cm5*m2 in the 
supine position was chosen as the main outcome variable (such a change was 
observed after both salbutamol and NTG). The number of subjects (n = 9) was found 
to have a power of 92% to detect a significant difference (400 dyn*s/cm5*m2) 
between the salbutamol and the placebo effect (α-level 0.05). 
 
Study II 
The software package R 2.10.1 was used in the statistical analyses and p-values <0.05 
were considered statistically significant (Nordhausen et al. 2011). All one-minute 
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averages of the study protocol were used in the statistical analysis. Robust 
nonparametrical methods were applied since the sample size was relatively small and 
the tonometric measurements were prone to temporary deviations. To evaluate the 
repeatability of the four different measurements, a multivariate Friedman test based 
on spatial signs was applied on the values of the first 15 minutes (study phase in the 
absence of research drugs). To study drug and placebo effects, a spatial sign test was 
applied to the differences of the values during the first 15 minutes (0-15 min), and the 
values during the last 15 minutes (16-30 min) of each subject. To compare if the drug 
and corresponding placebo effects differed, a spatial sign test was in turn computed 
for the difference of the aforementioned differences. To test if the drug effect depends 
on body position, differences of the estimated drug effects between the different 
postures were compared.  For the spatial sign tests the p-values were based on the 
permutation test version based on 1000 replications. Corresponding point estimates 
for the effects spatial medians were computed.  
 
Study IV 
The software package R 2.10.1 was used (Nordhausen et al. 2011). The general 
difference between controls and cases was evaluated using a multivariate Wilcoxon 
signed-rank test based on marginal signed-ranks. Due to the small sample size a 
permutation version of the test was applied using 1000 replications. For further 
interpretation the univariate sample quartiles (quartile 1 – median – quartile 3) were 
reported and exact marginal Wilcoxon signed rank tests results were given.  
 
Study V 
The software package R 2.8.1 was used (2008), and robust and nonparametric 
methods were applied. Univariate one-way ANOVA was performed using the 
Kruskal–Wallis test and independence in two-way contingency tables was evaluated 
using Fisher’s exact test. To evaluate haemodynamic differences between the four age 
groups, stratified multivariate c-sample tests were performed. The test applied here 
was the affine equivariant version of the spatial sign test and as corresponding point 
estimate the affine equivariant version of the spatial median was reported (Oja and 
Randles 2004). Stratification was done separately for sex, smoking, alcohol 
consumption level and for a binary indicator based on a canonical analysis between 
other confounding variables (baseline BP, AIx, PWV, aortic reflection time, waist and 
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hip circumference, cholesterol status, hematocrit, C-reactive protein, estimated GFR, 
Cornell voltage product) and the response. A robust linear MM-regression was used 
to model the reaction of a subject to the tilt-table test. The model selection was 
performed using the smallest complete subset and successively removing the 
explanatory variable with the highest p-value (>0.05), while always keeping age as 
the variable of interest in the model. All explanatory variables entered the model 
linearly and no interactions were considered. The final model was refitted using the 
largest possible subset of the data and the model assumptions graphically evaluated. A 
difficulty of the model fitting was the correlation between several explanatory 
variables (multicollinearity problem, i.e. an explanatory variable in the final model 
might rather stand for a group of variables).  
 
Clinical application with patients 
SPSS software version 17.0 was used, and p-values <0.05 were considered 
statistically significant. ANOVA, ANOVA for repeated measurements, and paired 
samples T-test were applied to compare the groups. Values were expressed as mean ± 
standard error of the mean (SEM). In the statistical analyses, one-minute averages of 
each 5-minute study phase were used. 
 
5. Ethical aspects 
 
All subjects gave a written informed consent. The study complies with the declaration 
of Helsinki, and was approved by the ethical committee of the Pirkanmaa Hospital 
District. 
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RESULTS 
 
1. Repeatability and reproducibility of the measurement protocol 
 
In the Study I, repeatability (2 consecutive measurements) and reproducibility (4 
measurements on separate days) were analysed using the statistical methods 
mentioned above both in supine position and during head-up tilt, and the values are 
presented in Table 7.  The repeatability and reproducibility index varies from 0 to 1, 
values approaching 1 indicating high consistency. Thus, values presented in Table 7 
demonstrate good repeatability and reproducibility except for the repeatability of HR 
measurements. In addition, limits of agreement according to Bland and Altman (1986) 
also showed good repeatability and reproducibility, comparable with previous reports 
on repeatability of haemodynamic measurements (Kööbi et al. 1997a, Kööbi et al. 
1997b, Filipovsky et al. 2000). Figure 12 represents the repeatability (Bland and 
Altman limit of agreement) of AIx, CO and SVRI measurements in supine position 
and during head-up tilt.  
 
In the Study II, all one-minute averages of the study protocol were used in the 
statistical analyses, and applied statistical methods were more sophisticated than in 
Study I. Thus, the analysis of reproducibility (measurements on 4 separate days, first 
15 minutes of each measurement) was repeated. Consistent with the Study I, all 
measured variables showed good reproducibility during the 15-minute measurement 
(supine and during head-up tilt) in the absence of research drugs (p<0.05).  
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Table 7. Repeatability and reproducibility of haemodynamic measurements in supine position and during head-up tilt (Study I). 
 
 Repeatability (supine/tilt) Reproducibility (supine/tilt) 
Variable Bland & Altman Index R Bland & Altman Index R 
Tonometry     
   Radial systolic BP (mmHg) 10/12 0.91/0.85 15/15 0.77/0.78 
   Aortic systolic BP (mmHg) 10/14 0.90/0.74 14/16 0.74/0.74 
   Radial diastolic BP (mmHg) 10/12 0.87/0.79 12/13 0.78/0.78 
   Aortic diastolic BP (mmHg) 10/12 0.87/0.79 12/13 0.79/0.78 
   Aortic pulse pressure (mmHg) 5/8 0.88/0.66 9/11 0.61/0.46 
   Aortic augmentation index (%) 5/6 0.95/0.94 12/13 0.78/0.69 
   Aortic reflection time (ms) 20/11 0.85/0.87 25/27 0.79/0.47 
   Ejection Duration (ms) 12/15 0.96/0.95 28/41 0.74/0.57 
Impedance cardiography     
   Stroke volume (ml) 4/3 0.99/0.99 15/8 0.88/0.92 
   Heart rate (beats/min) 23/29 0.22/0.22 15/18 0.67/0.66 
   Cardiac output (l/min) 0.62/0.45 0.92/0.97 1.48/1.22 0.70/0.81 
   SVRI (dyn*s/cm5*m2) 349/390 0.93/0.91 937/993 0.58/0.54 
   Pulse wave velocity (m/s) 0.40/- 0.99/- 1.45/- 0.87/- 
SVRI= systemic vascular resistance index, R= repeatability and reproducibility index
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Figure 12. Bland-Altman plots for the comparison of two consecutive measurements 
(repeatability) in supine position and during head-up tilt. Augmentation index (A and 
B), cardiac output (C and D) and systemic vascular resistance index (SVRI, E and F).  
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2. Heamodynamic response to passive head-up tilt 
 
Studies I-V included a head-up tilt without pharmacological stimuli and the average 
changes in haemodynamic variables in response to tilting were similar. In general, all 
of the variables changed significantly during the head-up tilt. Table 8 presents the 
average direction of the change in the haemodynamic variables, and as an example the 
percentage change in the Study I.   
 
Table 8. Average direction of the change in haemodynamic variables in response to 
head-up tilt in the absence of research drugs (all studies), and mean change in the 
Study I. 
Variable Average change Change in Study I (%) 
Tonometry   
   Radial systolic BP ↓ -2.1 ± 0.5 
   Aortic systolic BP ↓ -2.9 ± 0.4 
   Radial diastolic BP ↑ 5.2 ± 0.7 
   Aortic diastolic BP ↑ 5.6 ± 0.7 
   Aortic pulse pressure  ↓ -23.7 ± 1.0 
   Aortic augmentation index ↓ -11.8 ± 0.5 
   Aortic reflection time ↓ -5.9 ± 0.6 
   Ejection duration ↓ -20.7 ± 0.5 
Impedance cardiography   
   Stroke volume ↓ -24.6 ± 0.8 
   Heart rate ↑ 24.4 ± 1.2 
   Cardiac output ↓ -3.4 ± 0.6 
   SVRI ↑ 14.3 ± 1.3 
BP=blood pressure, SVRI=systemic vascular resistance index. Values are mean ± 
SEM 
 
3. Association between augmentation index and other haemodynamic variables 
 
Association between AIx and other haemodynamic variables was examined in the 
Study I. Supine AIx correlated with aortic systolic BP (r=0.423), aortic reflection time 
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(r=-0.647), PWV (r=0.287), and age (r=0.480). During the head-up tilt, AIx correlated 
significantly with ejection duration (r=0.504), HR (r=-0.339) and age (r=0.408). Both 
AIx and SV decreased in response to head-up tilt (Figures 13A-13B), but the 
correlation between the magnitude of the change between these two variables was not 
significant (p=0.131). The change in AIx during head-up tilt correlated with the 
change in aortic systolic BP (r=0.469), aortic pulse pressure (r=0.606), ejection 
duration (r=0.374) and HR (r=-0.445) (Figures 13C-13F). 
 
Figure 13. Individual changes from supine to head-up tilt in stroke volume (A) and 
augmentation index (B) and the correlation between the change in augmentation index 
and in aortic systolic BP (C), aortic pulse pressure (D), heart rate (E) and ejection 
duration (D) in response to head-up tilt. 
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4. Haemodynamic response to placebo and pharmacological stimuli 
 
4.1. Placebo 
 
In the Study II, sublingual NTG and placebo resoriblet, and salbutamol and placebo 
inhalations were administrated in a blinded, randomized fashion. Administration of 
placebo simultaneously tests the habituation of a subject to the measurement protocol 
during the same session. The effect of placebo drugs on haemodynamics was analysed 
by calculating the difference between the measurements before (0-15 min) and after 
(16-30 min) the placebo drug administration (study protocol in Figure 9). Small but 
statistically significant changes in some of the haemodynamic variables were 
observed. After placebo resoriblet, radial systolic BP (-1.9 mmHg, p=0.010), aortic 
and radial diastolic BP (-2.0 mmHg and -2.1 mmHg, p=0.005 and 0.040, respectively) 
and CI (-0.08 l/min/m2, p=0.010) were lower when compared with the preceding 
phase. After placebo inhalation, radial and aortic systolic BP (-2.0 mmHg and -2.2 
mmHg, p<0.001 for both) and HR (-1.0 /min, p<0.001) were lower when compared 
with the measurements before placebo inhalation. Other variables did not change 
significantly. Figure 14 represents the median of the change in aortic systolic and 
diastolic BP, HR and CI in response to placebo drug administration. 
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Figure 14. Change in aortic systolic BP (A, B), aortic diastolic BP (C, D), heart rate 
(E, F) and cardiac index (G, H) in response to placebo resoriblet and placebo 
inhalation administration. Median (bold line) and individual curves (gray lines). 
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4.2. Sublingual nitroglycerin 
 
In Study II sublingual 0.25 mg NTG was administrated in a placebo controlled 
fashion. The possible effect of placebo resoriblet was taken into account in the 
statistical analysis: if significant changes were observed both after placebo and NTG 
resoriblet administration, it was calculated whether the NTG effect differed from the 
placebo effect. In response to NTG, aortic BP and PP, finger BP and radial diastolic 
BP and PP decreased. HR, CI, SI and aortic reflection time markedly increased, while 
SVRI, AIX and PWV clearly decreased (<0.05).  
 
The effect of NTG on most variables was different in supine and upright positions. 
The effect on radial and aortic diastolic BP, finger BP, aortic and radial PP, HR, 
SVRI, CI and AIx was greater during tilt when compared with supine values (p<0.040 
for all). During the last supine phase the effect of NTG on aortic and radial BP and 
PP, HR, CI, SVRI, AIx and aortic reflection time was less marked when compared 
with the first supine phase after drug administration (p<0.040 for all).  Mean values of 
radial mean BP, AIx, aortic reflection time, HR, CO and SVRI during NTG, 
salbutamol and corresponding placebo drug administration are presented in Figure 15. 
The statistical analysis is based on the magnitude of the difference observed in 
variables before and after drug administration. 
 
In the Study III, the effect of sublingual 0.25 mg NTG was compared with placebo 
resoriblet effect. NTG decreased supine and upright SVRI (-6.7±1.7% and -7.8 ± 
5.8%) and increased supine and upright CO (+10.6±5.6% and +20.5±6.2%). Supine 
AIx was decreased (-18.7±3.2%), while HR (+40.4±7.5%) and aortic reflection time 
(+1.2±3.4%) were increased during the tilt when compared with the placebo effects 
(p<0.05 for all). NTG induced a small but significant reduction in PWV (-5.7 ± 2.4%) 
when compared with placebo resoriblet (0.9 ±1.7%) (p< 0.05). 
 
65 
 
Figure 15.  Mean values of radial mean BP (A), augmentation index (B), aortic 
reflection time (C), heart rate (D), cardiac output (E) and systemic vascular resistance 
index (F) before and after research drug or placebo administration (Study II). 
Mean±SEM. 
 
 
 
4.3. Inhaled salbutamol 
 
The effect of 400 µg salbutamol inhalation was also analysed in a placebo controlled 
fashion. Salbutamol administration induced significant changes in many variables, but 
in general the changes were less marked than those observed after NTG 
administration (Figure 15). Radial and aortic BP, aortic PP, finger diastolic BP, SVRI 
and AIx decreased, while HR and CI increased in response to salbutamol (p<0.05 for 
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all). The placebo-controlled effect of salbutamol on HR and CI was greater during the 
last supine phase when compared with the tilt-phase and the first supine phase after 
drug administration (p<0.040 for all). The effect on radial systolic BP and finger BP 
was greater during the last supine phase when compared with the first supine phase 
(p<0.040).  Mean values of radial mean BP, AIx, aortic reflection time, HR, CO and 
SVRI during NTG, salbutamol and corresponding placebo drugs administration are 
presented in Figure 15. 
 
In the Study III, the effect of inhaled salbutamol was compared with placebo 
inhalation effect. In response to salbutamol, supine SVRI decreased by -9.2±2.6% 
(p<0.05 when compared with placebo), while SVRI during head up tilt was 
numerically, but not statistically significantly lower with salbutamol than with 
placebo. Supine HR increased by +8.6±2.5% (p< 0.05 compared with placebo 
inhalation). In the supine position after the head-up tilt AIx was significantly lower 
after salbutamol when compared with placebo (numerical values 5.5±2.4% vs. 
14.1±3.2%, respectively). During the head-up tilt aortic systolic BP after salbutamol 
inhalation was lower than after placebo inhalation (106±2 mmHg vs. 113±2 mmHg).  
 
To document the salbutamol-induced synthesis and release of NO, exhaled alveolar 
NO concentration was measured in six study subjects both after placebo and 
salbutamol inhalations. Alveolar NO concentration in these subjects was 1.55 ±0.17 
parts per billion before salbutamol inhalation, while the concentration was 1.81 ±0.19 
parts per billion before placebo inhalation. After salbutamol inhalation alveolar NO 
concentration increased by 19%, whereas after placebo inhalation the concentration 
decreased by 10% (p = 0.01). Figure 16 depicts the change in alveolar NO 
concentration after salbutamol and placebo inhalations. 
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Figure 16. Change (%) in alveolar nitric oxide concentration after salbutamol and 
placebo inhalations. 
 
 
 
4.4. Intravenous L-arginine 
 
The haemodynamic effects of L-arginine infusion were compared with the preceding 
phase during the same measurement session, during which only saline was infused. 
The modest haemodynamic effects of L-arginine infusion were only observed during 
the head-up tilt (Table 9). Differences in comparison with saline infusion were 
detected in aortic and radial BP and aortic reflection time: BP was decreased (p<0.05) 
while time to reflection was numerically increased (p=0.162). However, aortic 
reflection time during head-up tilt with L-arginine infusion was significantly longer 
than with placebo resoriblet, placebo inhalation and salbutamol inhalation (p<0.05 for 
all). L-arginine had no significant effects in supine position on any of the studied 
variables. 
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Table 9. Mean values in the upright position during saline and L-arginine infusions. 
Variable 
Saline infusion 
head-up tilt 
L-Arginine infusion 
head-up tilt 
Tonometry   
   Radial  systolic BP (mmHg) 127 ± 2 121 ± 2* 
   Aortic systolic BP (mmHg) 111 ± 2 105 ± 2* 
   Radial diastolic BP (mmHg) 79 ± 1 74 ± 2* 
   Aortic diastolic BP (mmHg) 80 ± 2 74 ± 2* 
   Augmentation index (%) 4.2 ± 2.8 3.2 ± 2.6 
   Aortic reflection time (ms) 162 ± 4 170 ± 4† 
   Ejection duration (ms) 277 ± 8 290 ± 9 
Impedance cardiography   
   Stroke volume (ml) 68 ± 5 71 ± 5 
   Heart rate (beats/min) 68 ± 3 65 ± 2 
   Cardiac output (l/min) 4.58 ± 0.27 4.55 ± 0.24 
   SVRI (dyn*s/cm5*m2) 3052 ± 174† 2920 ± 166 
BP=blood pressure, SVRI= systemic vascular resistance index 
* p<0.05 when compared with saline infusion. Mean ± SEM; †p<0.05 when 
compared with salbutamol inhalation, placebo inhalation and placebo resoriblet 
 
5. Haemodynamics during NTG induced presyncope  
 
The haemodynamics of 21 subjects with presyncopal symptoms during nitrate 
stimulated tilt table test were compared with 21 age-, gender- and BMI-matched 
control subjects. Control subjects were selected from normotensive study subjects 
measured in the haemodynamic recording study project of our research group. The 
only haemodynamic information used in the selection was the lack of presyncopal 
symptoms after NTG administration. Three subjects encountered a brief total loss of 
consciousness during the head-up tilt in the presence of NTG, and their data was also 
analysed separately.  
 
69 
 
The haemodynamics of the study and control groups did not differ before NTG 
administration (in supine position or during head-up tilt) or during the first 5 minutes 
in supine position after NTG. The study protocol (Figure 9) was carried out 
completely in the control group, while the head-up tilt in the presence of NTG was 
aborted after 3.4 ± 0.2 minutes in the presyncope group. During the last minute prior 
tilt-back, subjects in the presyncope group had lower aortic and radial BP and SVRI, 
and longer aortic reflection time and ejection duration when compared with the 
control group. The decrease in HR during tilt was significantly greater in the 
presyncope group when compared with controls, but the absolute values during the 
last minute in the upright position did not differ. Other variables did not significantly 
differ between the groups. The values during the last minute prior tilt-back in the 
presence of NTG are presented in Table 10.    
 
Table 10. Mean values during the last minute before tilt-back during the nitroglycerin 
stimulated tilt table test. 
Variable 
Control 
n=21 
Presyncope 
n=21 
Tonometry   
   Radial systolic BP (mmHg) 121 ± 3 98 ± 4* 
   Aortic systolic BP (mmHg) 104 ± 3 86 ± 3* 
   Radial diastolic BP (mmHg) 76 ± 2 62 ± 3* 
   Aortic diastolic BP (mmHg) 77 ± 2 63 ± 3* 
   Aortic pulse pressure (mmHg) 27 ± 1 24 ± 2 
   Aortic augmentation index (%) -4 ± 2 -9 ± 3 
   Aortic reflection time (ms) 161 ± 4 199 ± 8* 
   Ejection duration (ms) 251 ± 5 277 ± 10* 
Impedance cardiography   
   Stroke index (ml/m2) 39 ± 1 39±2 
   Heart rate (beats/min) 84 ± 3 81 ± 3 
   Cardiac index (l/min/m2) 3.3 ± 0.1 3.1 ± 0.1 
   SVRI (dyn*s/cm5*m2) 1944 ± 99 1607 ± 77* 
BP=blood pressure, SVRI=systemic vascular resistance index 
* p<0.05 when compared with control. Mean±SEM  
70 
 
Subjects with a brief loss of consciousness 
Three subjects underwent a total loss of consciousness after reporting presyncopal 
symptoms, but the consciousness was rapidly restored after tilt-back. Due to the small 
number of subjects, their data was analysed separately, and was not compared with 
the other groups. During the tilt with NTG in these subjects, a decrease in SVRI and 
BP was documented first, with CI remaining constant (180-60 seconds before the tilt-
back). Just before the loss of consciousness a further, but a moderate decrease in 
SVRI, and a clear decrease in CO, HR and BP was documented (30-0 seconds before 
the tilt back).   
 
Additional measurements 
Measurements with an alternative study protocol (Figure 10) were performed to 19 
study subjects to investigate whether the administration of NTG in different body 
position would change the haemodynamic pattern observed during presyncope. In 
addition, the head-up tilt phases were longer (15-20 min) when compared with the 
initial protocol (5 min). It was documented that SVRI and BP (radial and aortic mean 
BP, aortic PP) decreased and aortic reflection time increased in the presyncope group, 
while CI was preserved at a higher level than it was before NTG administration. 
During the last minute in the upright position, SVRI was significantly lower (P = 
0.001) and aortic reflection time longer (P = 0.049) in the presyncope group when 
compared with the non-syncope group, while there were no statistically significant 
differences in other variables. These results support the initial finding of decreased 
vascular resistance as the principal haemodynamic alteration during NTG-induced 
presyncope. 
 
6. Impact of age on supine and upright haemodynamics 
 
The four age groups had some differences in the physical characteristics and 
laboratory values. BMI and waist circumference of subjects aged 20-29 years were 
lower than in 40-49 year-old and 50-59 year-old subjects, and those of 30-39 year-old 
subjects were lower than in 50-59 year-old subjects (p<0.05).  Estimated GFR was 
higher in 20-29 year-old subjects when compared with 40-49 and 50-59 year-old 
subjects, and in 30-39 year-old subjects when compared with 50-59 year-old subjects 
(p<0.05). Plasma LDL-cholesterol increased with age (p<0.05). The differences were 
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taken into account in the statistical analysis, since BMI, cholesterol status and 
estimated GFR were considered as confounding factors in multivariate analysis. 
 
The haemodynamic measurements of four different age groups in supine position and 
during head-up tilt are presented in Figure 17 (aortic BP and PP, AIx, aortic reflection 
time, HR, CI and SVRI). All of the comparisons were adjusted for several 
confounding factors in multivariate analysis (see statistical methods). Aortic and 
radial systolic BP and PP increased significantly with age, even after full adjustment 
for the confounders (Figure 17A and 17C, p<0.05). Aortic and radial diastolic BP 
increased with age after the adjustment for sex, but not after the adjustment for other 
confounders (Figure 17B). A decrease in aortic reflection time and an increase in AIx 
were documented with age, and the difference was significant after the adjustment for 
confounding variables (Figure 17D and 17E, p<0.05 for both). A general difference 
between the groups in the fully adjusted statistical model was observed in HR, but the 
mean or median values did not show a systematic direction of the difference with age 
(Figure 17F).  In addition, there was a general age-related difference in SVRI, but 
after adjustment for sex or other confounding variables the difference was no more 
statistically significant (Figure 17G). PWV increased significantly with age before 
and after adjustment for confounders, and the correlation between PWV and age is 
shown in Figure 18 (r=0.623, p<0.001). CI or SI did not differ by age (Figure 17H).  
 
All study subjects were further divided to subgroups according to their smoking status 
and alcohol consumption level. Smoking status or alcohol consumption did not have 
an influence on BP. HR differed by the smoking status and the level of alcohol 
consumption (p<0.05), so that the smokers and subjects consuming more alcohol had 
a higher HR during the head-up tilt but not in the supine position. Smoking status did 
not have an influence on the level of augmentation or the time of pulse wave 
reflection, but aortic reflection time differed by the level of alcohol consumption 
(p<0.05)  The difference was only observed during the tilt, so that lower alcohol 
consumption corresponded to a lesser decrease in aortic reflection time. CI, SI, SVRI 
or PWV did not differ by smoking status or the level of alcohol consumption.  
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Figure 17. Aortic systolic and diastolic BP (A, B), aortic pulse pressure (C), 
augmentation index (D), aortic reflection time (E), heart rate (F), systemic vascular 
resistance index (G) and cardiac index (H) in different age groups. 
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Figure 18.  Correlation between age and pulse wave velocity. 
 
 
 
Linear regression analysis was applied to study whether the changes in 
haemodynamic variables in response to head-up tilt differed by age. The age of 50-59 
years, PWV and baseline of aortic systolic BP were significant explanatory factors for 
the change in aortic systolic BP during the head-up tilt (p<0.007), with older subjects 
showing a more pronounced decrease when compared with younger ones. Figure 19 
presents the median change in aortic systolic BP in response to head-up tilt in the 
different age groups. However, age was not an explanatory factor for the observed 
changes in the other variables in the regression analysis, but the influence of the 
baseline level of each variable (i.e. the value in the first measurement point) remained 
significant in all final models. For example, the change in aortic reflection time 
(Figure 17E) clearly differed between the different age groups. However, in the 
regression analysis age was not, but the baseline value of the reflection time and PWV 
were significant explanatory factors for the change (p<0.05).  
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Figure 19. Median change (bold line) in aortic systolic blood pressure during head-up 
tilt in different age groups (interquartile range ± SD; outliers defined by circles).  
 
 
 
 
7. Subjects with essential hypertension or metabolic syndrome 
 
The characteristics of the subjects are presented in Table 11. In the haemodynamic 
measurements, subjects with MetS and hypertension had higher aortic and radial BP 
and SVRI when compared with controls (Figure 21). Subjects with MetS had higher 
HR and lower SI than the other groups, but CI did not differ between the groups 
(Figure 21). AIx or AIx adjusted to HR 75 beats/min did not differ between the 
groups. Control subjects had lower aortic PP than subjects with MetS, and longer 
aortic reflection time than hypertensive subjects in the supine position (p<0.05 for 
both). PWV of the subjects with MetS was significantly higher when compared with 
the other groups (Figure 20).  
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Table 11. Study population  
Variable Control Hypertensive MetS 
Number of subjects 19 19 19 
Age (years) 48±2 47±2 48±2 
Body mass index (kg/m2) 24.4±0.5 25.7±0.6 32.3±1.0* 
Waist circumference (cm) 91±2 93±2 112±2* 
Office systolic BP (mmHg) 126±1 159±5† 165±4† 
Office diastolic BP (mmHg) 81±1 99±2† 103±2† 
Office heart rate (1/min) 61±1 67±2 75±3* 
Fasting plasma glucose (mmol/l) 5.3±0.1 5.3±0.1 6.2±0.1* 
Uric acid (µmol/l) 268±30 315±21 417±14* 
Alanine aminotransferase (U/l) 23±2 30±3 53±5* 
Cholesterol (mmol/l) 5.2±0.2 5.0±0.2 5.8±0.2‡ 
LDL cholesterol (mmol/l) 3.2±0.2 3.0±0.2 3.5±0.2 
HDL cholesterol (mmol/l) 1.47±0.09 1.50±0.09 1.09±0.06* 
Triglycerides (mmol/l) 1.02±0.06 1.03±0.09 2.95±0.30* 
*p<0.05 when compared with hypertensive and controls. †p<0.05 when compared 
with controls, ‡p<0.05 when compared with hypertensive 
 
Figure 20.  Supine pulse wave velocity in in controls and in subjects with either 
essential hypertension or metabolic syndrome. 
 
 
MetS=Metabolic syndrome. *p<0.05. 
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Figure 21. Aortic systolic and diastolic BP (A, B), heart rate (C), systemic vascular 
resistance index (D), cardiac index (E) and stroke index (F) in controls and in subjects 
with either essential hypertension or metabolic syndrome. *p<0.05. 
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DISCUSSION 
 
1. Subjects 
 
The present investigations were designed to set up a novel measurement protocol for 
the study of cardiovascular function, and this was achieved by combining methods 
that were commercially available and had been previously used in many published 
reports. To avoid possible confounding factors induced by i.e. cardiovascular 
pathology, only normotensive subjects were included in the studies I-V. Finally, 
additional measurements were performed in subjects with essential hypertension or 
MetS to test the application in patients. None of the study subjects were taking 
medication for cardiovascular diseases.  
 
The subjects included in the present studies were all under the age of 60 years, and 
thus the results must be applied to elderly subjects with caution. More advanced age is 
known to be associated with enhanced large arterial stiffening thus increasing central 
and peripheral BP, PWV and arterial wave reflection (McEniery et al. 2005). 
Haemodynamic profile of aged individuals during tilt table test may be clearly 
different from that of the younger ones, as already suggested by the results in the 
Study V examining subjects less than 60 years of age. 
 
Recent reports have shown several haemodynamic differences between sexes (Gatzka 
et al. 2001, Shim et al. 2011). For example, higher AIx, higher central PP and lower 
PP amplification have been documented in women when compared with men (Shim et 
al. 2011). Only in the Study V the results were adjusted for sex, while in the Study IV 
gender-matched control-case pairs were examined. In the Studies I-III the data of 
male and female subjects was analysed together due to relatively small number of 
subjects. This can be considered as a limitation, and in future studies it is of 
importance to analyse the results of male and female subjects separately. 
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2. Methods and measurement protocol 
 
Impedance cardiography 
ICGWB is an easy, completely non-invasive and continuous method to measure several 
haemodynamic variables, and the possibility of inter-user related errors is minimal. 
As a criticism, ICG technology utilizes mathematical equations to derive the 
haemodynamic variables, and different softwares may use different algorithms and 
yield different results. However, good agreement of ICG-derived CO with 
thermodilution derived values has been demonstrated (Kööbi et al. 1997b, Cotter et al. 
2004, Paredes et al. 2006). It is also of note that the validation measurements of the 
CircMonR software used in the present study have also been performed during head-
up tilt with good results (Kööbi et al. 1997b).  
 
Pulse wave analysis 
Peripheral and estimated central BP and indices of pulse wave reflection were non-
invasively measured with pulse wave analysis system. In the present study a 
tonometric sensor for continuous radial pulse wave detection was used, and the probe 
was fixed on the radial artery with a wrist band. In previous reports, radial waveform 
has usually been detected with a pen-like tonometric sensor, and the operator holding 
the probe has selected only 10-20 successful cardiac cycles for the analyses (Hayward 
et al. 2002). Importantly, the sensor used in the present study enables continuous 
measurement, and the fixation of the probe significantly reduces measurement errors 
related to sensor movements. To ensure the reliability of the central BP results, the 
system was also calibrated approximately every 2.5 minutes. 
 
The SphygmoCor pulse wave analysis system utilizes a generalized transfer function 
to derive central BP from the radial BP signal. The use of transfer functions on 
measured peripheral signal has raised critical conversation about their validity. 
SphygmoCor system utilizes the only commercially available generalized aorto-radial 
transfer function, while several similar transfer functions have been developed and 
published by research groups (Fetics et al. 1999, Hope et al. 2003). Even though the 
functions involve mathematical equations with slight differences, it is unlikely that 
they produce significantly different results due to the relatively wide confidence 
intervals associated with these methods, as stated also by O’Rourke (2007), an 
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innovator of the pulse wave analysis technique. The estimation of the aortic waveform 
using generalized transfer function has been validated against invasive aortic BP 
measurements with good results in several studies (Karamanoglu et al. 1993, Chen et 
al. 1997, Fetics et al. 1999). However, also poor association between estimated and 
measured aortic pressures has been reported (Cloud et al. 2003). Hope et al. (2002) 
documented a relatively poor agreement when using the same generalized transfer 
function for the total study population, but the agreement was improved when using a 
gender-specific transfer function separately in male and female subjects. The results 
above suggest that the development of an accurate transfer function in an on-going 
process, and it must be taken into account when interpreting the results. 
 
Taken together, the knowledge of aortic BP greatly improves the characterization of a 
haemodynamic profile. However, invasive measurement of central BP is not justified 
in subjects without a clinical reason, and despite its limitations, the use of a transfer 
function on radial BP signal provides a non-invasive, easy and widely applicable 
method for central BP estimation. 
 
Measurement protocol 
As a distinction from previous studies on human haemodynamics, the measurements 
in the present study were performed in both supine position and during head-up tilt. 
The change in body position, a relatively simple physiological challenge, produced 
marked haemodynamic changes in all measured variables, and the response to 
sublingual NTG and inhaled salbutamol was also different in different postures. The 
repeatability and reproducibility of the measurement protocol, both supine and during 
tilt was comprehensively examined with good results.  
 
The change in body posture from supine to upright induces significant changes in 
blood distribution, arterial resistance and autonomic nervous system, and orthostatic 
challenge can thus be regarded as an exercise test addressing cardiovascular reactivity 
(Avolio and Parati 2011). Importantly, it can be argued that measurements performed 
only at rest provide very limited haemodynamic information. Previous reports have 
shown that the changes in haemodynamic variables in response to physical challenge 
have also prognostic value. Hypertension was more likely to develop to Japanese men 
with enhanced BP response to a simple 4-minute 2-step exercise test during a 16-year 
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follow-up (Tsumura et al. 2002). In addition, patients with an abnormal BP response 
during a treadmill exercise test have increased risk of cardiovascular complications at 
elective vascular surgery (de et al. 2011). With the present measurement protocol it is 
possible to examine how the functional change in response to head-up tilt differs in 
subjects with various cardiovascular pathologies, and this could also provide 
prognostic information. Since the change in body posture leads to clear changes in 
autonomic nervous tone, the lack of assessment of sympathetic activity in the present 
study must be considered as a limitation.  
 
3. Determinants of augmentation index 
 
As the AIx was introduced, it was generally considered as an easily available marker 
of arterial stiffness. However, recently it has been described as an indicator of central 
wave reflection, arterial stiffness being one of its determinants. In addition to age, 
arterial compliance and BP, AIx is influenced by cardiac function and sites of wave 
reflection (Wilkinson et al. 2002a). In the present study (Study I), AIx at rest 
correlated with aortic systolic BP, age and aortic reflection time, consistent with 
previous studies (Wilkinson et al. 2002b, Sakurai et al. 2007). AIx also correlated 
with PWV at rest, but the relatively weak correlation stresses the view that other 
determinants in addition to arterial stiffness markedly influence AIx. 
 
Both AIx and SV decreased in response to head-up tilt, thus showing that the changes 
in body position and cardiac function have a major influence on the level of 
augmentation. The magnitude of the decrease in AIx during head-up tilt correlated 
significantly with the changes in aortic systolic BP and PP, ejection duration and HR. 
An increase in HR is known to decrease the duration of ventricular ejection and 
systole, shifting the reflecting wave towards diastole, which subsequently causes the 
reduction of systolic BP and AIx. Previously, AIx has been reduced by 4–5 % for 
each 10 beats/min increment in HR during pacing (Wilkinson et al. 2000a). Thus, the 
increase in HR during tilt in the present study (~15beats/min) is not sufficient to 
explain the observed decrease in AIx (~11%), and also other mechanisms, like 
changes in stroke index, must be involved. 
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4. Effect of pharmacological stimuli on supine and upright haemodynamics 
 
The haemodynamic effects of sublingual NTG and inhaled salbutamol were assessed 
placebo-controlled (Studies II and III), so that the small but significant placebo-
induced changes in some variables were taken into consideration in the analysis of 
drug effects (chapter 5.3.1.) This approach further strengthened the findings.   
 
Sublingual nitroglycerin 
Small doses of sublingual NTG have been traditionally considered as venodilators, 
leading to increased venous pooling and subsequently reduced left ventricular 
preload. The effect on arterial tone has been considered to be lesser, and evident only 
at higher doses of NTG (Mason and Braunwald 1965). However, the results of the 
present study strongly imply that a small 0.25 mg dose of sublingual NTG induces 
arterial dilatation, since a marked decrease in SVRI and an increase in aortic 
reflection time were observed. In addition, the study provided no evidence of 
increased venous pooling after NTG. On the contrary, CO was clearly increased. NTG 
also decreased AIx, probably via the decrease in SVRI and subsequent reduction in 
PWV, and delayed the return of the reflected pressure wave. Autonomic nervous tone 
was not assessed in the present study, but in addition to its direct vasodilatory effect 
NTG can also sensitize the baroreflex arc, thus leading to reduced sympathetic tone 
and decreased SVRI (Zanzinger 1999). Results of a thorough statistical analysis 
showed, that the effect of NTG on many variables was enhanced during the head-up 
tilt when compared to the effect in the supine position. These changes may be 
explained by the alterations in baroreflex sensitivity, neurohormonal changes, and the 
effect of gravity during active vascular smooth muscle relaxation during the tilt. 
 
The mechanisms of nitrate-induced presyncope have remained controversial in the 
literature. Again, increased venous pooling has been suggested in several reports 
(Gisolf et al. 2004, Verheyden et al. 2007), while only few studies have documented 
decreased vascular resistance during presyncope (Mitro and Hijova 2006). In the 
Study IV, a clear decrease in SVRI and increase in aortic reflection time during 
presyncope was observed, while CO was maintained at a higher level than before 
NTG administration. Only in three subjects with a brief total loss of consciousness, 
the final measurements preceding the collapse were characterized by decreased CO 
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and HR, which may imply a central sympatho-inhibitory effect of NTG during the 
final phase of the tilt test.  
 
The present study protocol differed from the majority of the previous reports, since 
NTG was administrated supine instead of upright position. However, a decrease in 
SVRI, but not in CO, was also documented in the additional measurements in which 
NTG was administrated during the tilt. Since indices of arterial stiffness or wave 
reflection (AIx, PWV, aortic reflection time) did not differ between the presyncope 
and control groups, it can be argued that the mechanical properties on large arteries 
did not explain the increased sensitivity to NTG. However, as a difference of the 
previous reports on haemodynamics during presyncope (Gisolf et al. 2004, Verheyden 
et al. 2007), the subjects of the present study had not reported a history of unexplained 
syncope. In the future, the protocol should also be evaluated in syncopal subjects.   
 
Inhaled salbutamol 
The important role of vascular endothelium in haemodynamic regulation has also led 
to the development of methods assessing endothelial function in vivo. An ideal 
method would be easy, non-invasive and repeatable, and applicable to the whole 
arterial tree. In 2002, Wilkinson et al. (2002) introduced a method, in which changes 
in the tonometric measures of arterial wave, especially in AIx, after salbutamol 
inhalation were used as a measure of global endothelial function. A decrease of ~9 % 
in AIx was documented after salbutamol inhalation, while no significant change in 
AIx was observed when salbutamol was administrated after eNOS inhibitor infusion. 
Based mostly on these results, it has been considered that the salbutamol-induced 
changes in AIx are largely endothelium-mediated. Since its introduction, the method 
has been widely applied with similar results (Hayward et al. 2002). However, 
salbutamol-induced β2-adrenoceptor stimulation may also result in changes in cardiac 
function, which has not been commonly measured.  
 
An increase in alveolar NO concentration after salbutamol inhalation was documented 
when compared with placebo, verifying the salbutamol increased release of NO. The 
measurements were only performed in a small number of subjects (n=6), but as the 
result was clear, no further measurement were performed. It should be noted that in 
the haemodynamic measurements inhaled salbutamol not only decreased AIx, but also 
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reduced BP and SVR. In addition, HR and CO were increased, and the effect was 
greater in supine position when compared to tilt. This emphasizes the importance of 
the analyses of endothelial function to be performed also in the upright position. As 
PWV was not changed, this implies that the observed decrease in AIx indeed resulted 
from decreased and delayed wave reflection in response to decreased SVR, and not 
from changed large arterial compliance. 
 
Intravenous L-arginine 
L-arginine, a semi-essential amino acid, acts as a precursor for eNOS, thus inducing a 
largely endothelium-dependent vasodilatation. Measurable vasodilatation in response 
to L-arginine administration has been reported in both healthy subjects and in subjects 
with various cardiovascular diseases, but it should be noted that the results have 
remained rather controversial. For example, Drexler et al. (1994) demonstrated that 
improvement of coronary endothelial function with L-arginine was more likely in 
vessels with normal wall morphology(Drexler et al. 1994), while another report 
documented a more pronounced vasodilator effect of L-arginine in stenosed coronary 
arteries when compared with healthy vessel segments (Tousoulis et al. 1998). It has 
been stated that eNOS should be saturated with physiological levels of L-arginine, 
and not to be dependent on extracellular substrate supply. However, excess 
availability of L-arginine may overcome the effects of asymmetric dimethylaginine 
(ADMA), an endogenous molecule with eNOS inhibitory effects (Leiper and 
Vallance 1999). Elevated concentrations of ADMA are present in patients with 
vascular diseases, which explain the effects of L-arginine in these patients (Perticone 
et al. 2005). In healthy subjects, the vasodilatory effects of L-arginine may also be 
mediated via endocrine mechanisms, i.e. stimulation of growth hormone and insulin 
secretion (Merimee et al. 1967).  
 
In the present study, the relatively large dose of L-arginine should have been 
sufficient to induce cardiovascular changes, when compared with previous reports 
examining L-arginine effects (Delles et al. 2003, Koifman et al. 2006). However, the 
haemodynamic effects of L-arginine in healthy subjects were modest and documented 
only in the upright position, during which BP vas decreased and aortic reflection time 
increased. The time to reflected wave increases with the decrease in arterial 
compliance, and the reflected wave is shifted towards diastole. However, L-arginine 
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did not lower AIx, probably due similar effects on augmentation pressure and PP, the 
determinants of AIx. Since SVRI did not change after L-arginine, documented effects 
can be considered to have resulted from increased large arterial compliance. 
 
5. Ageing and haemodynamics 
 
Ageing is associated with structural and functional changes in the vasculature, 
including large arterial dilatation and stiffening (Greenwald 2007, O'Rourke and 
Hashimoto 2007). However, age-related changes in smaller arteries are considered not 
to be as profound as in the larger ones. In concert with the view above, results of the 
present study (Study V) showed a clear age-related increase in radial and aortic 
systolic BP and PP, PWV, AIx and a decrease in aortic reflection time, while no 
systematic age-related difference was observed in HR, SVRI or CO. Diastolic BP was 
lower in 50-59 year-old subjects when compared with the 40-49 year-old subjects, 
which may be explained by the increased stiffness in the older subjects, and shifting 
of the reflected pressure wave towards systole. AIx and PWV differed significantly 
already in younger age groups, while aortic PP was increased only after the age of 50 
years (Figure 17C). This suggests that PP is a relatively inaccurate marker of arterial 
stiffness in younger subjects. Indeed, the relationship between large arterial stiffening 
and age has been documented to be non-linear, with an acceleration of aortic 
stiffening after the 5th decade of life (McEniery et al. 2005). In the present study, the 
correlation between age and AIx or PWV seemed to be linear, probably due to the 
lack of older subjects (>60 years).    
  
The incidence of orthostatic hypotension increases with age (Rutan et al. 1992), but 
the underlying haemodynamic mechanisms are not completely clear. For example, 
increased arterial stiffness, increased venous pooling of blood and attenuated HR 
response due to decreased baroreflex sensitivity have been suggested as mechanisms 
of impaired haemodynamic regulation (Monahan et al. 2001, Mattace-Raso et al. 
2006, Verheyden et al. 2007). Increased arterial stiffness at sites rich in baroreceptors 
may further decrease baroreflex sensitivity (Monahan et al. 2001). 
 
In the Study V, adjusted regression models revealed that the age of 50-59 years was a 
significant explanatory factor for enhanced decrease in aortic systolic BP during tilt. 
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In addition, baseline PWV, the golden standard of arterial stiffness, explained the 
more pronounced change. Moreover, aortic reflection time decreased numerically 
more during the head-up tilt in younger than older subjects, and baseline PWV was a 
significant explanatory factor for the change. These results imply that increased 
arterial stiffness with ageing can explain the age-related haemodynamic differences in 
the responses to head-up tilt. In the present study, no systematic differences in HR or 
SVRI responses to tilt were observed, suggesting preserved baroreflex sensitivity. 
Futhermore, contrary to the view of increased venous pooling of blood in the older 
subjects (Verheyden et al. 2007), the decrease in CO during tilt did not differ with 
ageing in the present study. It is of note that the subjects of the present study were 
relatively young, although comparable with some of the previous studies with 
different findings (Monahan et al. 2001, Verheyden et al. 2007). In the future the 
measurements should be repeated in older subjects. In addition, a longitudinal study 
examining individual age-related changes would provide more detailed information 
about the age-associated changes than the present, cross-sectional view.   
 
6. Clinical implications 
 
Several haemodynamic factors that have an influence on BP or on individual 
cardiovascular risk profile, are not routinely assessed in clinical practice. For 
example, increased arterial stiffness and impaired endothelial function have been 
associated with increased cardiovascular mortality and morbidity, and BP measured 
from central arteries serves as a better predictor of cardiovascular outcome than 
peripheral BP. In addition, the determination of functional haemodynamic status 
utilizing a physiological challenge to the cardiovascular system could provide more 
crucial information than the measurements performed only at rest. 
 
To test the present application in patients, subjects with essential hypertension or 
MetS were examined in comparison with normal subjects. The BP level or SVRI of 
the two patient groups did not significantly differ from each other. However, subjects 
with MetS had higher HR and lower SI than the other groups, demonstrating 
differences in the regulation of cardiac function. In addition, despite very similar 
elevation of BP, subject with Mets had significantly higher PWV when compared 
with hypertensive subjects. These results demonstrate that the other components of 
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MetS in addition to hypertension clearly contribute to the increased arterial stiffness 
in these subjects. These preliminary results also strengthen the view that distinct 
haemodynamic alterations beyond mere elevation of BP can be found in different 
cardiovascular disorders. 
 
The present measurement protocol provides a repeatable and an easy method for the 
detailed characterization of patients’ haemodynamic profile. The method is applicable 
to almost all patients, since it is completely non-invasive and safe. In the future, the 
haemodynamic profile of patients with various cardiovascular disorders, both supine 
and upright, is going to be further evaluated. In addition, the prognostic value of the 
measured variables and the responses to head-up tilt can be analysed after follow-up 
measurements. Furthermore, the effects of interventions, both pharmacological and 
non-pharmacological, can individually be determined.
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SUMMARY AND CONCLUSIONS 
 
The present non-invasive haemodynamic measurement protocol is a novel 
combination of methods, utilizing both physiological and pharmacological challenges 
to cardiovascular system. In the future, the method can be applied to patients in 
clinical practice to gather detailed functional haemodynamic information. 
 
The results of the present study can be summarized as follows: 
 
1. Haemodynamic measurements with non-invasive ICG, continuous pulse wave 
analysis and plethysmographic finger BP measurements were highly 
repeatable and reproducible both in supine position and during passive 
orthostatic challenge. Head-up tilt as a physiological challenge induced 
significant changes in almost all measured variables. 
 
2. A small dose of sublingual NTG resulted in marked haemodynamic responses 
especially during the head-up tilt. Inhaled salbutamol induced several 
haemodynamic changes, and some of the effects were enhanced in the supine 
position, while the modest effects of intravenous L-arginine could only be 
observed during the tilt. The present results show that the administration of 
inhaled salbutamol combined to the measurement protocol can be applied to 
evaluate the role of the endothelium in cardiovascular responsiveness. 
Divergent drug effects in different body positions underline the importance of 
upright measurements. 
 
3. A significant decrease in SVRI was observed during NTG-induced presyncope 
when compared with control subjects without presyncopal symptoms. 
Contrary to the previously accepted view, no evidence of increased venous 
pooling and a subsequent decrease in cardiac output could be observed. 
 
4. Ageing was associated with increased arterial stiffening and wave reflection, 
while no age-related changes were observed in vascular resistance or cardiac 
function. In addition, the observed age-related changes in the responses to 
head-up tilt could be largely explained by the increased large arterial stiffness. 
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5. Haemodynamic profile of subjects with essential hypertension or MetS clearly 
differed from that of the control subjects. In addition, subjects with MetS had 
higher HR and PWV than hypertensive subjects, demonstrating differences in 
the regulation of cardiac function, and increased arterial stiffness in MetS. 
These results support the view of the clinical applicability of the present non-
invasive functional examination of the cardiovascular system. 
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Analysis of cardiovascular responses to passive head-up tilt using continuous pulse wave
analysis and impedance cardiography
Anna Tahvanainen1, Jenni Koskela1, Antti Tikkakoski1, Jorma Lahtela1, Miia Leskinen1, Mika Ka¨ho¨nen2,3,
Tuomo Nieminen4, Tiit Ko¨o¨bi3, Jukka Mustonen1,5 and Ilkka Po¨rsti1,5
1Department of Internal Medicine and 2Department of Clinical Physiology, University of Tampere, Tampere, Finland;
3Department of Clinical Physiology, Tampere University Hospital, Tampere, Finland; 4Department of Pharmacological Sciences,
University of Tampere, University of Tampere, Tampere, Finland; 5Department of Internal Medicine, Tampere University
Hospital, Tampere, Finland
Objective. To non-invasively measure central haemodynamics, arterial stiffness, cardiac function and vascular
resistance, with the subject in the supine position and during head-up tilt, in order to examine the haemodynamic
changes associated with alterations in the augmentation index, and to investigate repeatability and
reproducibility of the measurement protocol. Material and methods. Thirty-three healthy volunteers (21–51
years) were investigated using continuous pulse wave analysis from the radial artery with a tonometric sensor,
whole-body impedance cardiography and plethysmographic blood pressure (BP) recordings from the fingers. The
measurements were performed with the subject supine and during passive head-up tilt, and repeated during the
same session and on four separate days. Results. During the head-up tilt, diastolic BP (5.2¡0.6 %), heart rate
(27.6¡1.9 %) and vascular resistance (12.5¡1.7 %) increased (all pv0.05), while systolic BP (23.2¡0.6 %),
aortic pulse pressure (223.3¡1.4 %), augmentation index (211.6¡0.7 %), aortic reflection time (27.0¡1.0 %),
ejection duration (221.4¡0.7 %), stroke volume (226.1¡1.2 %) and cardiac output (25.0¡1.5 %) decreased
(all pv0.05). Augmentation index at rest correlated with aortic systolic BP (r50.423), aortic reflection time
(r520.647), pulse wave velocity (r50.287) and age (r50.480). The change in augmentation index during head-up
tilt correlated with the change in aortic systolic BP (r50.469), aortic pulse pressure (r50.606), ejection duration
(r50.374) and heart rate (r520.445). According to Bland-Altman and repeatability index analyses, repeatability
and reproducibility of the measurements were good during the same session and on separate days. Conclusions.
Combined pulse wave analysis and impedance cardiography with the subject in the supine position and during
head-up tilt is a repeatable and reproducible method for comprehensive investigation of the cardiovascular
function.
Keywords: Arterial stiffness; cardiac function; haemodynamics; systemic vascular resistance
Introduction
Hypertension and decreased arterial compliance are
major risk factors for target organ damage in various
cardiovascular disorders, and early detection of a
haemodynamic high-risk profile is an important
measure by which to decrease the incidence of
complications [1,2]. In addition to indirect determi-
nation of brachial blood pressure (BP), non-invasive
pulse wave analysis, which provides information
about central pressures in the circulation, has
improved possibilities to identify subjects with
increased cardiovascular risk [1,3,4]. At present, the
augmentation index (AIx), i.e. the amplitude of the
reflected pressure wave divided by pulse pressure, is
an acknowledged measure of central wave reflection
[2,5]. However, parallel recordings of peripheral
arterial resistance and cardiac output have seldom
been combined with pulse wave analysis, although
these variables are important determinants of AIx
and BP [6].
Pulse wave analysis is usually performed with a
pen-like sensor from 10 consecutive heart beats, with
the study subject resting quietly in the supine position
[7–9]. However, early alterations in arterial compli-
ance, wave reflection and cardiac function may
become more apparent during physical challenge,
since some reports have found that enhanced BP
response to exercise is a predictor of the development
of hypertension [10,11]. There have been very few
studies on pulse wave analysis during physical or
orthostatic challenge, but a recent report found
excellent concordance between invasively and
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non-invasively measured central pressures during a
cycling test [12].
The treatment of hypertension has become
increasingly active and the recommended BP targets
lower, which underscores the need for BP and
haemodynamics to be measured with subjects in the
upright position [13,14]. The purpose of this study
was to examine haemodynamics using continuous
recordings of central wave reflections, cardiac func-
tion and systemic vascular resistance in healthy
volunteers both at rest and during passive orthostatic
challenge, and to test the reproducibility and repeat-
ability of the measurement protocol.
Methods
Study subjects
The study population comprised 33 (17 F and 16 M)
healthy, normotensive individuals aged between 21 and
51 years. All of the subjects underwent physical
examination by a medical doctor. During the interview,
lifestyle habits, family history of cardiovascular disease
and medical history were recorded. All participants
gave written informed consent, and the study was
approved by the Ethics Committee of Tampere
University Hospital (approval no. R06086M).
Experimental protocol
Haemodymamic measurements were carried out by a
trained nurse in a quiet, temperature-controlled,
research laboratory. The study subjects had refrained
from taking caffeine-containing products and from
smoking or eating a heavy meal in at least the 4 h
prior to the study, and from alcohol in at least the
24 h prior to the investigation, but a light breakfast
or meal was allowed 1–3 h before the measurements.
The subjects rested supine on a tilt-table, with the
standard electrodes for whole-body impedance car-
diography placed on the body surface; the tonometric
sensor for pulse wave analysis on the radial pulsation
to the left wrist and oscillometric brachial cuff for BP
calibration to the right upper arm. Before the actual
measurement, an introductory head-up tilt was done
to familiarize the study subject with the tilt. The
actual measurement was haemodynamic data cap-
tured continuously during three consecutive 5-min
intervals. For the first 5 min, the subjects rested
supine on the tilt-table, followed by 5 min of head-up
tilt to 60 degrees. After 5 min standing, the tilt-table
was returned to the horizontal position for another
5 min. To test the repeatability of the method, the
same protocol was repeated immediately (5 min
supine–5 min standing–5 min supine). To elucidate
the reproducibility of the method, the study subjects
underwent the same haemodynamic measurements
on four separate days during a maximum period of 4
weeks (visits 1–4).
Pulse wave analysis
Radial BP and pulse wave form were determined
from the radial pulsation using a tonometric sensor
(Colin BP-508T, Colin Medical Instruments Corp.,
USA) fixed on the radial pulse with a wrist band. A
continuous radial BP signal was calibrated every
2.5 min by a brachial BP measurement. Continuous
aortic BP was estimated with the SphygmoCor pulse
wave monitoring system (SpygmoCor PWMx; AtCor
Medical, Australia) using the previously validated
generalized transfer function [15]. Ejection duration,
aortic reflection time and AIx (augmented pressure/
pulse pressure*100) were determined.
Whole-body impedance cardiography
A whole-body impedance cardiography device
(CircMonH; JR Medical Ltd., Tallinn, Estonia), which
records the continuous changes in body electrical
impedance during a cardiac cycle, and plethysmo-
graphic BP recordings from fingers (Finapres,
Ohmeda, Englewood, Colorado, USA) were used to
determine beat-to-beat heart rate, stroke volume,
cardiac output, systemic vascular resistance index
(SVRI) and pulse wave velocity (PWV) [16–19]. A pair
of current electrodes was placed on the distal parts of
the extremities, just proximal of the wrists and ankles.
Voltage electrodes were placed proximal of the current
electrodes, so that the distance between the centres of
the electrodes was 5 cm. The distal impedance was
recorded from a popliteal artery at knee joint level, and
the active electrode was placed on the lateral side of the
knee and the reference electrode on the calf – the
distance between the electrodes being 20 cm. When
the pulse pressure wave enters the aortic arch and the
diameter of the aorta changes, the whole-body
impedance decreases, and this can be measured by
the voltage electrodes on the distal parts of the
extremities. To calculate the PWV value, the
CircMon software measures the time difference
between onset of the decrease (‘foot’) in impedance in
the whole-body impedance signal and the popliteal
artery signal. The PWV can be determined from the
time difference and the distance between the electrodes.
The cardiac output values measured with
CircMonH whole-body impedance cardiography are
in good agreement with those measured by the
thermodilution method, with the subject in both in
the supine position and during head-up tilt [18]. A
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detailed description of the method and electrode
configuration has been reported previously [17–19].
PWV was not assessed during head-up tilt because of
less accurate timing of left ventricular ejection during
reduced stroke volume.
Laboratory analyses
Blood samples were obtained after a minimum of 12-h
fast in the morning for laboratory analyses, and a
standard 12-lead electrocardiogram was recorded.
Plasma sodium, potassium, calcium, glucose, creati-
nine, triglycerides and total, high-density and low-
density lipoprotein cholesterols were determined by
Cobas Integra 700/800 (F. Hoffmann-LaRoche Ltd,
Basle, Switzerland) and blood cell count by ADVIA
120 or 2120 (Bayer Health Care, Tarrytown, NY,
USA). Creatinine clearance was estimated using the
Cockcroft–Gault formula [20].
Statistical analysis
To compare the measurements performed on the same
day and on four different days (visits 1–4), one-way
analysis of variance (ANOVA) and ANOVA for
repeated measurements were applied. Repeatability
(two consecutive measurements) and reproducibility
(four measurements on different days) were analysed
using two statistical methods: 1) Repeatability and
reproducibility indexes (R) were calculated utilizing
one-way ANOVA: the outcome ranges from 0 to 1,
with 0 indicating no consistency and 1 complete
consistency (expressed as %). R was calculated from
the formula R51–MSw/MST, in which MSw and MST
are square sums indicating variation within a subject
and in the total study population, respectively. 2)
Repeatability and reproducibility values were also
calculated as recommended by Bland & Altman [21],
showing the range as ¡2 standard deviations (SD),
which covered 95 % of the observed differences
between repetitive measurements. To compare the
haemodynamic values with the subject in the supine
position versus the standing position, the paired
samples t-test was utilized. The associations between
the AIx and other variables were investigated using
Pearson’s coefficient of correlation test. P-values
v0.05 were considered statistically significant. Values
were expressed as mean¡standard error of the mean
(SEM) and the data were analysed using SPSS 11.5 for
Windows (SPSS Inc., Chicago, Ill., USA).
Results
Study population
Demographic data and basic laboratory values of the
study population are given in Table I. None of the
study subjects had a medical history of cardiovas-
cular disease or elevated BP. The use of medication
was minimal: 6 female subjects were taking an
oestrogen/progesterone combination for contracep-
tion. Four of the subjects were present smokers, while
five had a previous smoking history. Lipid profile,
fasting glucose, electrolytes and kidney function were
all within the normal range.
Haemodynamics of patients – supine position and head-
up tilt
The haemodynamic changes in response to head-up tilt
were reproducible on four separate days (Figure 1) and
during two consecutive measurements (not shown). All
of the variables changed significantly with the subject
in the upright position (pv0.05 versus supine values;
Table II): diastolic BP (+5.2¡0.6 %), heart rate
(+27.6¡1.9 %) and vascular resistance increased
(+12.5¡1.7 %), while systolic BP (23.2¡0.6 %),
aortic pulse pressure (223.3¡1.4 %), augmentation
index (211.6¡0.7 %), aortic reflection time (27.0¡
1.0 %), ejection duration (221.4¡0.7 %), stroke
volume (226.1¡1.2 %) and cardiac output (25.0¡
1.5 %) decreased. Radial systolic BP was significantly
higher than aortic systolic BP (pv0.05), while there
was no difference between radial and aortic diastolic
BP (Table II).
Association between augmentation index and other
haemodynamic variables
Supine AIx correlated with aortic systolic BP
(r50.423, p50.001), aortic reflection time
Table I. Study population (n533).
Variable Mean¡SEM
Age 33.9¡1.4
Female/male 17/16
Body mass index (kg/m2) 23.2¡0.5
Waist circumference (cm)
Male 87.4¡1.4
Female 79.1¡2.7
Smoking status (present/previous/never) 4/5/24
Plasma
Fasting glucose (mmol/L) 5.1¡0.1
Total cholesterol (mmol/L) 4.4¡0.1
HDL cholesterol (mmol/L) 1.7¡0.1
LDL cholesterol (mmol/L) 2.2¡0.1
Triglycerides (mmol/L) 1.0¡0.1
Creatinine (mmol/L) 77.5¡1.9
Potassium (mmol/L) 3.90¡0.01
Sodium (mmol/L) 139.9¡0.3
Calcium (mmol/L) 2.26¡0.01
Hematocrit (%) 41.9¡0.8
Estimated creatinine clearance (mL/min/1.73 m2) 111.3¡5.7
SEM5standard error of the mean.
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(r520.647, p50.000), PWV (r50.287, p50.024) and
age (r50.480, p50.005). During the head-up tilt, AIx
correlated significantly with ejection duration
(r50.504, p50.000), heart rate (r520.339,
p50.007), SVRI (r50.335, p50.007) and age
(r50.408, p50.005).
Figure 1. Mean values of aortic pulse pressure (A), augmentation index (B), stroke volume (C), heart rate (D), cardiac output
(E) and systemic vascular resistance index (F) of hemodymamic measurements performed on four separate days (visits 1–4).
Each subject (n533) underwent all four 15-min measurements and a 5-min head-up tilt was performed between 5 and 10 min.
P-values derived from ANOVA for repeated measurements.
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Both AIx and stroke volume decreased in response
to head-up tilt, but correlation between the magnitude
of the change between these two variables was not
significant (p50.131). The change in AIx during head-
up tilt correlated with the change in aortic systolic BP
(r50.469, p50.000), aortic pulse pressure (r50.606,
p50.000), ejection duration (r50.374, p50.002) and
heart rate (r520.445, p50.000).
Two consecutive measurements: repeatability
The repeatability values for the haemodynamic
variables are given in Table II. The repeatability
index, reflecting the variation between two consecu-
tive measurements, was good in both the supine
position and during head-up tilt for all other
variables with the exception of heart rate, for which
it was only 22–23 % (Table II). Repeatability of the
measurements according to Bland & Altman is
given in Table II and Figures 2 and 3, and the limits
of agreement are good compared with the
previous studies on repeatability of haemodynamic
measurements [9,17,18].
Measurements on four separate days: reproducibility
The reproducibility values are given in Table II. The
reproducibility index, which describes the variation in
the measurements performed on four separate days,
was lower than the repeatability index. Still, repro-
ducibility was good, with values varying from 59 %
to 89 % with the subject in the supine position and
from 46 % to 93 % during head-up tilt (Table II).
Reproducibility according to Bland & Altman was
also good (Table II).
Discussion
The purpose of the present study was to examine
haemodynamics both at rest and during orthostatic
challenge, and to test the repeatability and repro-
ducibility of the measurement protocol. The pre-
sent non-invasive approach provides information
about arterial stiffness, central haemodynamics,
cardiac function (heart rate, stroke volume, cardiac
output, ejection duration) and systemic vascular
resistance, all of which are important regulators of
BP. All of the measured variables changed sig-
nificantly in response to head-up tilt, and the
repeatability and reproducibility of the method
was good [9,17,18].
The present treatment strategies of hypertension
with lower treatment goals than ever, especially in
high-risk patients with complicated diabetes or
kidney disease, emphasize the importance of the
measurement of BP and haemodynamics with the
subject in the upright position [13,14]. Here we used
passive head-up tilt to induce the challenge to the
cardiovascular system, during which diastolic BP
increased slightly (5 %), while systolic BP decreased
slightly (22 %). However, major changes were
observed in heart rate, stroke volume, systemic
vascular resistance and AIx. It is notable that BP
response to a simple 4-min two-step exercise test has
been found to be a strong predictor of hypertension
in a Japanese population-based study, suggesting that
Table II. Haemodynamic variables, repeatability and reproducibility values supine and during head-up tilt.
Repeatability: two
consecutive measurements
Reproducibility: four separate
days
Bland-Altman R (%) Bland-Altman R (%)
Tonometry Supine Tilt Supine/Tilt Supine/Tilt Supine/Tilt Supine/Tilt
Radial systolic BP (mmHg) 127¡2 125¡3* 10/12 90/85 15/15 77/78
Aortic systolic BP (mmHg) 113¡2 109¡1* 10/14 90/74 14/16 74/74
Radial diastolic BP (mmHg) 76¡2 80¡1* 10/12 87/79 12/13 79/78
Aortic diastolic BP (mmHg) 77¡2 80¡1* 10/12 87/79 12/13 79/79
Aortic pulse pressure (mmHg) 36¡1 28¡1* 5/8 88/67 9/11 62/46
Aortic augmentation index (%) 13.7¡1.4 1.5¡1.4* 5/6 95/95 12/13 78/70
Aortic reflection time (ms) 166¡3 153¡2* 20/11 86/87 25/27 79/48
Ejection duration (ms) 334¡3 263¡3* 12/15 96/96 28/41 74/57
Impedance cardiography
Stroke volume (mL) 84¡3 62¡2* 4/3 99/99 15/8 89/93
Heart rate (beats/min) 61¡1 77¡2* 23/29 22/23 15/18 67/66
Cardiac output (L/min) 5.00¡0.14 4.75¡0.16* 0.62/0.45 92/97 1.48/1.22 70/82
Vascular resistance index (dyn*s/cm5*m2) 2478¡82 2741¡78* 349/390 93/91 937/993 59/54
Pulse wave velocity (m/s) 8.9¡0.2 – 0.40/– 99/– 87/– 87/–
Mean¡standard error of the mean. *pv0.05 compared to supine values. Repeatability and reproducibility values by Bland and Altman,
and index R.
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prognostic changes in BP may be evident even during
a relatively minor physical challenge [10]. In more
rigorous treadmill or ergometer tests, enhanced
exercise-induced reactivity of BP has been shown to
predict new-onset hypertension [11]. It remains to be
determined whether the changes in haemodynamic
Figure 2. Repeatability at rest: Bland-Altman plots for the comparison of two consecutive measurements showing the
differences against the mean value with the subject in the supine position. Augmentation index (A), aortic pulse pressure (B),
cardiac output (C), systemic vascular resistance index (D), heart rate (E) and stroke volume (F).
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variables induced by an orthostatic challenge provide
significant prognostic information, and whether these
changes can be used in the guidance of the treatment
of cardiovascular disease.
Decreased arterial compliance is an acknowledged
risk factor for cardiovascular morbidity and mortal-
ity [22]. Local arterial stiffness and vessel wall
properties, for example from carotid or brachial
Figure 3. Repeatability during orthostatic challenge: Bland-Altman plots for the comparison of two consecutive
measurements showing the differences against the mean value during the head-up tilt. Augmentation index (A), aortic
pulse pressure (B), cardiac output (C), systemic vascular resistance index (D), heart rate (E) and stroke volume (F).
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sites, can be defined by the use of ultrasound methods
[23]. Regional arterial stiffness, like carotid-femoral
and aortic PWV, can be analysed by means of arterial
tonometry, mechanotransducer methods and echo-
tracking devices [24–26]. At present, the AIx, derived
from arterial waveform consisting of incident and
reflecting wave, is one of the most commonly used
indicators of central wave reflection and arterial
compliance. The major determinants of AIx are BP,
PWV and cardiac function. In addition, age has a
major influence on all of the aforementioned
variables, while AIx is also affected by the site of
wave reflection [27,29]. However, the role of AIx as
marker of arterial stiffness has recently been ques-
tioned due to a lack of correlation between invasive
PWV and AIx [29–31]. In the present study, we
utilized continuous pulse wave analysis and determi-
nation of the AIx, combined with the analyses of
cardiac function and vascular resistance both at rest
and during orthostatic challenge. AIx at rest corre-
lated with aortic systolic BP, age and aortic reflection
time, consistent with previous studies [29,32]. AIx
also correlated with PWV at rest, but the relatively
weak correlation underlies the importance of the
other determinants affecting AIx.
In response to head-up tilt, both AIx and stroke
volume decreased, showing that the changes in body
position and cardiac function, especially heart rate,
have a major influence on the level of central pressure
augmentation. The magnitude of the decrease in AIx
during head-up tilt correlated significantly with the
changes in aortic systolic BP and pulse pressure,
ejection duration and heart rate. An increase in heart
rate is known to decrease the duration of ventricular
ejection and systole, and shift the reflecting wave
towards diastole, which subsequently causes the
reduction of systolic BP and AIx. Previously, AIx
has been reduced by 4–5 % for each 10 beats/min
increment in heart rate during pacing [32,33]. In the
present study, the heart rate increased by approxi-
mately 14–17 beats/min, which alone could explain a
6–8 % decrease in AIx. However, we observed a 12 %
decrease in AIx during the head-up tilt, and in
addition to the change in heart rate also the reduction
in stroke volume may have influenced the level of
augmentation.
Analysis of repeatability and reproducibility
using the Bland-Altman and repeatability index
methods included the variation of the measured
variable in the entire study population and within a
single study subject [34]. Good repeatability and
reproducibility of radial pulse wave analysis [9,35]
and impedance cardiography [17,36] at rest have
been described previously. In contrast to the
previous reports, we utilized a combination of
techniques and the measurements were continuous
with the subject in both the supine position and
during head-up tilt. The recordings carried out on
four separate days were in correspondence
(Table II); and successive recordings on the same
day were also highly repeatable (two consecutive
measurements). Heart rate was the only variable
showing relatively poor repeatability (Table II) and
a wide scale of variation (Figures 2E and 3E). This
probably contributed to the observed variation in
cardiac output (Figures 2C and 3C), and it could be
argued that the changes resulted from the rapid
responsiveness of heart rate to various external and
internal stimuli.
In conclusion, combined pulse wave analysis and
impedance cardiography enabled the measurement of
several haemodynamic variables during a simple
orthostatic challenge. We found that the observed
changes in haemodynamics induced by passive head-
up tilt were highly repeatable and reproducible.
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WHAT IS ALREADY KNOWN ABOUT
THIS SUBJECT
• Haemodynamic effects of endothelial
stimuli induced by salbutamol and
L-arginine in humans have been previously
studied predominantly at rest in selected
vascular beds.
• We studied the effects of salbutamol,
L-arginine and nitroglycerin on cardiac and
vascular function by continuous recording
of pulse wave analysis and impedance
cardiography both in the supine position
and during passive head-up tilt.
WHAT THIS STUDY ADDS
• The divergent effects of the research drugs
in supine position and during head-up tilt
indicate that human haemodynamics
should also be studied in the upright
position.
• Since inhaled salbutamol induced more
pronounced changes in haemodynamics, it
provides a clinically more applicable tool
than infused L-arginine for the assessment
of endothelial function in humans.
AIMS
To examine the effects of salbutamol and L-arginine, two compounds acting
largely on the endothelium, and the endothelium-independent agent
nitroglycerin on blood pressure, arterial compliance, cardiac function and
vascular resistance.
METHODS
Continuous radial pulse wave analysis, whole-body impedance cardiography,
and plethysmographic blood pressure from fingers in the supine position and
during head-up tilt were recorded in nine healthy subjects. Data were captured
before and after L-arginine (10 mgmg-1 min-1) or saline infusion, salbutamol
(400 mg) or placebo inhalation, and sublingual nitroglycerin (0.25 mg) or placebo
resoriblet.
RESULTS
The results of all measurements were comparable before drug administration.
The effects of inhaled salbutamol were apparent in the supine position: systemic
vascular resistance (-9.2 2.6%) and augmentation index (-4.0 1.5%)
decreased, and heart rate (8.6 2.5%) and cardiac output (8.8 3.1%) increased.
L-arginine had no clear effects on supine haemodynamics, but during head-up
tilt blood pressure was moderately decreased and reduction in aortic reflection
time prevented, indicating improved large arterial compliance.Nitroglycerin
reduced supine vascular resistance (-6.7 1.8%) and augmentation index
(-7.4 1.6%), and increased cardiac output (+9.2 2.7%).During head-up
tilt, nitroglycerin increased cardiac output (+10.6 5.6%) and heart rate
(+40 7.5%), decreased vascular resistance (-7.8 5.8%) and augmentation
index (-18.7 3.2%), and prevented the decrease in aortic reflection time.
CONCLUSIONS
Inhaled salbutamol predominantly changed supine haemodynamics, whereas
the moderate effects of L-arginine were observed during the head-up tilt. In
contrast, small doses of nitroglycerin induced major changes in haemodynamics
both supine and during the head-up tilt. Altogether, these results emphasize the
importance of haemodynamic measurements in both the supine and upright
positions.
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Introduction
The endothelium controls vascular tone via various
mechanisms including the release of nitric oxide (NO),
prostacyclin, and several pathways causing vascular
smooth muscle cell hyperpolarization [1]. In addition, the
endothelium actively regulates vascular permeability,
platelet and leucocyte adhesion and aggregation, and
thrombosis [2, 3]. Impairments in these mechanisms main-
taining vascular homeostasis lead to functional manifesta-
tions, which has emphasized the importance of studying
endothelial function in vivo. The present treatment strate-
gies of hypertension with lower treatment goals than ever,
especially in high-risk patients with complicated diabetes
or kidney disease, stress the importance of the measure-
ment of blood pressure (BP), haemodynamics and endot-
helial function also in the upright position [4, 5]
Peripheral endothelial function can be measured inva-
sively by venous occlusion plethysmography, and non-
invasively by measuring arterial diameter by ultrasound
systems after ischaemia or warming-induced increase in
blood flow [flow-mediated dilatation (FMD)] [6, 7]. Repeat-
ability of the plethysmographic measurements is good,
but as an invasive technique it is not convenient for mul-
tiple measurements. FMD requires good technical skills,
and the lack of universal standards in the measurement
protocol makes comparison between different laborato-
ries difficult [8]. The responsiveness of coronary arteries to
different endothelium-dependent stimuli has been evalu-
ated by observing changes in artery diameter [9] or
coronary blood flow [10, 11]. However, these methods
are invasive and laborious, and demand high technical
expertise.
Pulse wave analysis (PWA) is a non-invasive, repeatable
technique that analyses the arterial pulse wave form
providing information about arterial compliance [12].
Recently, the changes in PWA-derived measure of wave
reflection and arterial stiffness, the augmentation index
(AIx), after b2-adrenoceptor agonist-induced endothelial
stimulation have been used to assess the role of endothe-
lium in vascular responsiveness [13,14].Another possibility
to stimulate the endothelium is the administration of
the semi-essential amino acid L-arginine,which serves as a
precursor for endogenous NO synthesis. L-arginine admin-
istration has been shown to improve endothelium-
dependent vasodilation in animals [15, 16] and humans
[17, 18]. However, the effect of endothelial stimulation
on systemic vascular resistance or cardiac function has
seldom been studied [19, 20].
The purpose of this study was to evaluate the haemo-
dynamic effects of inhaled salbutamol and infused
L-arginine in comparison with the endothelium-
independent vasodilator nitroglycerin. For a comprehen-
sive analysis we applied continuous PWA combined with
the measurement of cardiac output and systemic vascular
resistance using whole-body impedance cardiography
both in the supine position and during passive orthostatic
challenge. The results suggest that inhaled salbutamol
induces changes in supine haemodynamics, the moderate
effects of L-arginine are observed during head-up tilt,
whereas already a small dose nitroglycerin influences hae-
modynamics in both the supine and upright positions.
Methods
Study subjects
The study population consisted of nine healthy (five male,
four female), normotensive individuals aged 25–44 years.
All participants gave written informed consent and there-
after underwent a physical examination performed by a
physician. During the interview, lifestyle habits, family
history of cardiovascular disease, and medical history were
documented. The study was approved by the Ethics Com-
mittee of Tampere University Hospital and the National
Agency of Medicines, Finland, and it complies with the
Declaration of Helsinki.
Laboratory analyses
Blood and urine samples were obtained after a minimum
of 12 h fast in the morning for laboratory analyses, and a
standard 12-lead electrocardiogram was recorded. Plasma
sodium, potassium, calcium, glucose, creatinine, triglycer-
ide, and total, high-density and low-density lipoprotein
cholesterol concentrations were determined by Cobas
Integra 700/800 (F. Hoffmann-LaRoche Ltd, Basel, Switzer-
land), and blood cell count by ADVIA 120 or 2120 (Bayer
Health Care, Tarrytown, NY, USA). Creatinine clearance was
estimated using the Cockroft–Gault formula [21].
Haemodynamic measurement protocol
Haemodynamic measurements were performed in a quiet,
temperature-controlled research laboratory by a trained
nurse on five separate days. The study subjects had
refrained from caffeine-containing products, smoking and
heavy meals for at least 4 h and from alcohol for at least
24 h prior to the investigation. The subjects were resting
supine on a tilt-table, and the electrodes for impedance
cardiography were placed on the body surface, the tono-
metric sensor for PWA on the radial pulsation to the left
wrist, and oscillometric brachial cuff for BP calibration to
the right upper arm. Before the actual measurement, an
introductory head-up tilt was performed to familiarize the
study subject with the method.
The actual measurement consisted of six consecutive
5-min intervals, during which haemodynamic data were
captured continuously. For the first 5 min, subjects were
resting supine on the tilt table, followed by 5 min of
head-up tilt to 60°, then the tilt table was returned to the
horizontal position for another 5 min. During this period
no research drugs were given, but saline was infused
before the head-up tilt with L-arginine. After that the
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research drug (L-arginine, salbutamol, placebo inhalation,
nitroglycerin or placebo resoriblet) was administered, the
same protocol was repeated (5 min supine–5 min head-up
tilt–5 min supine). The results of the haemodynamic mea-
surements during the first 15 min on the five separate
recording days did not differ either in the supine position
or during the orthostatic challenge before the test drug
administration (data not shown).
Research drugs
Administration of L-arginine, salbutamol, placebo inhala-
tion, nitroglycerin and placebo resoriblet was performed
on five separate measurements on different days. Placebo
inhalation and 400 mg salbutamol inhalation (placebo for
Ventolin® and Ventolin®, respectively; GlaxoSmithKline,
Uxbridge, UK) were given with a spacer device (Volumatic;
Allen & Hanbury’s, Uxbridge, UK) in a blinded fashion. The
400-mg salbutamol dose was chosen on the basis of test
experiments with the present study protocol and previ-
ously published work on the effects of inhaled salbutamol
on haemodynamics [13, 14, 22].
Sublingual placebo resoriblet and 0.25 mg nitroglyc-
erin (Nitro resoriblet; Orion Pharma, Espoo, Finland) were
also administrated in a blinded fashion.The placebo resor-
iblets were professionally manufactured by the University
Pharmacy, Helsinki, Finland, to resemble very closely the
commercial nitroglycerin resoriblets in both appearance
and taste. The nitroglycerin dose was chosen on the basis
of test experiments with the present study protocol, and a
previous report using the same dose [13].
In the fifth measurement, an intravenous (i.v.) 20-G
cannula was placed in a brachial vein and a slow saline
infusion was started. L-arginine hydrochloride 20 mgml-1
(B. Braun Melsungen Ag, Melsungen, Germany) was
diluted in 100 ml of saline, and infusion at the dose
10 mg kg-1 min-1 was started at 15 min and continued for
10 min.This administration protocol resulted in a relatively
high dose of infused L-arginine in 10 min.This dose can be
considered sufficient to induce cardiovascular changes, as
i.v. L-arginine infusion at the rate of (i) 3.33 mg kg-1 min-1
has induced vasodilation in the renal vasculature in
humans [23], (ii) 0.3 g min-1 has enhanced the acute hae-
modynamic effects of 50 mg of losartan [24], and (iii)
0.5 g min-1 has increased skeletal muscle glucose clear-
ance in humans, probably via increased NO production
[25]. On the basis of previous work, L-arginine has rarely
caused side-effects at infusion rates that do not exceed
1 g min-1 [26], and the dose of 1 g min-1 of L-arginine has
been used in many studies [27–29].
Pulse wave analysis
Radial BP and pulse wave form were continuously deter-
mined from the radial pulsation by a tonometric sensor
(Colin BP-508T; Colin Medical Instruments Corp., San
Antonio,TX, USA),which was fixed on the radial pulse with
a wrist band. The radial BP signal was calibrated every
2.5 min by a brachial BP measurement. Continuous aortic
BP was derived with the SphygmoCor pulse wavemonitor-
ing system (SpygmoCor PWMx; AtCor Medical,West Ryde,
Australia) using the previously validated generalized trans-
fer function [12]. Ejection duration, aortic reflection time
and AIx (augmented pressure/pulse pressure ¥ 100) were
determined.
Whole-body impedance cardiography
A whole-body impedance cardiography device (CircMonR;
JRMedical Ltd.,Tallinn,Estonia),which records the continu-
ous changes in body electrical impedance during a cardiac
cycle, and plethysmographic BP recordings from fingers
(Finapres; Ohmeda, Englewood, CO, USA) were used to
determine beat-to-beat heart rate, stroke volume (ml),
cardiac output (l min-1), systemic vascular resistance index
(SVRI, systemic vascular resistance/body surface area, dyn
¥ s cm-5 ¥ m2) and pulse wave velocity (PWV) [30–32]. The
cardiac output values measured with CircMonR whole-
body impedance cardiography are in good agreement
with the values measured by the thermodilution method,
both in the supine position and during head-up tilt [32]. A
detailed description of the method and electrode configu-
ration has been previously reported [30–32]. PWV was not
assessed during the head-up tilt due to less accurate
timing of left ventricular ejection during reduced stroke
volume.
Exhaled alveolar nitric oxide measurement
after salbutamol inhalation
To verify the salbutamol-induced production of NO, we
measured NO concentration from the alveolar air in six
of the study subjects using a Sievers NOA 280 analyser
(Sievers Instruments, Boulder, CO, USA) at three exhalation
flow rates (100, 200 and 300 ml s-1) [33, 34]. The measure-
ments were performed three times before (0, 10 and
20 min) and twice after (10 and 20 min) the placebo and
salbutamol 400-mg inhalations,and alveolar NO concentra-
tion was calculated as previously described [33, 34]. Briefly,
exhaled NO output (concentration ¥ flow rate) was plotted
against exhalation flow rate and a linear regression was
set. The slope and intercept of the regression line are
approximates of alveolar NO concentration and bronchial
NO flux, respectively. The exhalation flow rates were
computer-controlled using an adjustable flow restrictor,
and the subjects maintained the exhalation pressure
between 5 and 20 cmH2O, as described previously [34, 35].
Statistical analysis
Values are expressed as mean  standard error of the
mean (SEM) and the data were analysed using SPSS 11.5
for Windows (SPSS Inc., Chicago, IL, USA). To compare hae-
modynamic measurements, one-way analysis of variance
(ANOVA) and ANOVA for repeated measurements were
applied (RANOVA). P-values < 0.05 were considered statisti-
cally significant. The study power was analysed using the
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PS 3.0.2 power and sample size calculations program
(Vanderbilt Biostatistics, Nashville, TN, USA). A change in
SVRI > 400 dyn ¥ s cm-5 ¥ m2 in the supine position was
chosen as the main outcome variable (such a change was
observed after both salbutamol and nitroglycerin). When
using the variables of the salbutamol measurements in the
power calculations, the present number of subjects (n = 9)
was found to have a power of 92% to detect a significant
difference (d = 400 dyn ¥ s cm-5 ¥ m2) between the salb-
utamol and the placebo effect (a-level 0.05).
Results
Study population
The basic characteristics and laboratory values of the
study population were all within the normal range. The
mean age was 32  2.5 years, body mass index 24.5 
1.0 kg m-2, and waist circumference 80  5 cm in women
and 91  3 cm in men. None of the study subjects had a
medical history of cardiovascular disease or elevated BP,
and none of the subjects was a present smoker, while two
subjects had a previous smoking history. Plasma lipid
profile, fasting glucose, electrolytes, and kidney function
were all within the normal range. None of the study sub-
jects reported any adverse effects related to the research
drug administration.
Haemodynamic effects of L-arginine,
salbutamol and nitroglycerin in supine position
The average values of the first 5 min of the haemodynamic
recordings following drug administration in the supine
position are shown in Tables 1–3 for L-arginine, salbutamol
and nitroglycerin, respectively. The average results of the
second and fifth minute during each recording phase
(5 min supine–5 min tilt–5 min supine) are depicted in
Figures 1 and 2.
L-arginine infusion did not have any significant haemo-
dynamic effects in the supine position before the head-up
tilt (Table 1, Figures 1 and 2). In contrast, before the
head-up tilt salbutamol induced a 9.2  2.6% decrease in
SVRI (Table 2) and during the fifth minute an 8.6  2.5%
increase in heart rate (Figure 2) (P < 0.05 for both com-
pared with placebo inhalation). During the fifth minute
following nitroglycerin administration, supine cardiac
output was increased (+9.2 2.7%) and SVRI was reduced
(-6.7  1.8%) (P < 0.05 for both compared with placebo
resoriblet) (Figure 1).
During the second minute in the supine position after
the head-up tilt aortic mean BP was lower during
L-arginine infusion than during saline infusion, but
L-arginine infusion did not have any other effects on BP
values or supine haemodynamics (Table 1, Figure 1). In the
supine position after the head-up tilt AIx was significantly
lower after salbutamol (AIx value 5.5  2.5%) and nitro-
glycerin (AIx -1.4  2.5%) when compared with placebo
inhalation (AIx 14.1 3.2%),placebo resoriblet (AIx 12.1
3.7%) and with L-arginine infusion (AIx 11.4  2.6%) (P <
0.05 for all comparisons) (Figure 2). SVRI in the supine posi-
tion after the second head-up tilt was reduced after salb-
utamol when compared with placebo inhalation (5-min
averages 2105  89 and 2546  73 dyn ¥ s cm-5 ¥ m2,
respectively, P = 0.026) (Figure 1).
Supine PWV values were not significantly different after
L-arginine infusion, salbutamol inhalation or nitroglycerin
administration when compared with the respective
controls (Tables 1–3). However, nitroglycerin resoriblet
induced a small but significant reduction in PWV (-5.7 
2.4%)when comparedwith placebo resoriblet (0.9 1.7%)
(P < 0.05).
Table 1
Average haemodynamic effects of L-arginine (10 mg kg-1 min-1) and saline infusion during the first 5 min in the supine position and 5 min of head-up tilt
(mean  SEM)
Saline infusion L-arginine infusion
Tonometry Supine Head-up tilt Supine Head-up tilt
Radial SBP (mmHg) 131  3 127  2 127  3 121  2*
Aortic SBP (mmHg) 116  3 111  2† 110  3 105  2*
Radial DBP (mmHg) 76  2 79  1 73  3 74  2*
Aortic DBP (mmHg) 77  2 80  2 74  3 74  2*
Augmentation index (%) 11.8  3.3 4.2  2.8† 9.5  3.2 3.2  2.6†
Aortic reflection time (ms) 171  6 162  4† 169  8 170  4*
Ejection duration (ms) 342  4 277  8† 347  5 290  9†
Impedance cardiography
Stroke volume (ml) 100  9 68  5† 98  8 71  5†
Heart rate (beats min-1) 58  3 68  3† 55  2 65  2†
Cardiac output (l min-1) 5.71  0.44 4.58  0.27† 5.30  0.39 4.55  0.24†
Systemic vascular resistance index (dyn ¥ s cm-5 ¥ m2) 2385  191 3052  174† 2521  162 2920  166†
Pulse wave velocity (m s-1) 8.66  0.17 – 8.63  0.16 –
*P < 0.05 compared with corresponding value during saline infusion. †P < 0.05 compared with corresponding supine values. SBP, systolic blood pressure; DBP, diastolic blood
pressure.
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Haemodynamic effects of L-arginine,
salbutamol and nitroglycerin during the
head-up tilt
The average values of the haemodynamic recordings
during the 5-min head-up are shown inTables 1–3,and the
average results of the second and fifth minute in Figures 1
and 2.
During the head-up tilt aortic and radial BP were
reduced with L-arginine when compared with saline infu-
sion (Table 1). Aortic mean BP was also lower during
L-arginine infusion (85 2 mmHg) than during saline infu-
sion (90  1 mmHg, P = 0.02). During the head-up, aortic
reflection time was numerically but not statistically signifi-
cantly longer during L-arginine than saline infusion (P =
0.162, Table 1, Figure 2), and the respective changes in
aortic reflection time were not significantly different either
(8.0 8.8% vs. -6.8 2.4%, respectively, P = 0.147).
However, in additional comparisons aortic reflection time
was longer during the head-up tilt with L-arginine infusion
(170 4 ms) than during placebo inhalation (153 4 ms,
P = 0.02), placebo resoriblet (155  6 ms, P = 0.045) and
salbutamol inhalation (158  4 ms, P = 0.047, Table 3).
These results suggest that the reduction in aortic reflection
time during head-up tilt was prevented during L-arginine
infusion.
During the head-up tilt aortic systolic BP after salbuta-
mol inhalation was lower than after placebo inhalation
(Table 2, P = 0.024), while there was no significant differ-
ence in radial systolic, aortic and radial diastolic, or mean
BP (Table 2). Although SVRI was numerically lower during
Table 2
Average haemodynamic effects of 400 mg inhaled salbutamol during the first 5 min in the supine position and 5 min of head-up tilt (mean  SEM)
Placebo inhalation Salbutamol inhalation
Tonometry Supine Head-up tilt Supine Head-up tilt
Radial SBP (mmHg) 126  3 129  2 123  2 124  2
Aortic SBP (mmHg) 111  3 112  2 105  2 106  2*
Radial DBP (mmHg) 73  2 80  2† 702 75  2†
Aortic DBP (mmHg) 74  2 82  2† 70  2 75  2†
Augmentation index (%) 12.7  3.7 -0.4  4.4† 6.0  2.7 -1.9  2.5†
Aortic reflection time (ms) 172  10 158  5 168  8 158  4†
Ejection duration (ms) 342  7 270  7† 343  5 272  9†
Impedance cardiography
Stroke volume (ml) 91  6 66  5† 90  5 71  4†
Heart rate (beats min-1) 54  2 71  3† 61  2* 71  2†
Cardiac output (l min-1) 4.78  0.18 4.65  0.38 5.44  0.26 5.08  0.34
Systemic vascular resistance index (dyn ¥ s cm-5 ¥ m2) 2449  61 2769  176 2148  96* 2448  139†
Pulse wave velocity (m s-1) 8.40  0.29 – 8.54  0.18 –
*P < 0.05 compared with corresponding value during placebo inhalation. †P < 0.05 compared with corresponding supine values. SBP, systolic blood pressure; DBP, diastolic blood
pressure.
Table 3
Average haemodynamic effects of 0.25 mg nitroglycerin resoriblet during the first 5 min in the supine position and 5 min of head-up tilt (mean SEM)
Placebo resoriblet Nitroglycerin resoriblet
Tonometry Supine Head-up tilt Supine Head-up tilt
Radial SBP (mmHg) 122  3 121  2 124  1 116  3†
Aortic SBP (mmHg) 106  3 105  2 107  2 99  2†
Radial DBP (mmHg) 68  3 75  2† 70  2 69  3
Aortic DBP (mmHg) 69  3 76  2† 71  2 71  2
Augmentation index (%) 8.1  3.9 -0.9  5.3† 3.0  3.5 -15.8  1.6*†
Aortic reflection time (ms) 178  10 156  6 173  7 175  7*
Ejection duration (ms) 344  5 269  9† 330  6* 247  10†
Impedance cardiography
Stroke volume (ml) 90  6 66  5† 94  7 76  6†
Heart rate (beats min-1) 55  2 70  3† 62  3* 85  3*†
Cardiac output (l min-1) 4.89  0.26 4.64  0.47 5.740.36* 6.34  0.48*
Systemic vascular resistance index (dyn ¥ s cm-5 ¥ m2) 2438  148 2663  155 2089  119 1955  189*
Pulse wave velocity (m s-1) 8.47  0.12 – 7.89  0.28 –
*P < 0.05 compared with corresponding value during placebo resoriblet. †P < 0.05 compared with corresponding supine values. SBP, systolic blood pressure; DBP, diastolic blood
pressure.
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Figure 1
Mean values for aortic mean arterial pressure (a–c), cardiac output (d–f ) and systemic vascular resistance index (SVRI) (g–i) after L-arginine infusion
(10 mg kg-1 min-1), saline infusion, salbutamol inhalation (400 mg), placebo inhalation, nitroglycerin resoriblet (0.25 mg) and placebo resoriblet. Research
drug was administrated at measurement time 0 and head-up tilt was performed from 5 to 10 min. *P < 0.05 vs. saline/placebo, ANOVA
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the head-up tilt with salbutamol than with placebo inha-
lation, the difference was not significant (P = 0.196)
(Table 2, Figure 1).
During the head-up tilt, aortic and radial diastolic and
systolic BPwere not reducedwith nitroglycerin when com-
paredwith placebo resoriblet (Table 3),but during the fifth
minute of the head-up tilt aortic mean BP was lower with
nitroglycerin than with placebo resoriblet (80 2 vs. 91
2 mmHg,P = 0.002, Figure 1).However, during the head-up
tilt the other effects of 0.25 mg sublingual nitroglycerin on
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haemodynamics were very clear (Table 3, Figures 1 and 2):
cardiac output was higher in comparison with placebo
resoriblet, and also higher than during L-arginine infusion
and placebo inhalation (P < 0.05 for all), SVRI was lower
when compared with placebo resoriblet, placebo inhala-
tion and L-arginine infusion (P < 0.05), heart rate was
higher and AIx was lower in comparison with all other
measurements (P < 0.05), and aortic reflection time was
longer than with placebo resoriblet (P = 0.023).
Exhaled nitric oxide concentrations after
salbutamol
Alveolar NO concentration in six of the study subjects was
1.55 0.17 parts per billion before salbutamol inhalation,
while the concentration was 1.81  0.19 parts per billion
before placebo inhalation. After salbutamol inhalation
alveolar NO concentration increased by 19%,whereas after
placebo inhalation the concentration decreased by 10%
(P = 0.01).
Discussion
Here we evaluated the use of two pharmacological com-
pounds acting on the endothelium and the endothe-
lium-independent agent nitroglycerin on non-invasive
haemodynamics in healthy volunteers. The study has
shown that inhaled salbutamol decreased systemic vascu-
lar resistance and AIx and increased heart rate and cardiac
output, whereas L-arginine only resulted in a decrease of
BP during the head-up tilt. In contrast, nitroglycerin mark-
edly decreased systemic vascular resistance, AIx and BP,
and increased heart rate, cardiac output and aortic reflec-
tion time.
Although the observed haemodynamic changes with
L-arginine and salbutamol were moderate, the combina-
tion of PWA and impedance cardiography provided data
that would have remained uncovered when using only
one of these methods. The present non-invasive measure-
ment protocol provides continuous haemodynamic infor-
mation about central wave reflection and BP, arterial
compliance, systemic vascular resistance and cardiac func-
tion in both the supine and upright positions. Thus, beat-
to-beat changes in haemodynamics can be revealed,
which provides benefits when compared with single
tonometric measurements using a pen-like sensor, the
approach of which has been applied in the majority of
recent PWA studies [14, 36]. The present approach also
enables more thorough assessment of vascular respon-
siveness than methods like FMD in the upper arm arteries,
which examine only a section of the cardiovascular system.
It is important to notice that the effects of endothelial
stimulation on arterial tone may depend on the vascular
bed studied [37, 38].
The semi-essential amino acid L-arginine serves as a
precursor for endothelial nitric oxide synthase (NOS).
L-arginine administration has been reported to induce
vasodilation in healthy subjects and patients with cardio-
vascular disease [17–19]. L-arginine has rarely caused side-
effects at doses <30 g during a 30-min infusion (i.e. at a
maximum rate of 1 g min-1) [26], which favours its use
in clinical research. However, the beneficial effects of
L-arginine do not seem to be due to extracellular substrate
supply for endothelial NOS, as the enzyme should be satu-
rated with physiological L-arginine levels [39]. In contrast,
excess substrate availability can overcome the inhibition of
endothelial NOS activity due to accumulation of false
L-arginine derivatives during cardiovascular disease states,
the mechanism of which can explain the vasodilatory
effects of L-arginine. Furthermore, L-arginine has been
reported to improve vasodilation in healthy humans with
low concentrations of endothelial NOS-inhibitory sub-
stances [40, 41], and in this case other endocrine mecha-
nisms, i.e. stimulation of growth hormone and insulin
secretion, may play a role [42, 43].
In the present study the haemodynamic effects of
L-arginine infusion were modest. The BP-lowering influ-
ence was seen only during the head-up tilt, during which
the normal decrease in aortic reflection time was abol-
ished by L-arginine. As the compliance of the arteries
increases, the aortic reflection time lengthens and the
reflected wave shifts towards diastole, resulting in
decreased systolic BP. Since L-arginine did not decrease
systemic vascular resistance, the BP effect probably
resulted from increased compliance in large arteries. In
spite of the reduced BP and prolonged aortic reflection
time induced by L-arginine,AIx decreased correspondingly
during the head-up tilt in response to L-arginine, saline
infusion, salbutamol and placebo. The reduction in AIx in
the upright position cannot be attributed to changes in
large arterial compliance, but may result from a more pro-
nounced decrease in the augmentation pressure than
pulse pressure.Thus,AIx is not always a reliable indicator of
arterial compliance butmerely an indicator of central wave
reflection.
Although b2-adrenoceptors mediate vasorelaxation at
the level of vascular smooth muscle, the stimulation of
b2-adrenoceptors is known to increase endothelial release
of NO and cause largely endothelium-mediated vascular
relaxation [44, 45]. Therefore, the effect of the b2-
adrenoceptor agonist salbutamol on the PWA-derived
measure of wave reflection and arterial stiffness, the AIx,
has been applied as a method to evaluate the influence of
endothelial stimulation in the whole arterial tree [13, 46].
Inhaled salbutamol has induced an 8–12% decrease in the
AIx in healthy subjects, but in many studies the effects on
other haemodynamic variables have not been determined
[13, 14, 46]. As a standard methodological approach, the
AIx has been derived from 10 consecutive heart beats
every 5 min for up to 20 min, which provides a relatively
narrow window of observation when compared with con-
tinuous PWA recording. In the present study, the inhalation
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of 400 mg salbutamol reduced systemic vascular resistance
and BP and increased heart rate already before the
decrease in AIx was observed.These results favour the use
of continuous recording of haemodynamics in the assess-
ment of vascular responsiveness, and indicate that addi-
tional methods besides PWA increase the reliability of the
analysis.
Administration of sublingual nitroglycerin was
included in the study as an endothelium-independent
vasodilator, and even a small 0.25-mg dose of nitroglycerin
resulted in major haemodynamic changes in comparison
with salbutamol and L-arginine. Traditionally, venodilation
and venous pooling of blood into the lower extremities
and splanchnic vasculature, and subsequently reduced left
ventricular preload, have been regarded as major haemo-
dynamic effects of nitroglycerin in humans, whereas arte-
rial dilation is thought to occur to a lesser extent [47, 48].
However, in the present study nitroglycerin induced a clear
decrease in systemic vascular resistance and an increase in
cardiac output and aortic reflection time,strongly suggest-
ing reduced arterial resistance.
In the present study, alveolar NO concentration was
increased by 19% after salbutamol inhalation. Alveolar NO
concentration could be increased via three mechanisms:
increased NO production in the alveolar epithelium,
decreased NO diffusion from alveolar air to capillaries, or
increased NO release from the capillary walls. Previously,
increased alveolar NO concentration has been found in
diseases affecting pulmonary parenchyma, probably due
to increased inducible NOS expression in the alveolar epi-
thelium [34, 49]. Increased alveolar NO concentration has
also been reported in subjects with liver cirrhosis [50], pre-
sumably as a result of increased endothelial NO produc-
tion [51]. In addition, the administration of the ACE-
inhibitor enalapril has increased NO level in exhaled air,
which was thought to reflect enhanced NO release from
the capillary endothelium [52]. Since inhaled salbutamol is
not likely to influence NO production in the alveolar epi-
theliumor changeNOpermeability of the alveolar wall, the
present findings suggest that salbutamol inhalation
increased NO release from the capillary endothelium. This
supports the view that salbutamol stimulates the endot-
helial cells in the arterial tree.
The purpose of the present study was also to evaluate
the use of three pharmacological tools in the haemody-
namic screening of humans, and not directly to compare
the effects of L-arginine, salbutamol and nitroglycerin.
Therefore, a double-blind placebo infusion was not
included in the study protocol. The crucial role of the
endothelium in different cardiovascular disorders, and as a
target of pharmacological interventions, underlies the
importance of assessing endothelial function in vivo. The
more pronounced cardiovascular effects of salbutamol
than L-arginine, together with low-cost and easy adminis-
tration via inhalation, imply that salbutamol provides a
clinically more applicable tool for the assessment of the
role of endothelium in haemodynamic responsiveness.
Finally, the present study underscores the need for com-
prehensive methods in the measurement of haemody-
namics in humans.
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WHAT IS ALREADY KNOWN ABOUT
THIS SUBJECT
• Nitrates may facilitate syncope through
various pathways, but the precise
mechanism of nitrate-induced syncope is
still under debate. The purpose of the
present study was to compare the
underlying haemodynamic mechanisms in
subjects without and with presyncopal
symptoms during a nitroglycerin-stimulated
tilt-table test.
WHAT THIS STUDY ADDS
• A major decrease in systemic vascular
resistance was documented in subjects with
presyncope during 0.25 mg
nitroglycerin-stimulated tilt-table test, in the
absence of changes in cardiac output. These
findings indicated that even a small dose of
nitroglycerin significantly decreased arterial
resistance and cardiac afterload.
AIMS
The mechanism of nitrate-induced syncope remains controversial.We examined
the haemodynamic changes in healthy volunteers during
nitroglycerin-stimulated tilt-table test.
METHODS
Continuous radial pulse wave analysis, whole-body impedance cardiography
and plethysmographic finger blood pressure were recorded in a supine position
and during head-up tilt in 21 subjects with presyncopal symptoms (6 male/15
female, age 43  3 years) after 0.25 mg sublingual nitroglycerin and 21 control
subjects (6 male/15 female, age 43  2 years). The drug was administered in the
supine position and a passive head-up tilt followed 5 min later. Additionally,
nitroglycerin was only administered during head-up tilt in 19 subjects and the
haemodynamics were recorded.
RESULTS
Supine and upright haemodynamics were similar before nitroglycerin
administration in the two groups. During the nitroglycerin-stimulated tilt test,
aortic and radial mean blood pressure decreased significantly more in the
presyncope group when compared with the controls (P = 0.0006 and P = 0.0004,
respectively). The decreases in systemic vascular resistance (P = 0.0008) and
heart rate (P = 0.002), and increase in aortic reflection time (P = 0.0002) were
greater in the presyncope group, while the change in cardiac index was not
different between the groups (P = 0.14). If nitroglycerin was administered during
the upright tilt and not in supine position, the haemodynamic changes were
quite corresponding.
CONCLUSIONS
Presyncopal symptoms during nitrate-stimulated tilt test were explained by
decreased systemic vascular resistance and increased aortic reflection time,
while cardiac output remained unchanged. These findings indicated reduced
arterial resistance in nitroglycerin-induced presyncope.
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Introduction
Nitroglycerin (NTG) challenge during head-up tilt-table
testing is often utilized to determine the aetiology of unex-
plained vasovagal syncope [1, 2]. Nitrates may facilitate
syncope through various pathways, but the precise
mechanism of nitrate-induced syncope is still under
debate [3]. Traditionally, venodilatation and venous
pooling of blood into the lower extremities and splanchnic
vasculature, and subsequently reduced left ventricular
preload, have been regarded as major haemodynamic
effects of nitroglycerin in humans, while arterial dilatation
is thought to occur to a lesser extend [4, 5]. However, a
reduction in wave reflection and central rather than
peripheral blood pressure (BP) has been documented after
sublingual NTG in patients undergoing cardiac catheter-
ization [6].This implies that small doses of NTG dilate arter-
ies resulting in reduced left ventricular afterload.
Conflicting results concerning nitrate-induced changes
in haemodynamics during tilt-table testing have been
reported. In some studies, nitrate-induced presyncope has
been considered to be cardiac output-mediated without a
decrease in systemic vascular resistance [7, 8]. However,
another report demonstrated a decrease in systemic vas-
cular resistance without a marked change in heart rate
(HR) or cardiac filling during NTG-induced presyncope [9].
The latter response would be classified as ‘vasodepressive’
according to the Vasovagal Syncope International Study,
i.e. a positive tilt test is characterized by preserved cardiac
function during presyncope [10]. Besides direct haemody-
namic alterations, changes in autonomic tone, neurohor-
monal substances and central nervous system function
may be involved in nitrate-induced syncope [3]. Animal
models also support the view of a direct central sympatho-
inhibitory effect of NTG [11].
The purpose of the present study was to compare the
underlying haemodynamic mechanisms in subjects with
and without presyncopal symptoms during NTG-
stimulated tilt-table test using a protocol during which
NTGwas administered in the supine position and a passive
head-up tilt followed 5 min later.To examinewhether body
position affects the NTG response, some of the subjects
were invited for additional measurements during which
NTG was only administered during the head-up tilt. The
methods were continuous non-invasive pulse wave analy-
sis combined with themeasurement of cardiac output and
systemic vascular resistance by whole-body impedance
cardiography and continuous blood pressure (BP) record-
ings from a finger.
Methods
Study subjects
The study subjects participated as normal controls in an
ongoing haemodynamic measurement study (DYNAMIC–
study), in which non-invasive haemodynamics of hyper-
tensive and normotensive subjects were recorded in the
supine position and during repeated head-up tilt in the
absence and presence of 0.25 mg sublingual NTG.Thus far
211 subjects have been included in the study. The presyn-
cope group consisted of all normotensive subjects (n = 21)
who developed presyncopal symptoms and a progressive
fall of BP during the NTG-stimulated tilt-table test. From
the remaining normotensive subjects, 21 healthy, gender,
age (3 years) and body mass index (BMI 4 kg m-2)
-matched subjects were included in the control group, and
the absence of subjective presyncopal symptoms was the
only haemodynamic information that was used for the
selection. After the first measurements, 19 subjects (ran-
domly selected, n = 10 from the presyncope group, n = 9
from the control group) were invited for additional mea-
surements during which NTGwas only administered in the
upright position. The additional measurements were per-
formed to test the hypothesis with an alternative protocol,
and no matching of case-control pairs was performed. All
of the subjects underwent a physical examination per-
formed by a physician, and lifestyle habits, family history of
cardiovascular disease and medical history were docu-
mented.None of the subjects had spontaneously reported
unexplained syncope in their medical history. All subjects
gave written informed consent. The study complied with
the declaration of Helsinki and was approved by the ethics
committee of Tampere University Hospital.
Laboratory analyses
After fasting for a minimum of 12 h blood and urine
samples were obtained in the morning for laboratory
analyses, and a standard 12-lead electrocardiogram was
recorded. Plasma sodium, potassium, calcium, glucose,
creatinine, triglyceride, and total, high-density and low-
density lipoprotein cholesterol concentrations were deter-
mined by Cobas Integra 700/800 (F. Hoffmann-LaRoche
Ltd, Basel, Switzerland), and blood cell count by ADVIA 120
or 2120 (Bayer Health Care,Tarrytown, NY, USA). Creatinine
clearance was estimated using the Cockroft-Gault formula
[12].
Heamodynamic measurement protocol
Haemodymamic measurements were performed in a
quiet, temperature-controlled research laboratory by a
trained nurse. The study subjects had refrained from caf-
feine containing products, smoking and heavy meals for at
least 4 h and from alcohol for at least 24 h prior to the
investigation. The electrodes for impedance cardiography
were placed on the body surface, a tonometric sensor for
pulse wave analysis on the radial pulsation to the left wrist,
an oscillometric brachial cuff for BP calibration to the right
upper arm and a plethysmographic cuff for finger BP mea-
surement to the right middle finger.
The measurement consisted of six consecutive 5 min
intervals, and haemodynamic data were captured continu-
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ously. At first, the subjects were resting supine on the tilt
table (5 min) followed by head-up tilt to 60 degrees
(5 min), after which the tilt table was returned to the hori-
zontal position (5 min). Sublingual NTG 0.25 mg (Nitro
resoriblet, Orion Pharma, Espoo, Finland) was adminis-
tered, and the same protocol was repeated (5 min supine –
5 min head-up tilt – 5 min supine). If the subject reported
presyncopal symptoms during the 5 min head-up tilt after
NTG (dizziness, light-headedness, sweating, nausea), and
the research nurse observed progressively falling BP, the
tilt table was returned to the horizontal position before the
intended 5 min of head-up tilt were fulfilled.The total mea-
surement time in the control group was 30 min, and in the
presyncope group 27–29 min.Due to the shorter measure-
ment duration in the presyncope group, only the same
amount of data were analyzed from the matched control
subject so that the time scale would be comparable. The
repeatability and reproducibility of the measurement pro-
tocol has been previously demonstrated [13].
To examine the NTG response during an alternative
protocol, 19 study subjects were invited to additional mea-
surements. In this protocol the subjects were resting
supine on the tilt table (5 min) followed by a 15 min
head-up tilt to 60 degrees, after which the tilt table was
returned to the horizontal position (5 min). Then the sub-
jects were tilted to 60 degrees again, and sublingual NTG
0.25 mg was administered after 5 min in the upright posi-
tion, as a distinction from the previous protocol in which
NTG was administered supine. The tilt test was continued
for 20 min after NTG administration, or aborted if the
subject reported presyncopal symptoms.
Pulse wave analysis
Radial BP and pulse wave form were continuously deter-
mined from the radial pulse by an automatic tonometric
sensor (Colin BP-508T, Colin Medical Instruments Corp.,
USA),which was fixed on the radial pulse with a wrist band.
Radial BP signal was calibrated every 2.5 min by a brachial
BP measurement. Continuous aortic BP was derived with
the SphygmoCor pulse wavemonitoring system (Spygmo-
Cor PWMx, AtCor Medical, Australia) using the previously
validated generalized transfer function [14]. Ejection
duration, aortic reflection time and augmentation index
(AIx, augmented pressure/pulse pressure ¥ 100) were
determined.
Whole-body impedance cardiography
A whole-body impedance cardiography device (CircMonR,
JR Medical Ltd,Tallinn, Estonia),which records the continu-
ous changes in body electrical impedance during a cardiac
cycle, and plethysmographic BP recordings from a finger
(Finapres, Ohmeda, Englewood, Colorado, USA) were used
to determine beat-to-beat heart rate (HR), stroke index
(stroke volume in proportion to body surface area,ml m-2),
cardiac index (cardiac output/body surface area,
l min-1 m-2), systemic vascular resistance index (SVRI,
systemic vascular resistance/body surface area,
dyn s cm-5 m-2) and pulse wave velocity (PWV) [15–18]. To
calculate the PWV, the CircMon software measures the
time difference between the onset of the decrease (‘foot’)
in impedance in the whole-body impedance signal and
the popliteal artery signal. From the time difference and
the distance between the electrodes, the PWV can be
determined. The whole-body impedance cardiography
tends to overestimate the PWV when compared with
Doppler ultrasound method, and therefore a validated
equation was utilized to calculate values that corre-
sponded to the ultrasound method (PWV = (PWVimpedance ¥
0.696) + 0.864) [17]. The cardiac output values measured
with CircMonR whole-body impedance cardiography are in
good agreement with the values measured by the ther-
modilution method, both in supine position and during
head-up tilt [15].A detailed description of the method and
electrode configuration has been previously reported
[15–17]. PWV was not assessed during the head-up tilt due
to less accurate timing of left ventricular ejection during
reduced stroke volume.
Statistical analysis
The software package R 2.10.1 was used [19]. To address
the matched pair design of the study, differences between
controls and cases were analyzed. The focus was on the
average of the last minute during head-up tilt in the
absence of NTG (measurement point 4, Figure 1) and
the corresponding last minute in the presence of NTG
(measurement point 10, Figure 1). To adjust for possible
differences between controls and cases already present in
the absence of NTG, the differences of the two differences
(measurement point 4 – measurement point 10, Figure 1)
were used for statistical testing. The general difference
between controls and cases was evaluated using a multi-
variate Wilcoxon signed-rank test based on marginal
signed-ranks for the variables radial mean BP, aortic mean
BP,HR, cardiac index, SVRI, augmentation index (AIx), aortic
pulse pressure and aortic reflection time [20]. Due to the
small sample size a permutation version of the test was
applied using 1000 replications. For further interpretation
the univariate sample quartiles (quartile 1 – median –
quartile 3) were reported and exact marginal Wilcoxon
signed-rank tests results are given. Average graphs with
standard errors of the mean (SEM) are shown in Figure 1,
but the statistical analyses were based on the differences
between individual case-control pairs.
Results
Study population
The presyncope group consisted of 21 subjects (six male
and 15 female) aged 21–61 years (43 (36–53) years), and
the control group of 21 subjects (six male and 15 female)
aged 23–59 years (43 (37–53) years). None of the subjects
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Figure 1
Aortic mean blood pressure (A), heart rate (B), cardiac index (C), systemic vascular resistance index (D), augmentation index (E) and aortic reflection time (F)
in the presyncope (solid circles,n = 21) and control (open circles,n = 21) groups.Averages of the second and last minutes of each study phase are presented.
A passive head-up tilt was performed during measurement points 3–4 and 9–10, and 0.25 mg sublingual nitroglycerin was administered at measurement
point 6. Measurement point 10 is the last minute before tilt abortion. Mean  SEM. Control ( ); Presyncope ( )
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had amedical history of cardiovascular disease or continu-
ous medication. In the presyncope and control groups,
there were one and two current smokers, and six and six
subjects with a previous smoking history, respectively. BMI
of the subjects in the presyncope group was 23.3 (22.0–
27.0) kg m-2 and in the control group 23.8 (21.7–25.9)
kg m-2. Plasma lipid profile, fasting glucose, electrolytes,
and kidney function were all within the normal range, and
all electrocardiograms were normal. In the control group,
the study protocol was carried out completely, as
described above. In the presyncope group, the head-up tilt
after NTG administration was aborted after 3.4  0.2 min
due to presyncopal symptoms and a progressive fall of BP.
In spite of the security measures three subjects in the
presyncope group lost consciousness after NTG, but con-
sciousness was quickly restored when the tilt table was
returned to the supine position. These subjects were
excluded from the final analysis (the original number of
subjects in the presyncope group was 24).
In addition, 19 subjects participated in measurements
using an alternative protocol during which NTG was only
given in the upright position.Ten subjects (six female, four
male) experienced presyncopal symptoms, and the tilt test
was aborted 5.9  0.5 min after NTG administration. Nine
subjects (five female, four male) completed the protocol so
that the tilt test was continued for 20 min after NTG was
given. The basic characteristics of these groups did not
significantly differ. Two subjects classified to the presyn-
cope group in the alternative protocol were originally in
the non-syncope group (when NTG was administered in
supine position), and vice versa. Thus, 79% of the subjects
retained their classification whether NTG was given supine
or during the head-up tilt.
Haemodynamics before NTG administration
Before NTG administration the recordings of the presyn-
copeandcontrol groupsdidnot significantly differ (P>0.05
for all variables presyncope vs. control, Figure 1, Table 1).
During the head-up tilt HR and SVRI increased both in
the presyncope and control groups, while diastolic or sys-
tolic BP did not significantly change in either group when
compared with supine values. The following variables
decreased in response to head-up tilt: aortic pulse pres-
sure, AIx, ejection duration, stroke index and cardiac index.
The change in aortic reflection time was minor in both
groups. All variables except diastolic and systolic BP and
aortic reflection time changed statistically significantly in
both groups during the head-up tilt (P < 0.05 supine vs.
head-up tilt).
Haemodynamics after NTG administration
Supine position before head-up tilt During the 5 min in
the supine position following NTG administration (record-
ing from 15 to 20 min in the protocol), the changes in the
haemodynamic variables were similar in both study
groups (P > 0.05 presyncope vs. non-syncope, Figure 1).
When compared with the supine values before NTG
administration, aortic BP and radial BP decreased in both
study groups. A decrease was also observed in aortic
pulse pressure, AIx and SVRI. In the supine position, NTG
increased cardiac index, HR and aortic reflection time.
The change in stroke index was minor in both groups.
All variables except stroke index changed statistically
significantly after NTG administration when compared
with the supine values before drug administration
(P < 0.05).
Head-up tilt During the head-up tilt with NTG, the
changes in haemodynamics were more pronounced than
without NTG, and the haemodynamic patterns of many of
the variables were completely changed when compared
with the first head-up tilt (Figure 1).The general difference
during the NTG-stimulated tilt-table test between the
study groups for all variables of interest was significant at
the 0.05 level (P = 0.0020). For individual variables this
means that mean aortic BP decreased significantly more in
Table 1
Haemodynamics in the supine position and during head-up tilt in the absence of NTG,median (quartile 1 – quartile 3). No differences between cases and
controls were observed
Supine Head-up tilt
Control Presyncope Control Presyncope
Tonometry
Blood pressure (mm Hg)
Radial systolic 128 (124–134) 127 (116–137) 127 (119–136) 125 (118–130)
Radial diastolic 79 (71–85) 75 (73–83) 79 (73–87) 77 (74–85)
Finger systolic 110 (104–116) 112 (104–119) 105 (103–116) 110 (104–114)
Finger diastolic 59 (51–70) 64 (59–70) 62 (55–74) 64 (60–69)
Aortic pulse pressure 38 (34–43) 37 (32–43) 34 (29–37)* 28 (27–34)*
Ejection duration (ms) 337 (321–347) 339 (324–345) 291 (280–302)* 272 (258–279)*
Impedance cardiography
Stroke index (ml m-2) 52 (45–55) 45 (38–56) 37 (33–39)* 33 (31–37)*
Pulse wave velocity (m s-1) 7.3 (6.8–8.1) 7.3 (6.6–8.8) – –
*P < 0.05 supine vs. head-up tilt.
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the presyncope group (P = 0.0006) than in the control
group, and the same was observed in mean radial BP (P =
0.0004). The decreases in SVRI (P = 0.0008), HR (P = 0.002)
and increase in aortic reflection time (P = 0.0002) were also
greater in the presyncope group than in the control group.
The changes in aortic pulse pressure (P = 0.43), AIx (P =
0.15) and cardiac index (P = 0.14) were not different
between the study groups.
The haemodynamic variables during the last minute
before the tilt-back in both study groups are shown in
Figure 1 and Table 2. In Figure 2, boxplots of the difference
of the matched differences between controls and cases in
the absence and presence of NTG are presented, and the
value ‘0’ indicates that the effect of NTG was not different
between the groups.Table 3 gives the differences between
controls and cases in the absence and presence of NTG,
and a positive sign indicates that controls had larger values
than cases (first and second columns).Statistical results are
based on the differences of these two differences to adjust
for possible dissimilarities in the absence of NTG (measure-
ment point 4, third column). For all differences it was of
interest if they differed significantly from 0.
Haemodynamics in three subjects with
loss of consciousness
During the NTG-stimulated tilt test, three subjects rapidly
lost consciousness after reporting presyncopal symptoms.
The following immediate return of the tilt table to the hori-
zontal position quickly restored consciousness in all sub-
jects. The mean aortic BP, SVRI, cardiac index and HR of
these subjects during the last 90 s before tilt-back are
shown in Figure 3 as individual line-graphs.SVRI decreased
markedly during 90–60 s prior tilt-back (from 2030 to
1520 dyn s cm-5 m-2, Figure 3B) with a simultaneous
decrease in BP (from 76 to 60 mmHg, Figure 3A). During
the last 60 s before tilt-back, SVRI showed a moderate
further decrease, and the values were lower than in the
whole presyncope group (1280 vs. 2100 dyn s cm-5 m-2,P <
0.05). BP remained constant during 60–30 s and cardiac
index during 90–30 s before the tilt-back (Figure 3A and C).
Just before loss of consciousness the recordings showed a
clear decrease in cardiac index, HR and BP (30–0 s before
tilt-back, Figure 3A, C and D).
Alternative measurement protocol: NTG
administration during the head-up tilt
In 19 subjects NTG was administered in the upright posi-
tion and the tilt-table test was continued for up to
20 min, if possible. Aortic mean BP, SVRI and cardiac index
of presyncope and non-syncope groups are shown in
Figure 4. After the administration of NTG in the upright
position, both presyncope and non-syncope groups
showed an initial decrease in SVRI and an increase in
cardiac index. During presyncope, SVRI and BP (radial and
aortic mean BP, aortic pulse pressure) further decreased
and aortic reflection time increased in the presyncope
group, while cardiac index was preserved at a higher level
than it was before NTG administration (Figure 4). During
the last minute in the upright position, SVRI was signifi-
cantly lower (P = 0.001) and aortic reflection time longer
(P = 0.049) in the presyncope group when compared
with the non-syncope group, while there were no statis-
tically significant differences in other variables. The results
Table 2
Haemodynamics in the presence of 0.25 mg NTG (administered supine)
during the last minute prior to tilt-back, median (quartile 1 – quartile 3)
Control Presyncope P value
Tonometry
Blood pressure (mm Hg)
Radial systolic 121 (113–129) 97 (89–108)* <0.001
Radial diastolic 78 (71–82) 63 (55–70)* <0.001
Finger systolic 102 (95–112) 77 (71–91)* <0.001
Finger diastolic 67 (57–79) 52 (47–62)* 0.003
Aortic pulse pressure (mm Hg) 26 (24–30) 22 (18–28) ns
Ejection duration (ms) 245 (240–265) 266 (244–302)* 0.043
Impedance cardiography
Stroke index (ml m-2) 39 (37–43) 37 (35–43) ns
*P < 0.05 non-syncope vs. presyncope.
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Figure 2
Box plots of the difference of the matched differences between controls
and cases in the absence and presence of NTG.The value 0 indicates that
NTG administration had no effect. The general difference between con-
trols and cases for all eight variables of interest is significant at the 0.05
level (P = 0.0020). *P < 0.05 presyncope vs. control for individual variables.
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of the alternative measurement protocol strengthen the
view of decreased peripheral arterial resistance as a cause
for presyncopal symptoms during NTG-stimulated tilt
test.
Discussion
Since the precise mechanism of nitrate-induced syn-
cope is still unclear, the present study examined the
Table 3
Differences between the control and presyncope groups in the absence and presence of NTG (first and second columns), and the difference of these two
differences (third column). For all differences it was of interest whether they differed significantly from 0
Head-up tilt without NTG
(measurement point 4, Figure 1)
Head-up tilt with NGT
(measurement point 10, Figure 1)
Difference in the response
in the absence and presence of NTG
Median (quartile 1 – quartile 3) Median (quartile 1 – quartile 3) Median (quartile 1 – quartile 3)
Mean radial blood pressure (mm Hg) 2.6 (-6.4 to 10.2) 17.4 (7.0 to 23.7) -15.5 (-20.9 to -7.5)*
Mean aortic blood pressure (mm Hg) -0.3 (-6.7 to 9.8) 15.0 (7.3 to 21.0) -13.6 (-20.5 to -5.5)*
Aortic pulse pressure (mm Hg) 4.0 (-0.3 to 7.2) 4.1 (-1.2 to 8.3) 1.1 (-4.2 to 5.0)
Heart rate (beats min-1) -8.8 (-14.9 to -0.85) 4.0 (-9.1 to 14.4) -10.4 (-19.5 to -0.6)*
Cardiac index (l min-1 m-2) -0.02 (-0.34 to 0.26) 0.47 (-0.46 to 0.84) -0.53 (-0.75 to 0.24)
SVRI (dyn s cm-5 m-2) -40 (-778 to 281) 373 (-25 to 817) -474 (-757 to -253)*
Augmentation index (%) 7.8 (-0.6 to 19.2) 3.0 (-6.3 to 12.0) 3.7 (-2.3 to 13.6)
Aortic reflection time (ms) -3.0 (-13.9 to 6.9) -40.1 (-61.6 to -9.1) 36.2 (8.5 to 51.3)*
*P < 0.05, presyncope vs. control.
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Figure 3
Individual graphs of aortic blood pressure (A), systemic vascular resistance index (B), heart rate (C) and cardiac index (D) during the last 90 s of nitroglycerin-
stimulated tilt-table test in three subjects with short-lasting total loss of consciousness.
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haemodynamic alterations in subjects with presyncopal
symptoms during NTG-stimulated tilt-table test. The find-
ings demonstrated that the presyncopal symptoms were
caused by a decrease in arterial resistance, in the absence
of a compensatory increase in cardiac output.
Small doses of nitrates have been traditionally consid-
ered as potent venodilatators, leading to diminished ven-
tricular preload and cardiac output, with a lesser effect on
arterial resistance [4, 21]. Supporting this view, two studies
have suggested a decrease in cardiac output during
presyncope in the nitrate-stimulated tilt test without a
simultaneous decrease in systemic vascular resistance, as
evaluated from the pulsations of indirect finger arterial
pressures [7, 8]. However, the results remain controversial,
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and, for example, Koole et al. found no evidence of
increased venous pooling during nitrate-stimulated tilt
test in patients with a history of vasovagal syncope, as
studied using isotope techniques [22]. In addition, two
reports utilizing either thoracic bioimpedance or echocar-
diography did not support the view of decreased cardiac
filling after NTG administration [9, 23].
In agreement with the present findings, decreased sys-
temic vascular resistance has been previously suggested
as an explanation for the nitrate-stimulated presyncope, as
estimated from the pulsations of finger arterial pressures
or by means of thoracic bioimpedance [9, 24]. Here we
administered NGT in the supine position, followed by the
tilt test 5 min later, while an unmedicated tilt-phase had
preceded the administration of NTG in the previous inves-
tigations [8,21,25]. In the first head-up tilt without NTG,we
observed a major increase in SVRI (>20%, P < 0.05 com-
pared with supine values) as a result of activated vasopres-
sor mechanisms in the upright position [26], and
administration of NTG in the supine position appeared to
sensitize to the decrease in SVRI during the following
head-up tilt. Autonomic nervous tone was not assessed in
the present study, but in addition to its direct vasodilatory
effect NTG can also sensitize the baroreflex arc, thus
leading to reduced sympathetic tone and decreased SVRI
[11]. Reduced SVRI and increased HR after NTG administra-
tion explain why cardiac index was not reduced during the
subsequent head-up tilt.
As in the majority of previous reports, the tilt test in the
present study was aborted in the presyncope group,
except for the three subjects who developed rapid loss of
consciousness just prior to the tilt-back. In these subjects
the decrease of SVRI to a very low level was documented
first,while the final vasovagal reaction and the subsequent
total syncope were accompanied by a decrease in HR and
cardiac index (Figure 3). Also in the whole presyncope
group, HR decreased during the last minute after NTG,
which may be a sign of incipient vasovagal reaction
(Figure 1). However, the HR during presyncope was still
relatively high (~80 beats min-1, Figure 1) and did not
explain the onset of presyncopal symptoms. These find-
ings also imply a possible central sympatho-inhibitory
effect of NTG in the final phase of the tilt test [11].
After the first measurements the possibility remained
that methodological differences between the present and
the previous studies (NTG administered supine vs. upright)
could explain the divergent findings. Therefore, we per-
formed additional measurements with 19 study subjects
to examine the influence of body position on the NTG
response.We found that in those subjects with presynco-
pal symptoms SVRI was reduced clearly more than in the
non-syncope group,while cardiac index increased similarly
in both groups. In addition, 15/19 (79%) subjects
responded similarly to NTG whether the drug was admin-
istered before or during head-up tilt. Altogether, the hae-
modynamic pattern during presyncope remained very
similar whether NTG was administered in the supine or
upright position.
In addition to decreased SVRI, in the present study NTG
increased aortic reflection time and decreased pulse pres-
sure, further supporting the view of decreased arterial
resistance [27, 28]. A decrease in AIx was also observed in
both study groups, probably due to increased compliance
and reduced SVRI subsequently shifting the reflectedwave
towards diastole [29].However, increased HR decreases the
duration of systole and also shifts the reflected wave
towards diastole, thus diminishing the AIx. We observed
that AIx remained decreased during the last 5 min of the
protocol when compared with values before NTG admin-
istration (14  3% before and -11  2 after NTG), during
which period HR had already returned to the level preced-
ing NTG (not shown). Thus, decreased AIx was not solely
explained by increased HR, but rather reflected the effects
of NTG on wave reflection, large arterial compliance and
SVRI. Since the AIx, PWV or aortic reflection time did not
differ between the study groups at baseline, increased
arterial stiffness or different mechanical properties of the
large arteries were clearly not explanations for increased
sensitivity to NTG.
In the literature, a wide scale of methodological proto-
cols in nitrate-stimulated tilt tests has been presented [30].
NTG doses ranging from 0.3 to 0.8 mg have been used,but
this range of doses has not markedly affected the specific-
ity or sensitivity of the tilt test when used as a diagnostic
test for unexplained syncope [30]. Commonly, a passive
upright tilt phase of 20–60 min has preceded the adminis-
tration of NTG, which has been given in the upright posi-
tion, and the duration of the stimulated tilt phase has
varied from 10 to 30 min [25, 30, 31].Although NTG admin-
istration has shortened the protocol when compared with
the unstimulated tilt test, the test duration has remained
rather long. Recently, a shorter 30 min tilt test protocol
without a preceding unstimulated tilt phase has been pre-
sented [32].
The present continuous measurement protocol pro-
vides comprehensive haemodynamic information, and the
cardiac output values measured with CircMonR whole-
body impedance cardiography are in good agreement
with the values measured by the thermodilution method,
both in the supine position and during head-up tilt [15].By
simultaneously determining peripheral and central BP, AIx,
PWV, cardiac function and systemic vascular resistance we
could continuously monitor haemodynamics during both
unmedicated and NTG-stimulated tilt tests, in contrast to
the approach where only the changes in NTG-stimulated
tilt test would have been documented [7, 33]. Indeed,
already a short (5 min) tilt-table test in the absence of NTG
clearly increased SVRI and HR, and decreased cardiac
index, stroke index, pulse pressure and AIx, while all of
these changes were significantly influenced by NTG. Cor-
responding to previous results, BP measured from a finger
(plethysmographic cuff) and BP from the radial artery
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(pulse wave analysis, Tables 2 and 3) showed a systematic
difference due to the different methodology and anatomi-
cal site of the measurements [34]. Arteries progressively
narrow towards the periphery, and in general mean finger
arterial pressure is lower than BP measured more proxi-
mally as a result of the pressure gradient in the arterial tree
caused by flow [34]. In the present study the changes in
both finger and radial artery BP values in response to
head-up tilt and NTG administration were corresponded
well.
Most of the previous studies have been designed to
evaluate the test outcome, i.e. to uncover whether the sub-
jects develop syncope or not, while the purpose of the
present study was to examine the NTG-induced haemody-
namic changes in presyncope. The aim was not to study
the sensitivity or specificity of the protocol, and the sub-
jects in the presyncope group had not spontaneously
reported unexplained syncope in their medical history.
Indeed, the diagnostic use of the present protocol in syn-
copal patients should be evaluated in the future.However,
in previous reports control subjects with no history of
syncope have shown parallel haemodynamic changes
with the study subjects, but the changes were more pro-
nounced in subjects with a history of syncope [7]. Finally,
age may influence the haemodynamic pattern observed
during NTG-induced presyncope, with younger subjects
showing amore sudden fall of BPwhen comparedwith the
older ones [8]. In the present analysis, age was used as a
matching variable in control subject selection and its
effect on the results has thus been eliminated. Although
the study population was relatively small, the present
number of subjects was similar to those in the majority of
the previous studies [25, 35].
In conclusion, a major decrease in SVRI and an increase
in aortic reflection time were documented in subjects with
presyncope during NTG-stimulated tilt test, in the absence
of changes in cardiac index.These findings do not support
the view of decreased cardiac filling and preload as plau-
sible mechanisms for the NTG-induced presyncope but
indicate that a small dose of NTG significantly decreases
arterial resistance and cardiac afterload.
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a b s t r a c t
Objective: Ageing is associated with increased postural blood pressure changes and attenuated cardiovas-
cular reactivity. As the background of these changes remains uncertain, we examined arterial stiffness,
cardiac function and vascular resistance in healthy subjects in supine position and during orthostatic
challenge.
Methods: Haemodynamics of 179 normotensive subjects (109 female and 70 male, 21–59 years) were
examined using continuous radial pulse wave analysis, whole-body impedance cardiography, and plethys-
mographic ﬁnger blood pressures.
Results: Both in supine position and during head-up tilt central and peripheral blood pressure and aug-
mentation index (amplitude of the reﬂected pressure wave divided by pulse pressure) increased, and
time of pulse wave reﬂection decreased with age. Supine pulse wave velocity progressively increased
with age. There were only minor differences in supine and upright systemic vascular resistance, cardiac
index, stroke index, and heart rate that were not systematically related to age. In regression analysis, the
explanatory factors for a more pronounced decrease in central systolic blood pressure during the head-up
tilt were in the age of 50–59 years, higher baseline pulse wave velocity and central systolic BP. None of
the changes in other haemodynamic variables during tilt were related to age.
Conclusion: As no systematic age-related differences were observed in cardiac function or vascular resis-
tance, these results support the view that progressive reduction of large arterial compliance contributes
latedto the exaggerated age-re
. Introduction
Ageing is associated with progressive structural and functional
hanges in the cardiovascular system. With increasing age large
rteries dilate and stiffen as a result of thickening of the intima,
educed elastin content and vascular smooth muscle cell number,
nd increased collagen composition in the vessel wall [1–3]. Stiffen-
ng of the arteries leads to increased pulse wave velocity (PWV) and
arlier wave reﬂection, thus increasing systolic and pulse pressure
nd decreasing perfusion of the myocardium during the diastole
3,4]. Young, compliant arteries cushion the arterial pulsations so
hat the ﬂow in the capillary level remains continuous [3]. Reduced
rterial compliance transfers pulsatile ﬂow further to the periphery,
hich has harmful inﬂuences in the microcirculation [5]. Ageing is
∗ Corresponding author. Tel.: +358 3 3551 8306; fax: +358 3 3551 6164.
E-mail address: anna.tahvanainen@uta.ﬁ (A. Tahvanainen).
021-9150/$ – see front matter © 2009 Elsevier Ireland Ltd. All rights reserved.
oi:10.1016/j.atherosclerosis.2009.06.001decrease in central systolic blood pressure in response to head-up tilt.
© 2009 Elsevier Ireland Ltd. All rights reserved.
also associated with impairments in nitric oxide and prostanoid
pathways, resulting in endothelial dysfunction [6]. Today arterial
stiffening is recognized as an independent risk factor for cardiovas-
cular morbidity and mortality [7].
Circulatory regulation becomes attenuated with increasing age.
For example, the prevalence of orthostatic hypotension is greater
among elderly when compared with younger subjects, but the
determinants of postural blood pressure (BP) changes are not com-
pletely understood [8]. Changes in baroreﬂex sensitivity, arterial
stiffness, humoral regulation or blood volume distribution may play
a role [9–11]. Only few studies have examined the head-up tilt
induced simultaneous changes in central haemodynamics, arterial
stiffness, systemic vascular resistance and cardiac function.Here we tested the hypothesis whether reduced large arterial
compliance with increasing age could explain putative differences
in the cardiovascular responses induced by passive orthostatic chal-
lenge. We examined haemodynamics in 179 healthy, normotensive
in young to middle-aged adults utilizing continuous whole-body
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mpedance cardiography, radial pulse wave analysis and BP record-
ng from ﬁngers.
. Methods
.1. Study subjects
The study population was 179 healthy individuals, who were
ivided into four age groups: 20–29 (n = 34), 30–39 (n = 40), 40–49
n = 53) and 50–59 (n = 52) years. All subjects underwent a physical
xamination, and lifestyle habits, family history for cardiovascular
isease, and medical history were documented. All subjects gave
written informed consent. The study complies with the declara-
ion of Helsinki, and was approved by the ethics committee of the
ampere University Hospital.
.2. Laboratory analyses
Blood and urine samples were obtained after a minimum of 12-h
ast, and a standard 12-lead electrocardiogram was recorded. Blood
ell count was determined by ADVIA 120 or 2120 (Bayer Health Care,
arrytown, NY, USA), and other laboratory values by Cobas Integra
00/800 (F. Hoffmann-LaRoche Ltd., Basel, Switzerland). Glomeru-
ar ﬁltration rate was estimated using the Cockroft–Gault formula
12].
.3. Heamodynamic measurement protocol
Measurements were performed by a trained nurse, and the sub-
ects had refrained from caffeine, smoking and heavy meal for at
east 4 h and from alcohol for at least 24 h prior to the investiga-
ion. The electrodes for impedance cardiography were placed on
he body surface, a tonometric sensor for pulse wave analysis on
he radial pulsation to the left wrist, a brachial cuff for BP calibra-
ion (every 2.5 min) to the right upper arm, and a plethysmographic
uff for ﬁnger BP measurement to the right middle ﬁnger.
The subjects were ﬁrst resting supine on the tilt table (5 min)
ollowed by head-up tilt to 60◦ (5 min), after which tilt table was
eturned to the horizontal position (5 min), and data was cap-
ured continuously. The good repeatability and reproducibility of
he measurement protocol both at rest and during head-up tilt have
een demonstrated [13]..4. Pulse wave analysis
Radial BP and pulse waveform were continuously determined
y a tonometric sensor (Colin BP-508T, Colin Medical Instruments
able 1
haracteristics of the study population.
20–29 years 30
umber of subjects 34 40
emale/male 21/13 24
ody mass index (kg/m2) 23.1 (22.0–25.8) 23
aist circumference (cm) 84 (75–85) 81
moking status (present or previous/never) 11/23 12
lcohol consumption, doses/week (≤3/>3) 13/21 7/2
ornell voltage product (ms × mm) 1558 (1227–1744) 14
adial systolic BP (mmHg) 125 (115–129) 13
adial diastolic BP (mmHg) 74 (70–78) 80
ulse wave velocity (m/s) 8.40 (7.62–8.82) 9.1
-reactive protein (mmol/l) 0.7 (0.5–1.1) 0.9
DL cholesterol (mmol/l) 1.7 (1.5–2.0) 1.5
DL-cholesterol (mmol/l) 2.0 (1.6–2.4) 2.2
riglycerides (mmol/l) 0.8 (0.6–1.1) 0.8
reatinine (mol/l) 74 (65–82) 71
or smoking status and alcohol consumption the numbers do not add up to 179 due to m
* p < 0.05 compared with 20–29-year-old subjects.
# p < 0.05 compared with 30–39-year-old subjects.
† p < 0.05 compared with 40–49-year-old subjects.rosis 207 (2009) 445–451
Corp., USA). Aortic BP was derived with the pulse wave monitor-
ing system (SpygmoCor PWMx, AtCor Medical, Australia) using a
validated transfer function [14]. Ejection duration (ms), time to
pulse wave reﬂection (time to return of the reﬂection wave of the
aortic waveform, ms) and augmentation index (%, augmented pres-
sure/pulse pressure × 100) were determined.
2.5. Impedance cardiography
A whole-body impedance cardiography device (CircMon, JR
Medical Ltd., Tallinn, Estonia), and plethysmographic BP record-
ings from ﬁngers (Finapres, Ohmeda, Englewood, CO, USA) were
used to determine beat-to-beat heart rate, stroke index (stroke vol-
ume/body surface area, ml/m2), cardiac index (cardiac output/body
surface area, l/min/m2), systemic vascular resistance index (SVRI,
systemic vascular resistance/body surface area, dyn s/(cm5 m2))
and PWV (m/s) [15,16]. The description and the repeatability of
the method have been previously reported [15,16]. PWV was not
assessed during the head-up tilt due to less accurate timing of left
ventricular ejection during reduced stroke volume [15,16].
2.6. Statistical analysis
The software package R 2.8.1 was used [17]. The data contained
artifacts for example due to movements of the subjects during the
experiment or re-calibration of the machines. Therefore, robust and
nonparametric methods were applied instead of the classical meth-
ods to allow for outliers and heavy tails in the data.
As descriptive summary the three sample quartiles, denoted as
Q1, Q2 and Q3, were reported (Table 1). Univariate one-way ANOVA
was performed using the Kruskal–Wallis test and independence
in two-way contingency tables was evaluated using Fisher’s exact
test. As information about alcohol consumption or smoking was
not available from all subjects, division to fewer subgroups was
performed to increase the power of the multivariate analysis. All
participants with the exception of two subjects consumed none to
moderate amounts of alcohol, and for the statistical analysis the
subjects were divided into two subgroups: ≤3 alcohol doses/week
and >3 alcohol doses/week. Smoking status was divided into two
groups: present or previous smoker versus subjects who never
smoked.
To evaluate haemodynamic differences between the four age
groups, stratiﬁed multivariate c-sample tests were performed. The
test applied here was the afﬁne equivariant version of the spatial
sign test and as corresponding point estimate the afﬁne equivariant
–39 years 40–49 years 50–59 years
53 52
/16 30/23 34/18
.8 (22.0–27.5) 25.9 (22.8–28.7)* 26.8 (23.5–31.5)*,#
(73–95) 90 (80–96)* 95 (83–102)*,#
/20 12/26 10/13
6 14/23 11/11
23 (1067–1805) 1360 (1104–1710) 1562 (1242–1924)
0 (121–137)* 133 (123–139)* 136 (129–140)*,#
(73–84)* 83 (76–89)*,# 84 (79–88)*,#
4 (8.14–10.37)* 10.22 (8.82–11.95)* 11.34 (10.10–13.30)*,#,†
(0.5–2.2) 0.7 (05–1.1) 1.0 (0.7–1.8)
(1.2–1.9) 1.5 (1.3–1.8) 1.6 (1.3–1.9)
(2.1–3.0)* 2.8 (2.2–3.2)* 3.2 (2.6–3.6)*,#,†
(0.6–1.4) 1.0 (0.7–1.4) 1.1 (0.7–1.6)
(66–81) 74 (67–83) 72 (62–78)
issing values.
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ersion of the spatial median was reported [18]. Stratiﬁcation was
one separately for sex, smoking, alcohol consumption level and
or a binary indicator based on a canonical analysis between other
onfounding variables (baseline BP, augmentation index, PWV, aor-
ic reﬂection time, waist and hip circumference, cholesterol status,
ematocrit, C-reactive protein, estimated glomerular ﬁltration rate,
ornell voltage product) and the response.
A robust linear MM-regression [19] was used to model the reac-
ion of a subject to the tilt-table test. The model selection was
erformed using the smallest complete subset and successively
emoving the explanatory variable with the highest p-value (>0.05),
hile always keeping age as the variable of interest in the model.
ll explanatory variables entered the model linearly and no interac-
ions were considered. The ﬁnal model was reﬁtted using the largest
ossible subset of the data and the model assumptions graphi-
ally evaluated. A difﬁculty of the model ﬁtting was the correlationthe numerical explanatory variables used in the regression analysis.
between several explanatory variables (multicollinearity problem,
i.e. an explanatory variable in the ﬁnal model might rather stand
for a group of variables). The correlation structure of the variables
can be evaluated by the correlogram in Fig. 1, which is based on the
correlation matrix of the MCD [19].
3. Results
3.1. Study populationThe demographic data is shown in Table 1. The 179 healthy sub-
jects (109 females and 70 males) aged 21–59 years were divided
into four groups according to age (20–29, 30–39, 40–49 and 50–59
years). The proportion of females and males did not signiﬁcantly
differ between the groups. None of the subjects had a medical his-
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ory for cardiovascular disease or continuous medication. Smoking
abits or alcohol consumption did not differ between the study
roups. Blood cell count, plasma lipid proﬁle, fasting glucose, elec-
rolytes, and kidney function were all within the normal range, and
ll electrocardiograms were normal.
BMI and waist circumference of subjects aged 20–29 years were
ower than in 40–49- and 50–59-year-old subjects, and those of
0–39-year-old subjects were lower than in 50–59-year-old sub-
ects (p < 0.05, Table 1). Estimated glomerular ﬁltration rate was
igher in 20–29-year-old subjects when compared with 40–49-
nd 50–59-year-old subjects, and in 30–39-year-old subjects when
ig. 2. Spatial medians and standard errors for aortic systolic* (A) and diastolic blood pre
ugmentation index* (F) of study subjects aged 20–29, 30–39, 40–49 and 50–59 years. A
ge-related difference before and after adjustment for sex or other confounding variablesrosis 207 (2009) 445–451
compared with 50–59-year-old subjects (p < 0.05, Table 1). Plasma
LDL-cholesterol increased with age (p < 0.05), and the only com-
parison without statistical signiﬁcance was between 30–39- and
40–49-year-old subjects (p = 0.07) (Table 1). Other laboratory values
did not differ between the study groups.3.2. Haemodynamics
Data captured during the 15-min protocol is shown in
Figs. 2 and 3. There was a signiﬁcant age-dependent difference
in aortic (Fig. 2A) and radial systolic BP and aortic pulse pressure
ssure† (B), aortic pulse pressure* (C), heart rate* (D), aortic reﬂection time* (E) and
passive head-up tilt was performed from 5 to 10 min of the protocol. *A signiﬁcant
(p < 0.05). †A signiﬁcant age-related difference after adjustment for sex (p < 0.05).
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Fig. 3. Spatial medians and standard errors of cardiac index (A), stroke index (B)
and systemic vascular resistance index* (C) of study subjects aged 20–29, 30–39,A. Tahvanainen et al. / Athe
Fig. 2C) with older subjects showing higher values (p < 0.05). These
ifferences remained signiﬁcant after adjustment for sex or other
onfounding variables as presented in methods (p < 0.05). There
as also a signiﬁcant age-dependent difference in aortic and radial
iastolic BP (Fig. 2B) after adjustment for sex (p < 0.05), but the
ifference was no more signiﬁcant after adjusting for other con-
ounding variables. Smoking status or alcohol consumption did not
ave an inﬂuence on BP.
Heart rate of male and female subjects differed by age in the
tatistical analysis, but the spatial median values did not show a
ystematic increase or decrease with age (Fig. 2D). The difference
n heart rate was also signiﬁcant after adjustment for confounding
actors. Heart rate differed also by the smoking status and the level
f alcohol consumption (p < 0.05), so that the smokers and subjects
onsuming more alcohol had a higher heart rate during the head-up
ilt but not in the supine position.
Aortic reﬂection time decreased and augmentation index
ncreased in both sexes with age, and there was a signiﬁcant age-
elated difference before and after adjustment for confounding
ariables (p < 0.05, Fig. 2E). Smoking status did not have an inﬂuence
n the level of augmentation or the time of pulse wave reﬂection,
ut aortic reﬂection time differed by the level of alcohol consump-
ion (p < 0.05). The difference was only observed during the tilt, so
hat lower alcohol consumption corresponded to a lesser decrease
n aortic reﬂection time.
There was no age-related difference in cardiac index or in stroke
ndex (Fig. 3A and B) (p > 0.05, Fig. 3). There was a general age-
elated difference in SVRI, but after adjustment for sex or other
onfounding variables the difference was no more statistically sig-
iﬁcant (Fig. 3C). PWV increased signiﬁcantly with age in both sexes
efore and after adjustment for confounders (p < 0.05, Table 1). Car-
iac index, stroke index, SVRI or PWV did not differ by smoking
tatus or the level of alcohol consumption.
.3. Haemodynamic responses to head-up tilt
All haemodynamic variables changed signiﬁcantly during tilt
illustrated in Figs. 2 and 3). A robust linear MM-regression was
pplied to model whether the magnitudes of the changes differed
y age. The age of 50–59 years was a signiﬁcant explanatory fac-
or for the change in aortic systolic BP during the head-up tilt
p = 0.007), with older subjects showing more pronounced decrease
hen compared with younger ones. In addition, baseline PWV
p = 0.001) and central systolic BP (p < 0.001) remained signiﬁcant
xplanatory factors in the ﬁnal regression model for the change.
owever, age was not an explanatory factor for the observed
hanges in the other variables in the regression analysis, but the
aseline level of each variable (i.e. the value in the ﬁrst measure-
ent point) remained in all ﬁnal models. For example, the change
n aortic reﬂection time (Fig. 2E) clearly differed between the dif-
erent age groups. However, in the regression analysis age was not
ut the baseline value of the reﬂection time and PWV were signif-
cant explanatory factors for the change (p < 0.05). As stated in the
ethods, an explanatory variable in the ﬁnal model might stand for
group of variables due to multicollinearity (Fig. 1).
. Discussion
The present study showed that large arterial stiffness – reﬂected
s higher augmentation index, aortic pulse pressure, aortic reﬂec-
ion time, and PWV – increased with age, while only minor
ifferences were observed in cardiac function and vascular resis-
ance in the normotensive subjects of different ages. In response
o head-up tilt, the decrease in aortic systolic BP was greatest in
he highest age group, and higher baseline PWV and central sys-
olic BP were signiﬁcant explanatory factors for a more pronounced40–49 and 50–59 years. A passive head-up tilt was performed from 5 to 10 min of
the protocol. *A signiﬁcant age-related difference before but not after the adjustment
for confounding variables.
decrease. The present ﬁndings suggest that reduced arterial com-
pliance contributes to this age-related change during the tilt-table
test.
Increased arterial stiffness is an independent risk factor for car-
diovascular morbidity and mortality [7], and the close association
between ageing and large arterial stiffness has been well demon-
strated [4]. However, ageing does not seem to affect the mechanical
properties of smaller, muscular arteries to the same extent [20]. As
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ushioning of the pulsations generated by the heart is impaired due
o decreased arterial compliance, blood ﬂow in the microcirculation
ecomes pulsatile, which may damage the circulation especially in
he brain and the kidney [5,21]. In the present study, augmentation
ndex, PWV, and aortic pulse pressure increased and aortic reﬂec-
ion time decreased with age, indicating increased arterial stiffness
4]. It should be noted that augmentation index and PWV differed
igniﬁcantly already in younger age groups, while aortic pulse pres-
ure increased only after the age of 50 years (Fig. 2C). This suggests
hat aortic pulse pressure is not a sensitive marker of arterial stiff-
ess. As cardiac output, stroke volume, heart rate and SVRI did
ot systematically differ between the age groups, both cardiac and
mall artery function appeared to be maintained with increasing
ge in the present study.
Reduced arterial compliance and ageing have been linked to
mpaired haemodynamic regulation, for example to increased inci-
ence of orthostatic hypotension [10,22], but the mechanisms of
ifferent postural BP changes at different ages are not clear. As one
xplanation, decreased baroreﬂex sensitivity and attenuated heart
ate response to head-up tilt have been observed with increasing
ge [9], and arterial stiffness at sites rich of baroreceptors may
urther decrease baroreﬂex sensitivity [22]. In the present study,
he heart rate and SVRI responses to head-up tilt were preserved
n the 50–59-year-old subjects, indicating that baroreﬂex sensitiv-
ty was not impaired, in spite of several haemodynamic markers
f increased arterial stiffness. In previous studies differences in
umoral regulation, for example decreased plasma renin activity in
lder subjects, have also been suggested to impair upright haemo-
ynamics [11]. In addition, changes in blood volume distribution
ay play a role in the different haemodynamic responses to pos-
ural changes, with older people showing evidence of increased
enous pooling and decreased cardiac output in the upright posture
23].
We performed a regression analysis to examine whether the
aemodynamic changes during the head-up tilt differed by age.
ortic systolic BP decreased more with advancing age during the
ilt, and in the age of 50–59 years, baseline PWV, and central systolic
P remained as explanatory factors in the ﬁnal regression model.
owever, the increases in heart rate and SVRI were well preserved,
hile augmentation index, stroke index and cardiac index showed
similar decrease in all age groups. Thus, there were no signs of
ttenuated heart rate response or increased venous pooling dur-
ng tilt in up to 59-year-old normotensive subjects. In the younger
ubjects aortic reﬂection time decreased during the head-up tilt,
hile it hardly changed in the older age groups (Fig. 2E). Decreased
ulse wave reﬂection time during the tilt in younger subjects shifts
he reﬂected wave towards systole and prevents a reduction in sys-
olic BP (Fig. 2A). As the time of pulse wave reﬂection does not
hange during the tilt in older subjects, the simultaneous decrease
n cardiac index results in a decreased systolic BP. Baseline aortic
eﬂection time and PWV were signiﬁcant explanatory factors also
or the change in reﬂection time during the tilt. Taken together,
hese ﬁndings indicate that increased large arterial stiffness largely
ontributes to the observed age-related haemodynamic changes in
esponse to head-up tilt. However, the cross-sectional design could
e considered as a study limitation. The present study addresses
hether the responses differ in subjects of different ages, but a lon-
itudinal study is needed to examine how these responses change
n an individual with ageing.
The demographics of the study groups were well correspond-
ng except for higher BMI and LDL-cholesterol levels in the older
ge groups, and higher estimated glomerular ﬁltration rate in the
ounger age groups. Previously, an association between cholesterol
evel and arterial stiffness has been demonstrated in hypercholes-
erolemic patients in some [24] but not all studies [25], and it has
een shown that even in a population without atherosclerosis arte-rosis 207 (2009) 445–451
rial compliance decreases with increasing age [26]. It is unlikely that
the differences in subject characteristics were the primary explana-
tions for the observed haemodynamic differences with increasing
age, since they were included as confounding factors in the multi-
variate and regression analyses.
In conclusion, the present results demonstrated that arterial
stiffness increased with age in 21–59-year-old subjects, while only
minor differences were observed in the regulation of vascular resis-
tance or cardiac function that were not systematically related to age.
Altogether, the observed differences in cardiovascular responses to
passive head-up tilt were largely explained by reduced large arterial
compliance with increasing age.
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